CA2285001A1 - Catheters and related devices for forming passageways between blood vessels or other anatomical structures - Google Patents
Catheters and related devices for forming passageways between blood vessels or other anatomical structures Download PDFInfo
- Publication number
- CA2285001A1 CA2285001A1 CA002285001A CA2285001A CA2285001A1 CA 2285001 A1 CA2285001 A1 CA 2285001A1 CA 002285001 A CA002285001 A CA 002285001A CA 2285001 A CA2285001 A CA 2285001A CA 2285001 A1 CA2285001 A1 CA 2285001A1
- Authority
- CA
- Canada
- Prior art keywords
- catheter
- passageway
- lumen
- imaging
- location
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
- A61B17/3421—Cannulas
- A61B17/3439—Cannulas with means for changing the inner diameter of the cannula, e.g. expandable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/1204—Type of occlusion temporary occlusion
- A61B17/12045—Type of occlusion temporary occlusion double occlusion, e.g. during anastomosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2493—Transmyocardial revascularisation [TMR] devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B17/0643—Surgical staples, i.e. penetrating the tissue with separate closing member, e.g. for interlocking with staple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3478—Endoscopic needles, e.g. for infusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1477—Needle-like probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
- A61B2017/00252—Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
- A61B2017/003—Steerable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00491—Surgical glue applicators
- A61B2017/00504—Tissue welding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
- A61B2017/1107—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis for blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
- A61B2017/1139—Side-to-side connections, e.g. shunt or X-connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/12127—Double occlusion, e.g. for creating blood-free anastomosis site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22067—Blocking; Occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22068—Centering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22069—Immobilising; Stabilising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22072—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/30—Surgical pincettes without pivotal connections
- A61B2017/306—Surgical pincettes without pivotal connections holding by means of suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B2017/347—Locking means, e.g. for locking instrument in cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1425—Needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/08—Accessories or related features not otherwise provided for
- A61B2090/0807—Indication means
- A61B2090/0811—Indication means for the position of a particular part of an instrument with respect to the rest of the instrument, e.g. position of the anvil of a stapling instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic
- A61B2090/3929—Active markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
- A61B8/4444—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to the probe
- A61B8/445—Details of catheter construction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
- A61B8/4483—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device characterised by features of the ultrasound transducer
- A61B8/4488—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device characterised by features of the ultrasound transducer the transducer being a phased array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/40—Apparatus fixed or close to patients specially adapted for providing an aseptic surgical environment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30079—Properties of materials and coating materials magnetic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/009—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof magnetic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
- A61M25/0075—Valve means
- A61M2025/0076—Unidirectional valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
- A61M2025/0089—Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip
- A61M2025/009—Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip the needle having a bent tip, i.e. the needle distal tip is angled in relation to the longitudinal axis of the catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0133—Tip steering devices
- A61M25/0141—Tip steering devices having flexible regions as a result of using materials with different mechanical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0133—Tip steering devices
- A61M25/0147—Tip steering devices with movable mechanical means, e.g. pull wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0133—Tip steering devices
- A61M25/0155—Tip steering devices with hydraulic or pneumatic means, e.g. balloons or inflatable compartments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
Abstract
The inventions described in this patent application include i) a torqueable introducer sheath which is useable in conjunction with a transvascular passageway forming catheter to effect precise rotational control of the catheter; ii) an anchorable guide catheteer which is useable in conjunction with an intravascular imaging catheter and a transvascular passageway-forming catheter to effect precise positioning and aiming of the passageway-forming catheter; iii) a passageway-forming catheter having a torqueable proximal portion to facilitate precise rotational positioning of the distal portion of the catheter; iv) a deflectable-tipped passageway forming catheter, v) various markers and other apparatus useable in conjunction with any of the passagewayforming catheters to facilitate precise positioning and aiming of the catheter, and vi) an apparatus which may be formed within a catheter to prevent a member, apparatus of flow of material from being inadvertently advanced through a lumen of the catheter.
Description
CATHETERS AND RELATED DEVICES FOR FORMING PASSAGEWAYS
' S BETWEEN BLOOD VESSELS OR OTHER ANATOMICAL STRUCTURES
Related Application This patent application is a continuation-in-part oT
l0 co-pending United States Pater_t Application's Serial No. 08/730,327 filed October 11, 1996 and 08/730,=96 piled October 11, 1996, the entire disclosures of which are expressly ir_corporated herein by rezerer~ce.
Field of the Invention 15 The present invention relates generally to medical devices and methods, and more particularly to Catheters, catheter posi ti or_ing/ai;ning systems, ar_d related methods for forming interstitial passageways (e. g., interstitial tunnels) between two or more adjacently situated blood 2o vessels or other anatomical structures.
Background of the Invention Applicant has invented novel methods for bypassing obstructions in arteries and for performing other transvascular medical procedures, whereir_ a catheter device 25 is inserted transluminally into the blood vessel cr other luminal anatomical structure and a tissue-pene4ratir_g element (e.g., a puncturing member or a flow of energy) is passed out of the catheter, through the wall of the blood vessel or other anatomical structure in which the catheter 30 is positioned, and into a second blood vessel or other target anatomical structure. In this manner one or more interstitial passageways is/are formed from the blood vessel or other luminal structure in which the catheter is positioned, to a second blood vessel or other target 35 tissue. These transvascular procedures, ar_d certain WO 98/46119 PCT/fJS98/07134 passageraay forming catheters which are useable to perform these procedures, have previously been described in United States Patent Applications Serial No. 08/730,327 entitled METHODS AND APPARATUS FOR BYPASSING ARTERIAL
OBSTRUCTIONS AND/OR PERFORMING OTHER TRANSVASCULAR
PROCEDURES, filed on October 11, 1996 and 08/730,496 entitled, A DEVICE, SYSTEM AND METHOD FOR INTERSTITIAL
TRANSVASCULAR INTERVENTION, filed October 11, 1996.
In performing the above-summarized transvascular procedures, it is important that the passageway-forming catheter be properly positioned and oriented within the body in the order to ensure that the tissue-penetrating element will form the desired interstitial passageway, at the desired location. If the catheter is improperly positioned or improperly oriented, the resultant passageways) may fail to perform their intended function (e.g., to channel blood from one location to another) or the tissue penetrating element of the catheter may perforate or traumatize tissues) other than those intended to be canalized.
In many of the passageway-forming catheters devised by applicant, it is necessary to precisely control the rotational orientation of the catheter in order to accomplish the desired aiming of the tissue-penetrating element. However, when the passageway-forming catheter is formed of relatively small diameter, thin-walled polymeric material capable of navigating small, tortuous blood vessels, the catheter shaft may lack sufficient structural integrity to efficiently transfer torque from the proximal end of the catheter to the distal end thereof. Such diminished torque transfer of the catheter shaft can prevent or interfere with the precise rotational orientation and positioning of the distal portion of the catheter prior to formation of the extravascular passageway.
' S BETWEEN BLOOD VESSELS OR OTHER ANATOMICAL STRUCTURES
Related Application This patent application is a continuation-in-part oT
l0 co-pending United States Pater_t Application's Serial No. 08/730,327 filed October 11, 1996 and 08/730,=96 piled October 11, 1996, the entire disclosures of which are expressly ir_corporated herein by rezerer~ce.
Field of the Invention 15 The present invention relates generally to medical devices and methods, and more particularly to Catheters, catheter posi ti or_ing/ai;ning systems, ar_d related methods for forming interstitial passageways (e. g., interstitial tunnels) between two or more adjacently situated blood 2o vessels or other anatomical structures.
Background of the Invention Applicant has invented novel methods for bypassing obstructions in arteries and for performing other transvascular medical procedures, whereir_ a catheter device 25 is inserted transluminally into the blood vessel cr other luminal anatomical structure and a tissue-pene4ratir_g element (e.g., a puncturing member or a flow of energy) is passed out of the catheter, through the wall of the blood vessel or other anatomical structure in which the catheter 30 is positioned, and into a second blood vessel or other target anatomical structure. In this manner one or more interstitial passageways is/are formed from the blood vessel or other luminal structure in which the catheter is positioned, to a second blood vessel or other target 35 tissue. These transvascular procedures, ar_d certain WO 98/46119 PCT/fJS98/07134 passageraay forming catheters which are useable to perform these procedures, have previously been described in United States Patent Applications Serial No. 08/730,327 entitled METHODS AND APPARATUS FOR BYPASSING ARTERIAL
OBSTRUCTIONS AND/OR PERFORMING OTHER TRANSVASCULAR
PROCEDURES, filed on October 11, 1996 and 08/730,496 entitled, A DEVICE, SYSTEM AND METHOD FOR INTERSTITIAL
TRANSVASCULAR INTERVENTION, filed October 11, 1996.
In performing the above-summarized transvascular procedures, it is important that the passageway-forming catheter be properly positioned and oriented within the body in the order to ensure that the tissue-penetrating element will form the desired interstitial passageway, at the desired location. If the catheter is improperly positioned or improperly oriented, the resultant passageways) may fail to perform their intended function (e.g., to channel blood from one location to another) or the tissue penetrating element of the catheter may perforate or traumatize tissues) other than those intended to be canalized.
In many of the passageway-forming catheters devised by applicant, it is necessary to precisely control the rotational orientation of the catheter in order to accomplish the desired aiming of the tissue-penetrating element. However, when the passageway-forming catheter is formed of relatively small diameter, thin-walled polymeric material capable of navigating small, tortuous blood vessels, the catheter shaft may lack sufficient structural integrity to efficiently transfer torque from the proximal end of the catheter to the distal end thereof. Such diminished torque transfer of the catheter shaft can prevent or interfere with the precise rotational orientation and positioning of the distal portion of the catheter prior to formation of the extravascular passageway.
Additionally, to facilitate the use of anv on-board imaging system (e. g., an intravascular ultrasound system inserted or built into the passageway-forming catheter) or any separate intracorporeal or extracorporeal imaging services intended to assist in the precise aiming of the tissue-penetrating element, it is desi rable for the ti ssue-penetrating catheter to be provided with appropriate markers or other indicia to enable the operator to utilize to discern the present rotational orientation ar_d position of the catheter and the projected path or the tissue-penetrating element.
Thus, there remains a need in the art for further development and modification of applicant's previously described passageway-forming catheter devices so as to provide for i) improved torque transfer to the distal portion of the catheter and- ii) precise rotational orientation and aiming of the catheter prior to deployment of the tissue penetrating element.
Summary of the Invention The inventions described in this patent application.
include i) a torqueable introduces sheath which is useable ir_ conjunction with a transvascular passageway forming catheter to effect precise rotational cor_trol of the catheter; ii) an anchorable guide catheter whi ch is useable in conjunction with an intravascular imaging catheter and a transvascular passageway-forming catheter to effect precise positioning and aiming of the passageway-forming catheter; iii) a passageway forming catheter having a torqueable proximal portion to facilitate precise rotational positioning of the distal portion of the catheter; iv) a deflectable-tipped passageway forming catheter, v) various markers and other apparatus useable in conjunction with any of the passageway-forming catheters to facilitate precise positioning and aiming of the catheter, and vi) an apparatus which may be formed withir_ a catheter to prevent a member, apparatus of flow of material from being inadvertently advanced through a lumen of the catheter.
Additional details and objects of each of the above-summarized inventions will become apparent to those skilled in the art upon reading and understanding of the following detailed descriptions of preferred embodiments and the accompanying drawings.
Brief Description of the Drawings Figure 1 is a perspective view of a torqueable sheath through which a passageway-forming catheter of the present invention may be inserted, and which may be used to facilitate subsequent rotational positioning of the distal portion of the passageway-forming catheter.
Figure la is a cut-away perspective view of the distal end of the torqueable sheath of Figure 1, and shown in phantom lines the preferred operative positioning of a passageway-forming catheter within such torqueable sheath.
Figure lb is a partial cut-away perspective view of portion lb of Figure 1, showing the braided wire layer formed within the proximal portion of the tora_ueable sheath.
Figure 1c is a cross-sectional view through line lc-lc of Figure 1.
Figure ld is a cross-sectional view through line ld-ld oz Figure 1.
Figure le is a cross-sectional view through line l e-le of Figure 1.
Figure if is a perspective view of a typical passageway-forming catheter of Applicant's invention, as previously described it United States Patent Application Serial No. 08/730,327, entitled METHODS A.ND APPARATUS FOR
BYPASSING ARTERIAL OBSTRUCTIOhTS AND/OR PERFORMING OTHER
TRANSVASCULAR PROCEDURES filed on October 11, 1995.
Figure lg is a cross-sectior_al view through ? ir_e lg-l g of Figure lf, and additional showing in phantom lines the preferred operative positioning cf a torqueable sheath of the present invention relative to that portion of the passageway-forming catheter..
' S Figure 2 is a perspective view of a guide catheter of the present invention having an anchoring balloon formed on the distal end thereof.
Figure 2a is a partial longitudinal sectional view through line 2a-2a of the guide catheter of Figure 2, showing an intravascular ultrasound device operatively inserted into the guide catheter.
Fi gure 2b is a cross-sectional view through 1 i ne 2b-2b oz the guide catheter Figure 2 having an intravascular ultrasound catheter operatively inserted therethrough.
Figure 2c is a cross-sectional view through line 2c-2c of Figure 2a.
Figure 2a' is a partial longitudinal sectional view through line 2a-2a of the guide catheter or Figure 2, showing a passageway-forming catheter of the preser_t invention operatively inserted into the guide catheter.
Figure 2b' is a cross sectional view through line 2b-2b of the guide catheter of Figure 2 having a passageway-forming catheter of the present invention operatively inserted therethrough.
Figure 2c' is a cross-sectional view through line 2c' -2c' of Figure 2a'.
Figure 3 is a perspective view of the passageway forming catheter of the present inver_tion which is useable in conjunction with the guide catheter shown in Figures 2 2c'.
Figure 3a is a perspective view of portion 3a of Figure 3.
- Figure 3b is a longitudinal sectional view through line 3b-3b of Figure 3a.
Figure 3c is a cross-sectional view through line 3c-3c of Figure 3.
Figure 3d is a cross-sectional view Through line 3d-3d of Figure 3.
Figure 4a is a perspective view of a torqueable passageway-forming catheter device of the present invention.
Figure 4b is a cross-sectional view through line 4b-4b of Figure 4a.
Figure 4c is a cross-sectional view through line ~c-ac of Figure 4a.
Figure 4d is a perspective view of the distal portion of a passageway-forming catheter of the present invention.
incorporating a first marker thereon.
Figure 4e is a perspective view of the distal portion of a passageway forming catheter of the present invention incorporating a ,second marker thereon.
Figure 4f is a perspective view of the distal portion of a passageway forming catheter of the present invention incorporating a third marker thereon.
Figure 4g is a longitudinal sectional view of the distal portion of a passageway-forming catheter having a fourth marker of the present invention formed thereon.
Figure 4h is a longitudinal section view of the distal portion of a passageway forming catheter having a fifth marker formed thereon.
Figure 4h' is a longitudinal sectional view of the passageway formir_g catheter of Figure 4h wherein. the marker has been advanced to its operative position by insertion of an IWS catheter through one lumen of the passageway forming catheter.
Figure 4i is a perspective view of the distal portion of a passageway forming catheter having a sixth marker formed thereon.
Figure 4i' is a perspective view of the distal portior_ of a passageway forming catheter having a variation of the ., _7_ sixth marker of Figure 4i formed thereon.
Figure 4j is an elevational view of the distal portion of a passageway forming catheter having a seventh marker formed thereon.
Figure 4j' is an elevational view of the distal portion of the passageway catheter of Figure 4j wherein the seventh marker has been advanced to an operative position by insertion of an IWS catheter through or_e lumen of the passageway forming catheter.
Figure 4k is a longitudinal sectional view of the distal portion of a passageway forming catheter wherein i) a reduced-diameter guidewire lumen has been formed to permit a guidewire to be temporarily advanced into such guidewire lumen to act as a marker to facilitate precise rotational positioning of the catheter, and ii) an ultrasound chip~has been mounted on the catheter adjacent the outlet opening for the tissue penetrating element so as to cause ultrasonic vibration and enhar_ced imageability of the tissue penetrating element when it is deploved out of the opening.
Figure 41 is an exploded perspective view of a modified passageway-forming catheter, and a modified phased-array IWS catheter useable in conjunction therewi th to effect precise rotational positioning oL the passageway forming catheter.
Figure 41' is a schematic diagram of one type of system which may be utilized to electronicGlly mark or differentiate the image received from a single crystal on the phased array imaging catheter of Figure 41.
Figure am is a perspective view of the distal portion of a passageway forming catheter having ar_ eighth marker formed thereon.
Figure 4m' is an elevational view of the distal portion of a passageway forming catheter having a variant of the eighth marker of Figure 4m formed thereon.
_g_ Figure 5 is a longitudinal sectional view of an adjacent artery and vein, showing an energy-emitting/receiving guidance and positioning system of the present invention which is useable to effect precise S positioning and rotational orientation of the passageway-forming catheter.
'Figure 5a is a partial longitudinal sectional view of a passageway-forming catheter of the present invention having an alternative aiming/positioning system formed thereon., such system comprising an active (emitting) compor_ent and a passage {receiving) component.
Figure 5b is a partial longitudinal sectional view of another passageway-forming catheter o~ the present invention which incorporates another aiming/positioning system thereon, such system comprising an active (e. g., emitting) component mounted on the body of the catheter and an imaging catheter component (e. g., an IWS Catheter) advanceable through an imaging catheter lumen o= the passageway-forming catheter to image the target tissue after the target tissue has been affected by energy received from the active (emitting) componer_t.
Figure 5c is a partial longitudinal sectional view of another passageway forming catheter of the present invention having an alternative aiming/positioning system wherein the tissue penetrating element of the catheter is an elongate member having a sensor mounted thereor_ for sensing the location of the target tissue.
Figure 5d is a partial longitudinal sectional view of another passageway forming catheter of the present invention (having an alternative aiming/positioning system wherein an active {e.g., emitting) componer_t is mour_ted in specific relation to the outlet port for the tissue-penetrating element, and is adapted to emit a signal to arl imaging component (e.g., IV(1S catheter) to accentuate the location of the outlet port and facilitate aiming of the _g_ catheter by use of the imaging device.
Figure Se is a schematic diagram of one type of system which may be utilized to peak a signal received from the passive (e.g., receiving) component of an aiming/positioning system of Figures 5-5c hereabove.
Figure 6 is a schematic showing of the manner in which an extracorporeal imaging apparatus is useable in conjunction with marking scheme formed on a passageway-a forming catheter of the present invention, to efTect precise positioning and rotational orientation of the passageway-forming catheter.
Figure 6a is a showing of a first marking scheme useable with the tracorporeal imaging system of Figure ex 6.
Figure 6b is a showing of a second marking scheme useable with the tracorporeal imaging system of Figure ex 6.
Figure 6c is a showing of a third marking scheme useable with the tracorporeal imaging system of Figure ex 6.
Figure 7 is a perspective view of a deflectable-tipped passageway forming catheter system of the present irwention which comprises a) a deflectable tipped catheter; b) an imaging component which is advanceable through the deflectable-tipped catheter and c) a tissue-penetrating component which is passable through the deflectable-tinned catheter.
Figure 7a is a longitudinal sectional view of the handpiece portion of the deflectable tipped portion of Figure 7.
Figure 7b is a longitudinal sectional view of the distal portion of the deflectable-tipped catheter of Figure 7.
Figure 8 is a.longitudinal sectior_al view of another passageway-forming catheter which incorporates apparatus for preventing deployment of the tissue-penetrating element.
Figure 8' is a longitudinal sectional view of another passageway-forming catheter which ir_ccrporates apparatus for preventing deployment of the tissue-penetrating element and for stabilizing the catheter within a luminal anatomical structure, wherein such apparatus is in an initial configuration whereby the lumen. is blocked and the catheter is unstabilized.
Figure 8" is a longitudinal sectional view of another passageway-forming catheter which incorporates apparatus for preventing deplcyment of the tissue-penetrating element and for stabilizing the catheter within a luminal anatomical structure, whereir_ such apparatus is in an operative configuration wherein the lumen is open and the catheter is stabilized.
Detailed Descriptions Preferred Embodiments The following detailed description. and the accompanying drawings are provided for the purpose of describir_g and illustrating presently preferred embodiments of the invention only, and are not intended to limit the scope of the invention in any way.
It is to be appreciated that the individual elements and components of each of the embodiments described herebelow may be individually or collectively incorporated into each of the other embodiments capable o~ receiving or incorporating such elements) or component(s), and no effort has been made to exhaustively describe all possible permutations and combinations of the inver_ti~e elements and components described herein.
i. Torqueable Introduces Sheath Referring specifically to Figures 1-lg, the present invention includes a torqueable introduces sheath 10 comprising an elongate pliable tubular sheath bodv 12 having a proximal er_d PE and a distal end DE. The tubular sheath body 12 comprises a proximal segment 14, a medial segment 16 and a distal segment 18. A hollow lumen 20 extends longitudinally through the tubular sheath body 12, such hollow lumen 20 being defined by an inner luminal surface 22. A proximal hand piece ar connector assembly 24 may be mounted on the proximal end PE of the sheath body 12 to facilitate manipuiation~of the proximal end PE of the sheath body 12 and to receive and register against the hand piece 26 of any catheter which is inserted through the torqueable introduces sheath 10.
A tubular catheter engaging member 28 is formed or mounted withir_ the lumen 20 of the distal segment 18 of the i0 tubular sheath body 12. Such tubular catheter. engaging member 28 has a lumen 30 which extends longitudinally therethrough. The lumen 30 may be of any non-cylindrical or nonuniform configuration, such as "pair shape" or "egg-shape, " whereby the luminal surface or a portion thereof will engage and.prevent rotation of the catheter inserted through the sheath. An exampleyof a generally oval shaped lumen is shown in Figure la.
A plurality of elongate reinforcement members 32, formed of wire, fibers or other suitable material, are disposed within the proximal and medial segments 14, 16 of the tubular sheath body 12. These reinforcement members 32 may be helically wound about the lumen 20 of the sheath body 12 to form an overlapping braid structure 3~. OtheY
structures, such as a coil structure, may alsc be used. In particular, such overlapping braid structure 3~ may comprise two groups of individual elongate members 32 helically wound in opposite phase about the longitudinal axis LA. of the tubular ir_troducer sheath body 1 2 , and at cross over points of such groups of elongate members 32, the individual elongate members 32 of one group will be alternately passed over and under the individual elongate members 32 of the other group, so as to provide a braid structure 34 which will impart enhanced structural integrity and torque transfer to the proximal 1~ and medial 15 segments of the tubular sheath body 12. In some WO 98!46119 PCT/US98/07134 embodiments, the distal segment 18 may alsc be provided with the elongate members 32 and/or braided structure.
In embodiment of this sheath intended for coronary application, the individual elongate members 32 may preferably be formed of stainless steel of 0.001-0.005 inch diameter. Each group of elongate members 32 may consist of eight such stainless steel wire members in substar_tially parallel side-by-side relation to one ar_other. The first and second groups of elongate members 32 will be helically wound about a tubular inner liner 36, in opposite phase such that the first and second groups of elongate members will repeatedly cross over each other. At locations whereat the groups of elongate members 32 cross over each other, each individual elongate member 32 of each group may be alternately threaded over and under the ir_dividual elongate members 32 of the other' group, so as to provide an interwoven, braided structure 3a which will impart enhanced torqueability to the tubular sheath body 12. A tubular outer skin 1,5 is then formed over the wire braid structure 3~ such that the wire braid structure 3~ is captured or located between the tubular outer skin 15 and the tubular core member 36, as shown.
In at least some applications it may desirable to impart regionalized differences in rigidity or hardness to the proximal and medial segments 14, Z6 of the tubular sheath body 12. In this manner, the outer skin 15 of the proximal portion 1~ may be formed of material which i s more rigid or greater in hardness than that of the outer ski r_ 15 of the medial portion 16. For example, the outer skin 15 of the proximal portion 14 may be formed of thermoplastic, elastin (e.g., Pebax, polyurethane, silicone, polyester) or thermoset elastomer (e. g., polyurethane or flexibly epoxy) (e.g., Pebax) having a Shore D hardness of 60-72 while the outer skin 15 of the medial portion 16 may be fcrmed of polymeric material (e. g., pebax) having a lesser hardness, such as a 40-60 Shore D hardness or. the shore D scale. The . outer skin 15 of the distal portion 18 may preferably have a Shore D hardness in the range of 30-40. The relative lengths and hardness of the inner liner 36 and outer skin 15 may be varied to adjust the overall stiffness of the catheter and the locations of the transition areas between the proximal 14, medial 16 and distal 18 segments of the sheath 10.
In the preferred embodiment, shown in the drawings, the inner liner is formed of polytetrafl uoroethylere (PTFE) of consistent hardness from the proximal end PE to the distal end DE of the tubular sheath body 12.
With reference to Figures lf-1g, one type of passageway-forming catheter 40 which is useable in conjur_ction with the torqueable sheath 10 comprises an elongate pliable catheter 40 having an irregular cross sectional configuration defining an upper portion 42 through which a tissue-penetrating element 46 may pass and a lower portion 44 through which an imaging catheter (e.g., an IWS catheter) may pass.
A tissue-penetrating element 46 of the type previously described in United States Patent Application Serial No.
08/730,327 is advar_ceable out of the distal end DE oz the upper catheter portion 42 such that the tissue penetrating element 46 will diverge laterally from the longitudinal axis LA of the catheter device 40. Ir_ this manner, the tissue-per_etrating element 46 will pass through the wall of a blood vessel wherein the distal portion of the catheter device 40 is positioned so as to create an extravascular passageway extending from the blood vessel to another blood vessel or other extravascular target location.
As shown in Figure lg, when the catheter 40 is advanced through the torqueable introducer sheath 10, the upper portion 42 of the catheter body will engage the smaller diameter side of the lumen 30 of the catheter -1a_ engagement member 28, while the relatively large diameter lower catheter portion 44 will engage the opposite end of such lumen 30, and the passageway-forming catheter 40 will be thereby prevented by the catheter engaging ir_sert 28 from rotatably moving relative to the tubular body 12 of the sheath 10. In this manner, the operator may manually grasp the proximal connector 24 and may apply rotational force to the proximal connector 24, such that the rotational force will be transmitted through the tubular sheath body 12 so as to cause the distal segment.l8 of the tubular sheath body 12 to rotate in a substar_tially one to one (1:1) relation to the proximal connector 24. In this manner, the torqueable introducer sheath 10 will cause the catheter 40 which has been inserted through the sheath 10 to rotate in conjunction with the sheath 10, irrespective of whether the 'body of the catheter 40 has sufficient structural integrity to be capable of transmitting torque from its proximal end to its distal end. This construction allows the use of a passageway-forming catheter 40 which is of relatively small diameter and formed of pliable or subtle material, while the torqueable sheath ?0 may be of stronger and less pliable material capable of transmitting torque and acting as guide for insertion of the catheter 40. Additionally, the catheter engaging insert 28 may be positioned at or near the distal end of the sheath 10 so as to transmit torque to the catheter 40 at a location at or near its distal tip, thereby eliminating torque or rotational stress on the majority of the catheter shaft and eliminating the potential for kinking or buckling of the small diameter, pliable catheter body. In this manner, the use of the sheath 10 of the present inver_tion in conjunction with the catheter 40 provides for the maintenance of precise rotational control of the distal portion of the catheter 40.
ii. Anchorable Guide Catheter Referring to Figures 2-2b' there is provided an anchorable guide catheter which is useable in cor_junction with i) an imagir_g catheter such as a commercially available IVUS catheter (e. g., 29 French Ultra-Cross available from Boston Scientific, 27 Orleans Dr., Sunnyvale, California) and ii) a transvascular passageway forming catheter, one example of which is shown ir_ Figures 3a-3d of this application and other examples of which are described in U.S. Patent Applications Serial No. 08/730,327 and 08/730,496.
The anchorable guide catheter 50, comprises a pliable tubular catheter body 52 having a proximal end PE and a distal end DE. First and second lumens 54, 56 extend longitudinally through the catheter body 52. An opening 58 is formed in one side of the Catheter body 52, so as to provide an opening into the f it st lumen. 54 . A pressure exertive member such as a balloon 59 or other projectable apparatus such as a moveable foot, is mounted on the catheter body 52 at a location laterally opposite the location of the opening 58. P.n inflation fluid aperture 60 is formed in the sidewall of the catheter body 52 between the balloon 58 and the second lumen 56 such that balloon inflation fluid may pass into and out of the balloor_ 59, through the second lumen 56.
A proximal connector assembly 62 is mour_ted or_ the proximal end PE of the catheter body 52. Such proximal connector assembly 62 has a side arm port 64 in communication with the second lumen 56 such that balloon inflation fluid may be ir_jected or withdrawn through the side arm port 64 to cause al ternate inflation and deflation of the balloon 59. Also, the proximal connector assembly 62 has a proximal port 66 through which any elongate member of suitable size and configuration, such as the imaging (IWS) catheter, a passageway forming catheter 40, or other catheters equipped for introducing channel connectors, channel sizers, lumen blockers, etc. as described in Applicant's earlier-filed United States Patent Application Serial Nos. 08/730,327 and 08/730,490', may be advanced through the first lumen 54 of the catheter body 52. The first lumen 54 of the catheter body 52 may be of a shape or configuration which is analogous to one or both of the catheters which are to be inserted through the first lumen 54 such that when such IWS catheter, passageway forming catheter 70 or other elongate member 15 inserted into the first lumen 54, the outer surfaces) thereof will engage the inner surface of the first lumen 54 such that the T_VLTS
catheter, passageway forming catheter 70 or other elongate member will be prevented from rotatably moving relative to ~S the body of the catheter 52, and the operator will thereby maintain precise control over the rotational orientation of these apparatus. Tn particular, as shown in Figures 2b-2c, the first lumen 54 may have an inner lumenal surface 64 of a "D" shape.
Referring to Figures 3a-3d, a particular passageway forming catheter 70 which is useable in conjunction with the anchorable guide catheter 50 may comprise a pliable catheter body 72 having at least a distal portion 7~-_ having a generally D-shaped outer surface 76 which is of substantially the same size and configuration as the D-shaped luminal surface 64 of the first lumen 54. A tissue penetrating element 78 extends through the pliable catheter body ?2 ar_d is connected to a trigger 80 formed or_ the proximal hand piece 82 of the catheter device 70 such that, when the trigger 80 is actuated, the tissue penetrating element 78 will pass out of a side opening 80 formed in the D-shaped portion of the catheter body 72 such t_nat the tissue penetrating element 78 will diverge laterally from the longitudinal axis LA of the catheter body 72, in this manner, the tissue penetrating element 78 may be utilized to form an extravascular passageway which extends through the wall of the blood vessel into which the catheter 70 is inserted, to another blood vessel or other target location within the body.
Referring back to Figures 2a-2c' , the anchorable guide catheter 50 is initially inserted into the vasculature and advanced to a position where the distal end DE of the balloon catheter body 52 and side oper_ing 58 are located adjacent the location at which it is desired to form an extravascular passageway. An imaging catheter 80, such as an IVL1S catheter, is inserted through the proximal por t 66 , and is advanced through the first lumen 54 until the imaging catheter 80 is in a position relative to the side opening 58 of the catheter body 52 to provide an image of anatomical structures located in alignment with such side opening 58. Thereafter, the guide catheter body 52 may be manually rotated until the image received thrcugh the imaging catheter 58 indicates that the opening 58 is directly aligned with the location. at which the extravascular passageway is to be formed. In this regard, the catheter body 52 is of a torqueable construction, and may have the same dual-layer braided construction as described hereabove with respect to the torqueable sheath 10. In this manner, the anchorable guide catheter 50 may be manually rotated by the operator to effect precise rotational positioning of the opening 58 of the balloon anchorable guide catheter within the vasculature or other luminal anatomical structure within which the guide catheter SO is inserted.
After the opening 58 of the balloon anchorable guide catheter 50 has been precisely rotationally positioned so that a passageway forming catheter 70 subsequently inserted through the guide catheter 50 will be appropriately aimed at the target anatomical location, the balloon 59 of the guide catheter 50 will be inflated (or the other pressure exertive member will be actuated) to engage the surrounding luminal anatomical wall and to hold the distal portion of the guide catheter 50 in substantially fixed longitudinal and rotational position/orientation. In this regard, the material in which the balloon 59 is formed may be fractionally textured or coated with adhesive or otherwise modified with a friction producing outer surface to er_hance its friction against the luminal wall. In this manner the balloon 59 will soundly engage the surrounding luminal wall IO to hold the distal portion of the guide catheter 50 in fixed position.
Thereafter, the imaging catheter 80 will be extracted from the first lumen 54, and a passageway-forming catheter such as that shown in Figures 3a-3d Gnd described hereabove, will then be inserted through the lumen 5a. The passageway forming catheter 70 ' may be advanced ur_ti 1 the distal end DE of the passageway forming catheter body 72 abuts against the distal end surface 82 oz the first lumen 54 of the guide catheter 50. When so inserted, the D-shaped outer surface 76 of the distal portion 7~ of the passageway forming catheter body 72 will be in abutment with the D-shaped luminal surface 64 of the First lumen 54 of the guide catheter body 52, as shown in Figure 2c'. In instances where the proximal portion (i.e., that portion proximal to the distal portion 7a) of the passageway forming catheter body 72 is not of the same D-shaped configuration, such proximal portion may simply reside within the D-shaped first lumen 54 ir_ the manner shown in Figure 2b. Thus, it is not necessary that the entire length of the passageway-forming catheter body 72 have the D-shaped outer surface 76, but only that a distal portion 72 thereof have the D-shaped outer surface 76 so as to fractionally engage the D-shaped luminal surTace 6a of the first lumen 54 in the manner shown.
Because the anchoring balloon 59 has beer_ inflated, the guide catheter body 52 will be prevented from rotating within the vasculature and will be held in a substantially fixed rotational orientation such that the side opening 58 is in direct alignment with the other blood vessel or target location to which the extravascul ar passageway is to extend. Thus, after the passageway-forming catheter 70 has been' inserted into the first lumen 54 in the above-described manner, the triggering member 80 may be actuated to cause the tissue penetrating element 78 to pass out of the passageway forming catheter body 72, through the side opening 58 of the guide catheter,, through the wall of the blood vessel in which the guide catheter 50 is located, and into another blood vessel or other extravascular target location. Ir_ some embodiments, the tissue penetrating element 78 may comprise a tubular member having a guidewi re lumen 81 extending longitudinally therethrouah. When such guidewire lumen. 81 is present, a guidewire 79 may optionally be advanced through the tissue penetrating element 78 and into the other blood vessel or extravascular target location, after the tissue-penetrating element 78 has been advanced thereinto. After such guidewire 79 has been advanced into the other blood vessel or extravascular target location, the tissue penetrating element 78 may be retracted into the body of the passageway forming catheter 70, and the passageway forming catheter 70 and balloon anchorable guide catheter 50 may be extracted from the body, leaving the guidewire 79 in place to guide other devices or operative instruments through the newly created extravascular passageway.
iii. Passaaeway-Forming Catheter Device Having Toraueable Proximal Portion Figures 4a-4e show another passageway-forming catheter device 100 of the present invention, which generally comprises an elongate catheter body 102 with definable proximal 104, medial 106 and distal 108 segments of varying flexibility and torque strength.
The proximal segment 104 and medial segment 106 of the catheter body 102 incorporate reinforcement members, such as a reinforcement member braid 110, which will impart S structural integrity to the proximal segment 104 and medial segment 106, and will enhance the ability of the proximal segment 104 and medial segment 106 to transmit torcrue from the proximal end of the catheter body 102. ~r_ some embodiments, the distal segment 108 may also incorporate such reinforcement members and/or braid 110. The reinforcement members and braid may be similar to or the same as that described in detail hereabove ir_ reference to Figure 1.
As shown in Figure 4a, the proximal segment 104 may be of greater diameter than the medial segment 106. In this manner, the proximal segment 104 may comprise a cylindrical, dual lumen core member 140a of a first diameter D1 about which the reinforcement members or wire braid 110 are wrapped. An outer jacket 142a is then formed about the reinforcement members or wire braid 110, as shown in Figure 4b.
The mid-portion 106 comprises a cylindrical core member 140b of diameter D2, about which the reinforcement members or wire braid 11 0 are wrapped. A cyli ndri cal outer jacket 142b is also formed about the mid-portion 106 of the catheter body 102, and is continuous with the outer surface of the distal portion 108, as showr_ in Figure 4a.
It would be appreciated that the individual portions or members which make up each segment of 104, 106, 108 of the catheter body 102 may be formed of materials whi ch have different physical properties (e. g., hardness, flexural.
properties, etc.) so as to bring about the desire~a regionalized variations in pliability and torque strength the catheter body 102. For example, in a presently preferred embodiment, the cylindrical core member 140a of the proximal portion 104 is formed of a polymer material of a first hardness (e.g., Pebax of 63E Shore Hardness) and the cylindrical core member 140b of the mid-portion 106 is formed of a polymer material having a different hardness (e.g., Pebax of 40D Shore Hardness). The outer jacket 142 a of the proximal portion 104 is formed of another polymeric material having yet a different hardness (e. g., Pebax 70D Shore Hardness) and the outer jacket 142d of the mid-portion 106 is formed of polymeric material having the same or similar hardness of that of the mid-portion 106 (e. g., Pebax of 40D Shore Hardness) other polymeric materials which may be used to form por~ions or members o the catheter body 102 include nylon, polyurethane, polyester, polyvinyl chloride (PVC) etc.
The catheter body 102 has a bottom portion BP and an upper portion UP. A curved or~slanted frontal surface is formed on the distal end of the upper portion. UP.
A first lumen 130 extends longitudinally through the catheter body from the proximal end to the distal end of the upper portion of the catheter body, and terminates distally at the distal outlet aperture 134.
A second lumen 132 al so extends longitudinally through the catheter body from the proximal end thereof to a closed end wall or plug at the distal end of the lower portion LP
of the catheter body 102. A proximal connector 136 is mounted on the proximal end of the catheter body. A
proximal connector 136 has a proximal end port 134 and a side arm port 138. The proximal end port 134 is in communication with the first lumen 130 of the catheter body 102, and the side arm port 138 i s in communication with the second lumen 132 of the catheter body 102. A tissue-penetrating element 150 extends through the first lumen 130. This tissue penetrating element 150 may be any suitable type of tissue penetrating element member, device, or flow of energy, as previously described in United States Patent Application Serial No. 08/730,324, of which this application is a continuation-in-part. In embodiments wherein the tissue penetrating element 150 is an advanceable member or device, a handpiece of the type shown in Figure 3a-3b may be mounted on the proximal end port 134 such that the trigger 80 is connected to the tissue penetrating element 150 and is useable to alternately advance and retract the tissue penetrating element 150, out of/into the outlet aperture 134.
An imaging catheter, such as an intravascular ultrasound (IWS) catheter may be inserted through one of the ports 134, 338 of the proximal connector 136 connected to the second lumen 132. In this manner the imaging catheter (IWS) may be advanced through the second lumen 132 such that a distal portion of the imaging catheter extends into or out of and beyond the distal extent of the second lumen 3.32, thereby placing the imaging transducer or image receiving apparatus at a vantage point which is distal to the outlet aperture 134.
Such imaging catheter may then be utilized to image anatomical structures which are situated adjacent to in the vicinity of the outlet aperture 134, and to view the passage of the tissue-penetrating element 150 out of the outlet aperture 134 and through/into the adjacent anatomical structure.
iv. A Deflectable Catheter System for Formincs ,~.xtralumi.nal,, passageways Figures 7-7b show another type of catheter system which may be utilized to form interstitial passageways between a luminal anatomical structure (e. g., a blood vessel) within which the catheter is positioned and another target anatomical location (e. g., another blood vessel, chamber of the heart, organ, tumor, etc.}.
As shown in Figure ~, the system 1000 comprises a deflectable tipped catheter 110 which is useable in combination with an imaging catheter 112 (e.g., an IWS
r catheter? and a tissue penetrating element 114 (e.g., a sharp-tipped elongate member, or a flow of tissue-penetrating energy).
The deflectable tip catheter 110 comprises an elongate pliable catheter body 1016 having a deflectable distal end DE and a proximal end PE which is connected to a handpiece 2018 .
A presently preferred construction of the handpiece 1118 is shown in Figure 7a, and a presently preferred to construction of the distal end DE of the catheter body 1016 is shown in Figure 7b.
A working lumen 1020 extends longitudinally through the catheter body 1016 and through an opening 1022 in the distal end DE of the catheter body 1016. A secondary lumen 1026 extends longitudinally through the catheter body 1016, at an off center location along one side oL the catheter body. Such secondary lumen 1026 terminates within the catheter body near the distal end thereof, and is thus a blind lumen. A pull wire 1024 extends longitudinally through the secondary lumen 1026 and the distal end 1028 of the pull wire 1024 is anchored or attached to the catheter body at a location within the catheter body, near the distal end thereof. The pull wire 1024 is axially moveable within the secondary Lumen 1026 such that, when the pull wire 1024 is retracted in the proximal direction, it will cause the distal end DE of the catheter body 1016 to deflect in lateral direction, toward the side on which the secondary lumen 1026 is formed, as shown in Figure 7b.
The handpiece 1018 comprises a rear body portion 1030 and a forward body portion 1032 a knob 1034 is formed on the forward body portion 1032. The proximal end of the forward body portion 1032 is received within ar_ inner bore 1036 of the rear body portion 1030 and is slidably retractable and advanceable within such bore 1036. A
tubular member 1038 is positioned axially within the bore 136 of the rear body portion 1030 and extends through a portion of the forward body portion 132 as shown. This tube member 1038 is attached and anchored within the handpiece 1018 by way of a nut 1039. The catheter body 1016 extends through the tubular member 1038 and the proximal end PE of the catheter body 1016 is ar_chored within the rear body portion 1030, as shown. A slot 1040 is formed in the side of the tube member 1038. The pull wire 1014 extends through a small hole formed in the side of the catheter body 1016 within the forward body portion 1032 and through the slot 1040. The proximal end of the pull wire 1024 is attached to a set screw 1042 mounted in the side of the forward body portion 1032. Pn O-ring lo4b is mounted within an annular groove formed ir_ the proximal portion of the forward body portion 1032 such that the O-ring will ride against the inner surface of the bore 1036 of the rear body portion 130 as the forward body portion 1032 is advanced and retracted therewithin.
In operation, when it is desired to cause the distal end DE of the catheter body 1016 to deflect laterally, the operator will grasp the knob 1034 of the forward body portion 1032 and will proximally retract the forward body portion 1032 into the bore 1036 of the rear body portion 1030, while the catheter body 1016 remains axially stationary due to its affixation to the proximal body portion 1030. In this manner, the pull wire 1024 will be proximally retracted within the secondary lumen 1026 and will cause the distal end DE of the catheter body 1016 to deflect in the desired lateral directior_, as shown. Such deflection of the distal end DE of the catheter body 1016 may be utilized to cause the distal end outlet aperture 1022 to be specifically di rected or aimed at the lumi nal wall of a luminal anatomical structure within which the catheter body 1016 is inserted.
A first frusto conical bore 1050 is formed within. an ,.
insert member 1052 located in the rear body portion 1030, and within which the proximal end PE of the catheter body 116 is extended. This frusto conical bore 1050 leads directly into the proximal end of the working lumen 1020 of the catheter body 1016 and will Tacilitate distally directed advancement of a guidewire, imaging catheter 1012, tissue penetrating element 1014, or other elongate apparatus through the main lumen 1020 of the catheter body 1016.
Ar_other insert member 105 having an opposite redirected frusto conical bore 1050 is also mounted withi.~.
the bore 1036 of the rear body portion 1030, proximal to the first insert member 1052. This oppositely directed frusto conical bore 1056 will serve to guide and center the proximal end of a guidewire or similar elongate apparatus over which the catheter body 116 may be advanced such that it passes out of the proximal end PE c' the catheter body 116.
Optionally, a hemostasis valve and/or gripping apparatus 1060 may be mounted on the proxi mal erd of the rear body portion 130, immediately adjacent the proximal end opening 1062 of the bore 136 through which the guidewire(s), imaging catheter 1012, tissue penetrating elerrient 101a or other elongate apparatus may be passed.
In a preferred mode of operation, the catheter body 1016 is initially inserted into a luminal anatomical structure such that the distal end DE of the catheter body 1016 is located generally adjacent a site at which an interstitial passageway is to be formed through the wall of the luminal anatomical structure within which the catheter body 1016 is positioned. The imaging catheter 1012 (e. g., an IWS catheter) is advanced through the proximal opening 1062, through the frusto conical bore 1050, ar_d through the working lumen 1020 of the catheter body 1016 ux~tll the transducer or image-receiving element o~ the imaging catheter 1012 is appropriately positioned to image the side wall of the luminal anatomical structure within which the catheter body 1016 is inserted and/or the target anatomical location to which the interstitial passageway is desired to extend. In many instanced, this will reauire that a distal portion of the imaging catheter 1012 protrudes slightly out of and beyond the di stal end opening 1022 oz the working lumen 1020. With the image catheter'1012 in its operative position, it may be utilized to precisely locate the distal end DE of the catheter body 1016 in the desired longitudinal location and rotational orientation which will cause the distal end opening 1022 to be in alignment with the specific site on the wall of the luminal anatomical structure through which the passageway is to be zormed. T_r_ this manner, one or more imageable markers cr other aiming/positioning systems as 'described ir_ this patent application or in applicant's related patent applications may be incorporated into the system 1000 to facilitate precise aiming and positioning of the distal end DE of the catheter body 1016.
After the distal end DE of the catheter body 1016 has been longitudinally and rotationally positioned/oriented, the imaging catheter 1012 will be extracted and removed, and the tissue-penetrating element lOla will then be advanced through the proximal opening 1062, through the frusto conical bore 1050, and through the working lumer_ 1020 until the tissue-penetrating elemer_t is near the distal end opening 1022 but still contained within the working lamer. 1020. Thereafter, the operator will grasp the knob 1034 of the handpiece 1018 and will retract the forward body portion 1032 of the handpiece rearwardly, into the rear body porticn 1030. This will cause the pull wire 102 to retract and will cause the distal end DE o~ the catheter to become laterally deflected such that the distal end opening 1022 is positioned in direct alignment with the site on the wall of the luminal anatomical structure through which the passageway is to be formed. Thereafter, the tissue-penetrating element lOla will be further advanced out of the distal end opening 1022 of the catheter body 1016, through the wall of the luminal anatomical structure, and through any intervening tissue, until the tissue-penetrating element 1012 emerges into the intended target anatomical location.
Thereafter, the tissue-penetrating element 101~-_ may be retracted through the working lumen 1020 and removed.
Thereafter, one or more secondary apparatus (e. g., channel connector delivery catheters, channel enlarging/modifying catheters, blocker catheters, etc.), may be advanced through the working lumen 1020 of the catheter to perform any desired modifications of the interstitial passageway or delivery of ancillary devices to facilitate flow of blood or biological fluids through the passageway, as desired.
Thereafter, when the procedure has been completed, the operator may again grasp the knob 1034 of the forward body portion 1032 and may distally advance the forward body portion. to its original position, thereby allowing the distal end DE of the catheter body 1016 to return to its substantially straight, non-deflected cor_figuratior..
Those skilled in the art will appreciate that various modifications or changes may be made to the above-described system 1000 without departing from the intended spirit and scope of the invention. For example, although the preferred embodiment has beer_ shown with a single wcrking lumen 1020 extending through the deflectable catheter 1010, a plurality of such lumens may be formed to allow multiple components (e. g., the imaging catheter 112 and the tissue penetrating element 101 and/or a guidewire (not shown) to extend through the catheter body 1016 simultaneously.
However, in many applications it will be desirably to minimize the diameter of the catheter body 1010' and to maximize its pliability or flexibility, thereby rendering it desirable to utilize a single lumen 1020 in such applications.
Optionally, a side port 1057 may be formed in the rear body portion 1030 to permit infusion/withdrawal of fluid through the working lumen 1020 of the catheter 1000.
v_ Markers and Related Apparatus for Positionina/Aimin~
The Passageway Forming Catheters F figures 4d-6c show vari ous markers and other apparatus which may be incorporated into any of the passageway forming catheters described in this patent application. or any other suitable catheter, to provide a means for visually determir_ir_g (e. g., by intracorporeal imaging such as intravascular ultrasound, or by extracorporeal imaging such as fluoroscopy) the precise positioning and rotati oval orientation of the distal portion of the catheter and/or for precisely aiming the tissue-penetrating element so that it will create the desired interstitial passageway as i t is passed out of the passageway-forming catheter.
In particular, Figures 4d-4e show markers which are particularly suitable for use on passageway-forming catheters which have a stepped or slanted distal end configuration, such as that of the torqueable catheters shown in Figure 4a. The remaining showings of Figures 4g-6c show markers and guidance/aiming apparatus which are useable with passageway-forming catheters which have various distal end configuration..
Referring to Figure 4d, there is showr_ a distal portion of a passageway-forming catheter 100 hereupon a generally U-shaped marker 180 is mounted on the upper surface of the lower catheter body, distal to the tissue penetrating outlet opening 134. The longitudinal midline of the marker 180 is in alignment with the path which will be followed by the tissue penetrating element 150 as it is ,.
advanced out of the opening 134 in the catheter 100. In this manner, an imaging apparatus such as an IWS catheter positioned withir_ the lower catheter body portion. at a vantage point distal to the distal end of the t~ssue-penetrating element outlet opening 134, may be utilized to er_sur2 that the marker 180 is in direct alignment with the target tissue prior to advancement of the tissue penetrating element 150. out of the opening 134.
Figure 4e shows a passageway forming catheter 100 having a marker strip 182 mounted on the upper portion. of the lower catheter body, distal to the location of the tissue-penetrating element outlet opening 134. This marker strip 182 creates an image artifact which extends out radially to allow *point* in a specific direction which corresponds to the path of the tissue penetrating element.
The longitudinal midline of t?z,~s marker strip 182 is in alignment with the path which will be followed by the tissue-penetrating element 150 as it passes out o. the opening 134. In this manner, an imaging apparatus such as an IWS catheter positioned within the lower catheter body portion at a vantage point distal to the distal end of the tissue-penetrating element outlet opening 13x, may be utilized to ensure that the marker strip 184 is ir_ direct alignment with the target tissue, prior to advancement of the tissue penetrating elemer_t 150 out of the opening 134.
Figure 4f shows a wire marker 186 mounted on the distal portion of a passageway-forming catheter 100 which has an optional imaging window 101 formed in the lower catheter body, distal to the tissue-penetrating element outlet opening 13x. The details of this imaging window were previously described in applicant's earlier-filed United States Patent Application Serial No. 08/730,x96.
The wins marker,186 comprises a single, elor_gate wire which is attached at its opposite ends, to the proximal and distal boarders of the window 101. The elongate wire WO 98/46119 PCT/US98/0'7134 marker 186 is preferably in the center of the window 101 and in alignment with the path which will be followed by the tissue penetrating element 150 as it is advanced out of the opening 134 in the catheter 100. 2n this manner, an imaging apparatus such as an IVLTS catheter positioned within the lower catheter body portion so as to obtain an image through the imagir_g window 101, may be utilized to ensure that the marker wire 186 is ir.~ direct alignment with the target tissue prior to advancement o~ the tissue penetrating element 150 out of the opening 134.
Figure 4g shows another passageway-forming catheter 100' which has an imaging lumen 300 through which ar_ imaging catheter may be advanced, and a working lumen 302 through which a tissue-penetrating element 150 may pass, such working lumen 302 terminating distally in an outlet opening 134 formed in the side~of the catheter 100' at a spaced distance proximal to the distal er_d of the imaging lumen 300, as shown. A pliable distal tip member 189 is mounted on the distal end of the catheter 100', and the imaging lumen 300 extends through such tip member 189 and terminates in a distal opening formed therein.
Additionally, a hollow passageway 191 extends longitudinally through such tip member 189 in direct alignment with the main portion of the working lumen. 302.
An imagable marking wire member 188, preferably formed of a combination of platinum and stainless steel, extends through the hollow passageway 191 in the tip member 189, and is surrounded 1 aterally by a gap or space 193 within such passageway 191, as shown. The proximal end of this wire member 188 is embedded in a mass of imagable material 190 located within the body of the catheter 100'. Such mass of imagable materi ai 190 is preferably a mixture of tungsten and a plastic (e.g., Pebax) or platinum. The distal er_d of the wire member 188 protrudes out of and beyond the distal end of the catheter body, as shown.
Figures 4h-4h' show another passageway-forming catheter 100" comprising an elongate pliable catheter body having an imaging lumen 300 and a working lumen 302. Pn imaging apparatus, such as IVt7S catheter, is advanceable through the imaging lumen 300. A tissue penetrating element (not shown) is passable through the working lumen 302 and out of the outlet aperture 134. A marker wire lumen 314 extends through a distal portion of the catheter 100" between a proximal opening 316 formed in the upper wall of the imaging lumen 300, and a distal outlet aperture 318 formed in the distal end of the catheter 100" , above the distal end outlet 320 of the imaging lumen. 300. =.
marker wire 310 is disposed within the imaging wire lumer_ 314. A proximal bulb 322 is formed on the prOXimal end of the marker wire 310, and an optional distal bulb 324 may be formed on the distal end therebf. Initially, the marker wire 310 is fully retracted into the marker wire lumen 3i4 such that its distal tip and any distal bulb 324 is wholly contained within the body of the catheter 100" , and with the proximal bulb 322 protruding slightly into the imaging lumen 300. The marker wire may be spring loaded or otherwise biased to this proximally retracted position.
Thereafter, when an IVL1S catheter is advanced through the imaging lumen 300, the distal end oT the advancing IWS
catheter will drive the proximal bulb 322 of the marker wire 310 into a proximal cavity 326 formed at the proximal end of the marker wire lumen 314, thereby advancir_g the marker wire 310 such that a portion of the marker wire and its distal bulb 322 extends out of the distal end outlet aperture 318 and protrudes beyond the distal end of the catheter 100" , as shown in Figure 4h. The distal bulb 322 and a longitudinal axis of the marker wire 310 are ir.
direct with the path which will be followed by a tissue-penetrating element (not shown) as it passes out of the outlet aperture 134. Thus, when the distal bulb 322 of the distally advanced marker wire 310 is ir_ direct alignment with the target tissue on the image received by the IVLTS
catheter, such will ensure that when the ti ssue penetrating element is advanced out the outlet aperture 1 3~ , it will be properly aimed and will advance into the target tissue, as desired.
Figures 4i and 4i' show another passageway-forming catheter 100' ' ' having an imaging lumen which terminates ir~
a distal outlet aperture 320 and a working lumen which terminates in a side outlet aperture 134. An imaging catheter, such as an IWS is advanceable through the imaging lumen, and a tissue-penetrating elemer_t (not shown) is advanceable out of the side outlet aperture 134.
In the particular embodiment shown. in Figure 4i, an arcuate wire marker 330 is mounted on the distal end of the catheter 100' ' ' , ir~ a generally i~orizorta 1 plane, above the distal out end outlet 320 of the imaging lumen 300. This arcuate wire marker 330 may be imaged by the transducer of an imaging catheter which protrudes out of the distal end outlet 320, and a specific, region of the artifact or image produced by the arcuate wire marker 330 may be fused, ai med or aligned with the target tissue, taking into account the distance between the catheter 100 and the target tissue, thereby ensuring that when. the tissue penetratir_g element (not shown) is advanced out of aperture 134 it will extend into the intended target anatomical location or tissue.
In the alternative embodiment shown in Figure 4i', there is provided a 3-legged wire marker 332 rnour_ted or. the distal end of the catheter 100" '. Such 3-legged wire marker 332 comprises bottom legs 334 formed of single wire strands and ar_ upper leg 336 formed cf a singl a wire strand additionally having an outer wire coil formed therearound.
The single wire strand and the outer wire coil may be formed of different materials. The upper leg 336 is in direct longitudinal alignment with the half which will be followed by the tissue penetrating element as i t passes out of the side outlet aperture 1 34 of the catheter 100" ' . In this manner, when an imaging catheter such as an IVUS is advanced out of the distal end opening 320 of the imaging lumen, it may be utilized to directly align the upper leg 336 of the three-legged wire marker 322 with the intended target tissue, thereby insuring that when the tissue penetrating element is passed out of the side outlet aperture 134, it will form the desired passageway into the target tissue.
Figures 4j-4j' show a passageway forming catheter 100" ' having the same configuration as that of Figures 4i-4i', but wherein a deflectable wire marker 340 is mounted on the end of the catheter 100" ', as shown. Such deflectable wire marker 340 preferably comprises a singe wire strand having an additional wire coil formed therearound. This deflectable wire marker 340 has a top end 342 which is attached to the bodv of the catheter 100" ' at a site which is in direct longitudinal alignment with the side outlet aperture 134. Wher_ the deflectable wire marker 3Q0 is in its non-deflected position (Figure 4j) its bottom end 344 will protrude downwardly over the distal end outlet 320 of the imaging lumen 300. Thus, when an imaging catheter such as an IWS catheter is advanced through the imaging lumen 300 and out of the distal end outlet aperture 320 it will abut against the bottom portion of the deflectable wire marker 340, thereby causing the deflectable wire marker 340 to assume a deflected positior_ as shown in Figures 4j'. When the deflectable wire marker 340 is in such deflected position, the longitudinal axis of the deflectable wire marker 340 will be in direct aligr_ment with the path which will be followed by the tissue penetrating element (not shown) as it is passed out of the side outlet aperture 134. In this manner, the imaging catheter (IVI1S) may be utilized to directly align the WO 98/46119 PCT/US9810?134 _3g_ longitudinal axis of the deflectable wire marker 3~-_0 with the target tissue, thereby insuring that when the tissue penetrating element is passed out of the side outlet aperture 134 it will form the desired interstitial passageway into the target tissue.
Figure 4k shows the same tissue-penetrating catheter 100" ' wherein a secondary guidewire lumen 348 extends longitudinally through the body of the catheter 100" ', from a proximal aperture 350 formed ir_ the distal curved surface of the working lumer_ 302 to a distal guidewire outlet aperture 352 formed in the distal end of the catheter body, as shown. In this embodiment, the tissue penetrating element 150' comprises an elongate member having a sharpened distal end and a hollow guidewire lumer_ extending longitudinally therethrough. A guidewire 356 is advancable through the guidewire lumen or the tissue penetrating element 150'. When the tissue penetrating element 150 is retracted into the working lumen 302 as shown in Figure 4k, the guidewire 356 may be advanced out of the distal end of the tissue penetrating element 150, through the secondary guidewire lumen 348, wherein it will act as a marker which may be imaged by a imaging apparatus (e . g . , an IWS catheter) passed through the imagi ng luT,er_ 300. The longitudinal axis of the guidewire 356, when.
positioned within the secondary guidewire lumen 3~8, will be in direct alignment with the path which will be followed by the tissue penetrate ng element 150 as it i s advanced out of the side outlet aperture 134.
The showing of Figure 4k also incorporates a separate image-enhancing means whereby energy (e. g., ultrasonic vibration) may be imparted to the tissue penetrating elemer_t 150' as it is advanced out of the side outlet aperture 134 to render the distal portion of the tissue penetrating element 150' more easily visible by the imaging apparatus (e. g., IWS catheter) positioned in the imaging lumen 300. This is accomplished by an energy emitting member 370, such as an ultrasound generating device is mounted in the wall of the catheter 100" ', about the side outlet aperture 134. A connector wire 372 extends longitudinally through the catheter 100" ' to its proximal end, to permit the energy-emitting apparatus 370 to be connected to an appropriate source of energy. As the tissue penetrating element 150' is advanced out of the side outlet aperture 134, the energy emitting apparatus 370 is energized via the connector wire 372, thereby .imparting energy to the distal portion of the tissue penetrating element and enhancing its visibility by the imaging apparatus positioned within the imaging lumen 300. One example of an ultrasound emitting chip which may be used as the energy emitting apparatus 370 such as a piezoelectric crystal of the type generally known in the art as a PZT
crystal (lead-zirconate titanate).
Figure 41 shows a passageway-forming catheter 100" ' of the same general configuration shown in Figures 4i-4k, but wherein at least a portion of the imaging lumen 30o is of non-round configuration. In the preferred embodiment shown, the imaging lumen 300 is . of rectangular configuration having a longitudinal groove 373 extending along the upper surface thereof, as shown. A
correspondingly shaped engagement member 378 is formed on the catheter 374 and such engagement member incorporates a longitudinal tongue 379 which fits slidably into the corresponding groove 373. In this manner, the catheter 374 can be inserted only in the desired rotational orientation, as shown. A phased array imaging catheter 37~ having a phased array imaging transducer 376 mounted thereon is advanceable through the imaging lumen 300 of the catheter 100 " '. The irregularly shaped or non-round engagement member 378 formed on the outer surface of the phased array imaging catheter 374 and is configured to fractionally engage the wall of the imaging lumen 300 to prevent the phased array imaging catheter 374 from rotating within the imaging lumen 300. An electronic marker is formed within.
the circuitry of the phased array imaging catheter 374 so as to mark a desired location L which is in direct alignment with the outlet aperture 134 of the catheter 100" ' when the phased array imaging catheter 374 is ron-rotatably inserted into the imaging lumen 300. girl this manner, the electronically marked location L may be placed in direct alignment with the target tissue viewed on the image received through the phased array imaging catheter 374, thereby insuring that the outlet aperture 134 is also in alignment with the target tissue. It should be appreciated, that as an alternative to internally or electronical ly marking the desired location L on the phased array transducer 376, various imagable markers may be formed on the body of the catheter 100" ' to mark the rotation of the outlet aperture 13a, examples os such imagable markers being described hereabove and shown ir_ Figure 4d-4k.
One example of an electrical system which may be utilized to electronically mark a desired locaticn L or. the image received from the phased array transducer 376 is shown, in schematic fashion, in Figure 41'. With reverence to Figure 41 and 41' , the phased array trar_sctucer 376 0 the phased array imaging catheter 374 has a plural i ty o~
individual crysta 1 s 900 formed at spaced-apart 1 ocations on the transducer 376. Wires 902 extend from each of the individual crystals 900 of the phased array transducer 376, through the body of the phased array imaging catheter 374 and out of the proximal end thereof. One of these individual wires 902a is separated from remair_ir_g wires 902b, and the remaining wires 902b extend directly into a monitoring console 904 which produces the viewable image from the phased array transducer 376. The selected wire 902a is connected to a switch 906. Wher_ the switch 906 is in its open posi tion, the signal received from the selected wire 902a will be shunted through a bypass circuit 908 which rejoins the remaining wires 902b prior to entry into the monitoring console 904. In this manner, when the switch 906 is open, the signal received from the selected wire 902a will bypass the signal modifying apparatus 903 and will rejoin the signals received from the remaining wires 902b to provide an image on the image monitoring console 904 which is unchanged and unmarked. .~iowever, when the switch 906 is closed, the signal received from the selected wire 902a will pass through a signal modifying apparatus 903. This signal modifying apparatus 903 may simply be an open switch which terminate the signal, thereby providing a void in place of the image which would be displayed from the individual crystal 90C from which the selected wire 902a extends. Alternatively, such signal modifying apparatus 903 may be a saturation apparatus which will produce white noise, or a color imparting apparatus which will tint or color the image received from the selected wire 902a. In either case, the image which subsequently appears on the image monitoring console 904 from the selected crystal 900 from which the selected wire 902a extends will be visually discernable by the operator and will provide a marking of the desired location L on the phased array imaging transducer 976.
Figures 4m and 4m' the presently preferred embodiment comprising a catheter 100" " wherein a segment of the catheter body is cut away, with a plurality (e. g., (three (3)) struts 402, 404, 406 formed a connectior_ between a proximal portion 408 of the catheter 100" " and a distal portion 410 thereof, so as to form an imaging cage wherein the imaging catheter (e.g., IVL1S) may be positicned. The top strut member 404 is of elongate configuration, and it longitudinal axis is directly aligned with the side outlet _88_ aperture 134 through which the tissue penetrating element will pass . In this mar_ner, when an imagir_g catheter is passed through the imaging lumen 300 such that its imaging transducer is located within ar distal to the oben area 400, such imaging catheter may be utilized to directly image the upper strut 404 and the catheter body 100' ' ' ' may be rotated until the upper strut 404 is in direct alignment with the image of the intended target tissue, thereby insuring that when the tissue penetrating el emer_t passes out of the side outlet aperture 134 it will form the desired interstitial passageway into the target tissue.
Optionally, a pliable, hollow tip member 412 may be mounted on the distal end of the catheter 100" " . In the embodiment shown in Figure 4m the optional tip member 412 is a frusto conical configuration, while in the embodiment of Figure 4m' the tip member~412' is of hemispherical configuration. It will be appreciated that this cage-like structure may be formed in many ways including by EDN
technology or by forming the struts 402, 406, 408 of individual wires.
Any of the above-described markers shown in Figures 4d-4m' may incorporate regions thereon or discrete markings formed thereon, each such region or discrete marking being correlated to a specific range or distance from the catheter 100 to the anatomical target location. In this manner, the imaging apparatus (e.g., IVL7S catheter? may be selectively used to align a specific region or distance-correlated marking on the marker with the target anatomical locations, based on the operator's knowledge, estimate or .calculation of the range or distance from the catheter 100 to the target anatomical location. Additior_ally or alternatively, in embodiments wherein the imaging apparatus is mounted on a catheter which is insertable through an imaging lumen 300 in the passageway-forming catheter 100, the passageway forming catheter 100 may be provided with length markings or friction-producing regions within the imaging lumen 300 to provide increased resistance or some other tactile sensation whereby the operator may judge the length of the imaging catheter (e. g., IVLTS catheter) which has been advanced through the imaging lumen 300 and the present location of the imaging transducer or other image receiving apparatus thereon. In this manner, the operator may precisely position the imaging transducer or image receiving apparatus at a specific location (e.g.,, extended out of the distal end oper_ing 320 and immediately distal to the distal end of the catheter 100) which provides the optimal vantage point for visualization of the target anatomical structure and marker, and for resultant aiming of the marker by rotational and longitudinal adjustment of the catheter 100.
Any of the imageable markers described herein, including but limited to those shown in Figures 4d-am, may be formed of materials which affect the form of energy which is sensed by the imaging apparatus or catheter (e. g., ultrasound being received by an IVtTS catheter) to modify or enhance the artifact created by the marker. For example, any of these markers may be formed of material (e. g., soft plastic having low acoustic impedance) which is absorptive of the ultrasound or other energy form received by the imaging apparatus and, therefore, will appear as a void or black area on the image screen. Similarly, these markers may be formed of material (e.g., metals or alloys such as stainless steel, beryllium, or Nitinol) which is partially internally reflective of the energy form so as to give rise to an artifact (e.g., a streak or ray) which appears to emanate from in one or more directions from the exact location of the marker. In this manner, the marker may be positioned at a precise location and may be formed of material which is partially internally reflective such that an artifact (e. g., a ray or streak) is formed on the image screen which directly correlates to the path which will be followed by the tissue-penetrating element, such artifact (e. g., ray or streak? being useful to er_able the operator to determine the precise path which will be followed by the tissue penetrating element. In other applicatior_s, the marker may be formed of material which is reflective of the energy form such that a bright spot or exaggerated area will appear on the image screen wher_ such marker is surrounded by tissue or other matter which is less then totally reflective of the energy form. Thus, in addition to the above-described methods for modifying the markers by applying energy (e.g., ultrasound) to the body of the marker, the exact form of the image or artifact produced by the marker may also be altered or optimized by forming the marker of a particular material of varied acoustic impedance, ranging from air or~fluid filled cavities, to solid materials, to produce a range of marker effects on the image produced.
Figure 5 shows an alternative positioning-aiming system which is useable to facilitate precise positioning and aiming of the passageway forming catheter 100a. In this system, a signal emitting apparatus 500 is positioned in the target area (e. g., within a second blood vessel BVZ) and a signal receiving apparatus 502 is mounted within the passageway-forming catheter 100a located within in a first blood vessel BV1. The sigr_al emitting apparatus 500 comprises a signal emitting wire 504 having a tubular shield 506 surrounding the shaft of the wire such that only a distal portion 508 of the wire 504 extends out of the distal end of the shielding tube 506. The shielding tube 506 may comprise any suitable electromagnetic shielding material, and is preferably formed of a pliable plastic tube having an aluminum braid formed therein. Those ski 1 led in the art wi 1 1 appreciate that the signal emi tting wire 504 may be attached to an extracorporealiy located _a1_ signal generating apparatus capable of passing ar~
electromagnetic signal through the wire 504. Such electromagnetic signal may be a 20 Khz signal.
The signal receiving apparatus 502 is preferably formed within the wall of the passageway forming catheter 100a laterally outboard of the working lumen 302 through which the tissue penetrating element is passed, and in direct alignment with the tissue penetrating element outlet aperture 134 formed in the side of the catheter 100a.
30 Optionally, the catheter 100a may also include an imaging lumen 300 through which and imaging catheter (e. g., an IVUS
catheter) may be passed. However, tr~ose skilled in the art will appreciate that in many applications the signal emitting apparatus 500 and signal receiving apparatus 502 will be operable to control the precise positioning and rotational orientation of the catheter 100a, and such imaging lumen 300 may be unnecessary.
The signal receiving apparatus 502 formed in the passageway-forming catheter 10.0a comprises a signal receiving wire 520 having a tubular shielding apparatus 512 formed therearound. The tubular shielding apparatus 512 surrounds the shaft of the receiving wire 514 and G short distal portion 514 of the receiving wire 510 extends out of and beyond the distal end of the tubular shield 512. The tubular shield 512 may be formed in the same manner as the above-described tubular shield 506 of sigr_al emitting apparatus 500. The exposed distal portion= 51~-_ of the signal receiving wire 510 is located immediately adjacent, and in longitudinal al ignment with the side outlet aperture 134. In this manner, an electro magnetic sigr_al may be emitted through the signal emitting apparatus S00 after it has been positioned within- the second blood vessel BVz or other target tissue. The longitudinal positioning and rotational orientation of the passageway-forming catheter 100a inserted withir_ the first blood vessel Bvl may then be adjusted until the signal rece-ved by the signal receiving apparatus 502 of the catheter 100a is at its t~e''u-k intensity, thereby indicating that the exposed distal portion 514 of the receiving wire 510 has been positioned at its closest possible point to the exposed distal portion 508 of the signal emitting wire 504. This wi?1 ensure that the passageway forming catheter 100a is longitudinally positioned at the closest straigrt-lined point from the signal emitting apparatus 500 located with~n the second l0 blood vessel BVZ or other target tissue, and .that the catheter 100a has been rotated to a rotational orier_tation wherein the outlet aperture 134 is directly aimed at the signal emitting apparatus 500 located within the second blood vessel BVz or other target tissue . It wi 11 be Further appreciated by those skilled in the art that various types of energy-emitting signals may be utilized into, such that the signal emitting apparatus 500 lccated within the second blood vessel BVZ or target tissue is an "active" element and the signal receiving apparatus 502 associated with the passageway forming catheter 100a is a "passive" or receiving element. The types oz signals which may be utilized include, but are not necessarily limited to, electromagnetic signals (as specifically described hereabove), sonic signals (e. g., doppler), ultrasonic signals, high inter_sity light, laser, radiozrequer_cy, etc.
Figure 5a shows another positioning/aiming system which is wholly incorporated into the passageway-formi ng catheter 100b. A signal emitting or "active" component 520, such as a piezoelectric crystal is mounted upon or formed within the catheter 100b so to emit a signal or fl ow of energy which will strike, er_ter or be reflected from the target tissue T. A passive or receiving apparatus, such as another piezoelectri c crystal may be mounted at a second location within or upor_ the catheter 100d so as to receive a reflected signal or returning signal from the target r ,.
_a3_ tissue T. The positior_ oz the passive or receivir_g apparatus 522 relative to the active or emitting apparatus 520 is known, and may be utilized to precisely determir_e the longitudinal position and rotation orientation of the catheter 100b. In this manner, this positioning/aiming system may be utilized to effect precise longitudinal positioning and rotational orientation of the catheter such that when the tissue penetrating element is passed out of the outlet aperture 134, it will extend ir_to the target tissue T, as desired. Those skilled ir_ the art will appreciate that, as an alternative to the passive receiving apparatus 522, or in addition thereto, an optional imaging lumen 300 may extend through the body of the catheter 100b such that an imaging catheter (e.g., IVL1S catheter or receivir_g catheter carrying the passive receiving apparatus 522 may be passed through such'lumen 300 and utilized to alternatively cr Gdditionally facilitate the positioning and rotational orientation of the catheter 100b.
Figure 5b shows yet another alternative positioning/aiming system wherein a signal emitting crystal 530 is positioned on or within the catheter 100c so as to emit a signal (e.g., ultrasound or sound waves) in a direction which is specifically aligned with the path which will be followed by the tissue penetrating element as it passes out of the side outlet aperture 13a ar_ imaging catheter. An imaging catheter (e. g., an IVT1S cGtheter) positioned within the imaging lumen 300 is utilized to receive the signal from the crystal 530 after it has reflected front the target tissue T, thereby discerning the specific point of impingement X on the target tissue T
where it is struck by the energy being emitted by the signal emitting crystal 530. In this mar_ner, the imaging catheter positioned within the imaging lumen 300 may be utilized, to precisely position and aim the outlet aperture 134 of the passageway-forming catheter at the energy impingement point X on the target tissue T, thereby insuring that, when the tissue. penetrating element is advanced out of the outlet aperture 134, it will extend into the target tissue T at a desired site.
Further referring to Figure 5b, the signal emitting crystal S30 may be alternatively utilized as a signal receiving crystal, such that it will receive re=lected ultrasound from the IVLS, as indicated by the dotted arrows on Figure Sb. Since the signal receiving crystal 530 is specifically positioned and oriented in relation to the outlet 134 and/or path of the tissue penetrating element 150, such receipt of the IVL1S ultrascund by the signal receiving crystal 530 will enable the operator to precisely position and rotatior_ally orient the catheter such that the tissue penetrating element 150 will pass directly into the target tissue T, in parallel -to the path of reflected ultrasound received by the signal receiving crystal 530.
Figure Sc shows yet another positior~ing/aimir_g system wherein the passageway-forming catheter 100d has a working lumen 302 which terminates in a side outlet aperture 134 and through which a tissue-penetrating element 500 in the nature of an elongate member S40 havir_g a sharpened distal end may be advanced through such working lamer- 302 Gnd out of the side outlet aperture 134 of the catheter 100d. The elongate member 540 in this embodiment is equipped with a sensor apparatus 548 positioned Gt or rear the sharpened distal end of the elongate member 540. A connector wire 550 may extend longitudinally through the elongate member 540 to permit the sensor 548 to send a signal through the shaft of the member 540 to an extracorporeai locatior_ at which such signal may be processed and/or monitored. The sensor 548 may be any suitable type o= sensor which will sense the presence and/or location of the inter_ded target tissue T. Parameters or variables which may be ser_sed by the sensor 548 include temperature, pulse, flow, or other r characteristics of the target tissue T, capable of being mechanically, electronically or optically sensed.
Additionally or alternatively, an energy emitting or "active" apparatus, such as the energy emitting apparatus 500 described hereabove with reference tc Figure 5, may be positioned within the target tissue T and the sensor 5~3 formed on the tissue penetrating member 5~0 may be adapted to receive and sense energy emitted by the active energy emitting member located within the target tissue T. In this manner, the tissue penetrating member 540 serves its own sensing function and enables the operator to control the longitudinal and rotational position of t he catheter 100d prior to or during the advancemen~. o. the tissue penetrating member 540 out of the outle~ aperture 13~ and ir_to the target tissue T. It will be apprecia~ed by those skilled in the art, when a tissue penetrating member S~0 having an onboard sensor 5~8 of the type desc=ibed here'n 1S utl.llZed, SLCh W111 ellminate the need f0'' anV Other extracorporeal or intracorpcreal imagir_g cr sensing apparatus for aiding in positioning or rotational orientation of the catheter 100b. Alterr_atively, the catheter 100b may also be provided with c~her onboard aiming/positioning apparatus or an imaging lumen 300 as described in reference to various other embodiments shown in Figures a-5.
Figure 5d shows another aiming/positicnins system which is similar to that shown in Figure 5b, but wherein the emitting member 530 (e. g., ar_ ultrasound emitting piezoelectric crystal) is aimed downwardly at the transducer or receiving port of the imaging catheter (e. g., IWS catheter) , ar_d the emitting member 530 is specifically positioned relative to the outlet openir_g 13~ so as to provide an imageable marking at the outlet opening 13~. In this manner, the imaging catheter (IVLJS catheter) may be used to specifically site and identify the location of the .y. .__.___ __ ____~__",~___""~y1 ~~...
3~ rotationally move the catheter until the signal received WO 9$/46119 PCTIUS98/07134 outlet aperture 134, thereby facilitating longitudinal positioning and rotational aiming of the catheter prior to deployment of the tissue penetrating meiaber 150.
Figure Se shows one embodiment of a system 790 which may be utilized to facilitate optimization or peaking of the signal received from a sensor or receiving component r~hich is utilized to position and aim the catheter, such as those described hereabove and identified by reference numerals 502, 522, 530 and 598. In this system 794, the wire 510, 521, 531, 550 through which a signal is received from the receiving coiaponent 502, 522, 530, 548 is connected to a switch 818. When the switch 818 is open, the signal received will not enter the system 790.
However, when the switch 818 is closed, the signal received from the receiving or sensing component 502, 522, 530, 548 will enter a signal conditioning and filtering component 880 wherein the signal will undergo condit~.oning and filtering. Thereafter this signal will pass through a rectifier 810 wherein the signal will be rectified, and through a leaky integrator 812 of the type well known in the art. Such leaky integrator 812 may comprise a capacitor and a resistor in parallel. The integrated signal from the leaky integrator 812 may then pass into an analog to digital convertor 814, if desired, whereby it will be converted to a digital signal, and such digital signal will then be fed to a display 816 of a type suitable for indicating the relative intensity of the signal received. Such display may be an LED or multiple light display, whereby a column or array of lights are provided and the intensity of the signal received is indicated by the height of the column or the number of lights in the array which are lit at any given time.
In this manner, the system 790 shaven in Figure 5d may be utilized to enable the operator to longitudinally and rotationally move the catheter until the signal received from the receiving component or sensor 502, 522, 530, 5~8 has been peaked or optimized, thereby indicating that the catheter is properly positioned such that the tissue penetrating element will extend from the outlet 130 into the target anatomical location T.
Figures 6-6c show other catheter marking schemes which may be used in conjunction with an extracorporeal imaging apparatus 118, such as a fluoroscope, positioned adjacent a mammalian body MB. In the showing o~ Figure 6, a to catheter 100 has been advanced into the blood vessel Bv"
and such catheter is marked with one of the marking schemes of this embodiment of the present inventior_. Figures o'a-6c show the manner in which the marking scheme o~ the catheter 100 will appear on the fluoroscopy screen 120 as the catheter is rotated within the blood vessel BV..
Referring to Figure 6a, there is provided a marking scheme which comprises a first radio-opaque linear marking 122 on one side of the catheter body, and a second radio-opaque linear marking 122b. The second linear marking 122b is located directly and 180° opposite the first linear marking 122a, but slightly more distal to the first marking 122a. An additional rotation indicating indicia 200, comprising the letter "R° formed of radio-opaque or other imagable material, is formed to the right of the first linear marking 122a. As shown in Figure 6a, when. the catheter is in its desired rotational orier_tatior_, the first ar_d second linear markings 122a and 122b will appear next to and in linear aligr_mert with one another on the fluoroscopy screen 120. When such markings 122a and 122b are viewed from the right side RS of the catheter body the rotational marking indicia 200 will appear as the letter "R". However, when the catheter is rotated 180° such that the fluoroscope 118 views the catheter from the left side ZS of the catheter body, the rotational marking indicia 200 will appear as the inverted mirror image of the letter "R" , thereby inforrraing the operator that the catheter is rotated 180° from the desired rotational orientation.
Figure 6b shows a similar markir_g scheme wherein the rotational marking indicia 200 is formed adjacent a radio s opaque circle 24 formed on the right side RS of the catheter body such that, when the catheter bcdy is in its desired rotational position, a radio-opaque dot 126 formed on the left side LS of the catheter body will appear within the circle 124 on the fluoroscopy screen 120, and the rotational marking indicia 200 will appear as the letter "R" to the right of the radio-opaque circle 124. However, when the catheter body is rotated 180° such that the fluoroscope 118 is viewing the left side LS of the catheter body, the rotational marking indicia 200 will appear as the inverted mirror image of the 1 etter "R" or the ? ef t side of the circular markir_g indicia 124, as illustrated in Figure 6b.
Similarly, as shown in Figure 6c, the catheter X00 may be provided with two (2) through holes 128a, 128b formed in direct linear alignment with one another o:. opposite sides of the catheter 100. Adjacent one of the through holes is an imageable marker in the form of the letter "R". When the catheter 100 is rotated such that the through holes 128a, 128b are in direct alignment with the extracorporeal imaging apparatus 118, both through holes 128a, 128b will appear as a single aperture on the image provided on the image viewing apparatus 120. However, when the through holes 128a, 128b are not in direct alignment with one another, they will appear as separate images on the image viewing apparatus 120. In this manner, these through holes 128x, 128b may be utilized to discerr_ the correct rotational orientation of the catheter using an extracorporeal imaging apparatus 118. Similarly, as described hereabove, the letter R will appear differently depending or_ which side of the catheter 100 is closest to the imaging apparatus 118, thereby avoiding any possible inadvertent 180° mis-rotation of the catheter.
vi. Apparatus For Preventing Inadvertent De~lovment of Tissue Penetrating Element Figure 8 shows another embodiment of the catheter l0oe which incorporates apparatus for preventing inadvertent deployment of the tissue-penetrating element 150. Ir_ this catheter 100e, a lumen closure member 548 is pivotally mounted on one side of the working lumer_ 302 through which the tissue penetrating element 150 will pass sucr. that, when in an upwardly pivoted position, such member 548 will block the lumen and prevent inadvertent advancement of the tissue penetrating element out of the opening 134. A
balloon 544 or other pressure exerting member is mounted within the body of the catheter~l00e, adjacent the blocking member 548 in the embodiment shown, a balloon inflation lumen 546 extends through the catheter to permit alternate inflation and deflation of the balloon. In this manner, when the balloon 544 is inflated, as shown in Figure 8, the member 548 will pivot upwardly so as to block the working lumen 302 in a manner which will prevent inadvertent deployment of the tissue penetrating element 150.
Alternately, when the balloon 544 is deflated, the member 548 will pivot downwardly thereby restoring the working lumen 302 to an oper_ configuration through which the tissue-penetrating element 150 may pass.
Figure 8' shows another embodiment of the catheter 100e which incorporates apparatus for stabilizing the catheter within a vessel after proper orientation has been confirmed. This apparatus also prevents inadvertent deployment of the tissue penetrating element 150 in combination with the stabilization. Ir_ this catheter 100e, a lumen closure member 548' is pivotally mounted near the working lumen 302 through which the tissue penetrating element 150 will pass . The lumer_ cl osure member 548' is biased or spring loaded by spring member 998 such that when the balloon, 544' or other pressure exerting member is deflated, lumen 302 is blocked preventing inadvertent advancement of the tissue penetrating element out of the opening 134 . A balloon inflation 1 umer_ 546 extends through the catheter to permit al ternate inflation and deflation of the ball oor_. After proper orientation of the catheter 100e has been confirmed, the balloon is inflated which causes a portior_ of the balloon to exit the side of the catheter through exit port 999 which secures the catheter in place within the vessel, 997 as is shown in Figure 8" .
Simultar_eous with anchoring the catheter ir_ place, inflation of the balloon causes lumen closure member 548' to pivot thereby opening the working lumen 302 to allow advancement of the tissue penetYating element 150.
Materials, construction and treatments of the balloon, 544' may be made to prevent undesired movement or dislodgment in the vessel during its inflated state.
Treatment may include surface modificatior_, Dacron, or other means.
It should be appreciated that the general concept of combining ar_ anchoring device which is deployed after confirmation of proper orientation of the tissue penetrating element which simultaneously or nearly thereafter, removes a safety device previously in place to prevent inadvertent advancement of the tissue penetrating element, can be accomplished in other ways not completely described above.
It will be appreciated by those skilled in the art that the invention has beer. described hereabove with reference to certain presently preferred embodiments and examples only, and no effort has been made to exhaustively describe all possible embodiments and examples in which the invention may take physical form. Furthermore, it will be appreciated that each of the specific components and elements of the above-described embodiments and examples may be combined or used in conjunction with any of the other components shown in relation to other embodiments or examples, to the extent such recombination of elements or components may be accomplished without rendering the device, apparatus, or system unusable for its intended purpose. Furthermore, various additions, deletions, modifications, and alterations may be made to the above-described embodiments and examples without departing from the intended spirit and scope o~ the inventior_.
Accordingly it is intended that all such variations, recombination, additions, deletions ar_d modifications be included within the scope of the following claims.
Thus, there remains a need in the art for further development and modification of applicant's previously described passageway-forming catheter devices so as to provide for i) improved torque transfer to the distal portion of the catheter and- ii) precise rotational orientation and aiming of the catheter prior to deployment of the tissue penetrating element.
Summary of the Invention The inventions described in this patent application.
include i) a torqueable introduces sheath which is useable ir_ conjunction with a transvascular passageway forming catheter to effect precise rotational cor_trol of the catheter; ii) an anchorable guide catheter whi ch is useable in conjunction with an intravascular imaging catheter and a transvascular passageway-forming catheter to effect precise positioning and aiming of the passageway-forming catheter; iii) a passageway forming catheter having a torqueable proximal portion to facilitate precise rotational positioning of the distal portion of the catheter; iv) a deflectable-tipped passageway forming catheter, v) various markers and other apparatus useable in conjunction with any of the passageway-forming catheters to facilitate precise positioning and aiming of the catheter, and vi) an apparatus which may be formed withir_ a catheter to prevent a member, apparatus of flow of material from being inadvertently advanced through a lumen of the catheter.
Additional details and objects of each of the above-summarized inventions will become apparent to those skilled in the art upon reading and understanding of the following detailed descriptions of preferred embodiments and the accompanying drawings.
Brief Description of the Drawings Figure 1 is a perspective view of a torqueable sheath through which a passageway-forming catheter of the present invention may be inserted, and which may be used to facilitate subsequent rotational positioning of the distal portion of the passageway-forming catheter.
Figure la is a cut-away perspective view of the distal end of the torqueable sheath of Figure 1, and shown in phantom lines the preferred operative positioning of a passageway-forming catheter within such torqueable sheath.
Figure lb is a partial cut-away perspective view of portion lb of Figure 1, showing the braided wire layer formed within the proximal portion of the tora_ueable sheath.
Figure 1c is a cross-sectional view through line lc-lc of Figure 1.
Figure ld is a cross-sectional view through line ld-ld oz Figure 1.
Figure le is a cross-sectional view through line l e-le of Figure 1.
Figure if is a perspective view of a typical passageway-forming catheter of Applicant's invention, as previously described it United States Patent Application Serial No. 08/730,327, entitled METHODS A.ND APPARATUS FOR
BYPASSING ARTERIAL OBSTRUCTIOhTS AND/OR PERFORMING OTHER
TRANSVASCULAR PROCEDURES filed on October 11, 1995.
Figure lg is a cross-sectior_al view through ? ir_e lg-l g of Figure lf, and additional showing in phantom lines the preferred operative positioning cf a torqueable sheath of the present invention relative to that portion of the passageway-forming catheter..
' S Figure 2 is a perspective view of a guide catheter of the present invention having an anchoring balloon formed on the distal end thereof.
Figure 2a is a partial longitudinal sectional view through line 2a-2a of the guide catheter of Figure 2, showing an intravascular ultrasound device operatively inserted into the guide catheter.
Fi gure 2b is a cross-sectional view through 1 i ne 2b-2b oz the guide catheter Figure 2 having an intravascular ultrasound catheter operatively inserted therethrough.
Figure 2c is a cross-sectional view through line 2c-2c of Figure 2a.
Figure 2a' is a partial longitudinal sectional view through line 2a-2a of the guide catheter or Figure 2, showing a passageway-forming catheter of the preser_t invention operatively inserted into the guide catheter.
Figure 2b' is a cross sectional view through line 2b-2b of the guide catheter of Figure 2 having a passageway-forming catheter of the present invention operatively inserted therethrough.
Figure 2c' is a cross-sectional view through line 2c' -2c' of Figure 2a'.
Figure 3 is a perspective view of the passageway forming catheter of the present inver_tion which is useable in conjunction with the guide catheter shown in Figures 2 2c'.
Figure 3a is a perspective view of portion 3a of Figure 3.
- Figure 3b is a longitudinal sectional view through line 3b-3b of Figure 3a.
Figure 3c is a cross-sectional view through line 3c-3c of Figure 3.
Figure 3d is a cross-sectional view Through line 3d-3d of Figure 3.
Figure 4a is a perspective view of a torqueable passageway-forming catheter device of the present invention.
Figure 4b is a cross-sectional view through line 4b-4b of Figure 4a.
Figure 4c is a cross-sectional view through line ~c-ac of Figure 4a.
Figure 4d is a perspective view of the distal portion of a passageway-forming catheter of the present invention.
incorporating a first marker thereon.
Figure 4e is a perspective view of the distal portion of a passageway forming catheter of the present invention incorporating a ,second marker thereon.
Figure 4f is a perspective view of the distal portion of a passageway forming catheter of the present invention incorporating a third marker thereon.
Figure 4g is a longitudinal sectional view of the distal portion of a passageway-forming catheter having a fourth marker of the present invention formed thereon.
Figure 4h is a longitudinal section view of the distal portion of a passageway forming catheter having a fifth marker formed thereon.
Figure 4h' is a longitudinal sectional view of the passageway formir_g catheter of Figure 4h wherein. the marker has been advanced to its operative position by insertion of an IWS catheter through one lumen of the passageway forming catheter.
Figure 4i is a perspective view of the distal portion of a passageway forming catheter having a sixth marker formed thereon.
Figure 4i' is a perspective view of the distal portior_ of a passageway forming catheter having a variation of the ., _7_ sixth marker of Figure 4i formed thereon.
Figure 4j is an elevational view of the distal portion of a passageway forming catheter having a seventh marker formed thereon.
Figure 4j' is an elevational view of the distal portion of the passageway catheter of Figure 4j wherein the seventh marker has been advanced to an operative position by insertion of an IWS catheter through or_e lumen of the passageway forming catheter.
Figure 4k is a longitudinal sectional view of the distal portion of a passageway forming catheter wherein i) a reduced-diameter guidewire lumen has been formed to permit a guidewire to be temporarily advanced into such guidewire lumen to act as a marker to facilitate precise rotational positioning of the catheter, and ii) an ultrasound chip~has been mounted on the catheter adjacent the outlet opening for the tissue penetrating element so as to cause ultrasonic vibration and enhar_ced imageability of the tissue penetrating element when it is deploved out of the opening.
Figure 41 is an exploded perspective view of a modified passageway-forming catheter, and a modified phased-array IWS catheter useable in conjunction therewi th to effect precise rotational positioning oL the passageway forming catheter.
Figure 41' is a schematic diagram of one type of system which may be utilized to electronicGlly mark or differentiate the image received from a single crystal on the phased array imaging catheter of Figure 41.
Figure am is a perspective view of the distal portion of a passageway forming catheter having ar_ eighth marker formed thereon.
Figure 4m' is an elevational view of the distal portion of a passageway forming catheter having a variant of the eighth marker of Figure 4m formed thereon.
_g_ Figure 5 is a longitudinal sectional view of an adjacent artery and vein, showing an energy-emitting/receiving guidance and positioning system of the present invention which is useable to effect precise S positioning and rotational orientation of the passageway-forming catheter.
'Figure 5a is a partial longitudinal sectional view of a passageway-forming catheter of the present invention having an alternative aiming/positioning system formed thereon., such system comprising an active (emitting) compor_ent and a passage {receiving) component.
Figure 5b is a partial longitudinal sectional view of another passageway-forming catheter o~ the present invention which incorporates another aiming/positioning system thereon, such system comprising an active (e. g., emitting) component mounted on the body of the catheter and an imaging catheter component (e. g., an IWS Catheter) advanceable through an imaging catheter lumen o= the passageway-forming catheter to image the target tissue after the target tissue has been affected by energy received from the active (emitting) componer_t.
Figure 5c is a partial longitudinal sectional view of another passageway forming catheter of the present invention having an alternative aiming/positioning system wherein the tissue penetrating element of the catheter is an elongate member having a sensor mounted thereor_ for sensing the location of the target tissue.
Figure 5d is a partial longitudinal sectional view of another passageway forming catheter of the present invention (having an alternative aiming/positioning system wherein an active {e.g., emitting) componer_t is mour_ted in specific relation to the outlet port for the tissue-penetrating element, and is adapted to emit a signal to arl imaging component (e.g., IV(1S catheter) to accentuate the location of the outlet port and facilitate aiming of the _g_ catheter by use of the imaging device.
Figure Se is a schematic diagram of one type of system which may be utilized to peak a signal received from the passive (e.g., receiving) component of an aiming/positioning system of Figures 5-5c hereabove.
Figure 6 is a schematic showing of the manner in which an extracorporeal imaging apparatus is useable in conjunction with marking scheme formed on a passageway-a forming catheter of the present invention, to efTect precise positioning and rotational orientation of the passageway-forming catheter.
Figure 6a is a showing of a first marking scheme useable with the tracorporeal imaging system of Figure ex 6.
Figure 6b is a showing of a second marking scheme useable with the tracorporeal imaging system of Figure ex 6.
Figure 6c is a showing of a third marking scheme useable with the tracorporeal imaging system of Figure ex 6.
Figure 7 is a perspective view of a deflectable-tipped passageway forming catheter system of the present irwention which comprises a) a deflectable tipped catheter; b) an imaging component which is advanceable through the deflectable-tipped catheter and c) a tissue-penetrating component which is passable through the deflectable-tinned catheter.
Figure 7a is a longitudinal sectional view of the handpiece portion of the deflectable tipped portion of Figure 7.
Figure 7b is a longitudinal sectional view of the distal portion of the deflectable-tipped catheter of Figure 7.
Figure 8 is a.longitudinal sectior_al view of another passageway-forming catheter which incorporates apparatus for preventing deployment of the tissue-penetrating element.
Figure 8' is a longitudinal sectional view of another passageway-forming catheter which ir_ccrporates apparatus for preventing deployment of the tissue-penetrating element and for stabilizing the catheter within a luminal anatomical structure, wherein such apparatus is in an initial configuration whereby the lumen. is blocked and the catheter is unstabilized.
Figure 8" is a longitudinal sectional view of another passageway-forming catheter which incorporates apparatus for preventing deplcyment of the tissue-penetrating element and for stabilizing the catheter within a luminal anatomical structure, whereir_ such apparatus is in an operative configuration wherein the lumen is open and the catheter is stabilized.
Detailed Descriptions Preferred Embodiments The following detailed description. and the accompanying drawings are provided for the purpose of describir_g and illustrating presently preferred embodiments of the invention only, and are not intended to limit the scope of the invention in any way.
It is to be appreciated that the individual elements and components of each of the embodiments described herebelow may be individually or collectively incorporated into each of the other embodiments capable o~ receiving or incorporating such elements) or component(s), and no effort has been made to exhaustively describe all possible permutations and combinations of the inver_ti~e elements and components described herein.
i. Torqueable Introduces Sheath Referring specifically to Figures 1-lg, the present invention includes a torqueable introduces sheath 10 comprising an elongate pliable tubular sheath bodv 12 having a proximal er_d PE and a distal end DE. The tubular sheath body 12 comprises a proximal segment 14, a medial segment 16 and a distal segment 18. A hollow lumen 20 extends longitudinally through the tubular sheath body 12, such hollow lumen 20 being defined by an inner luminal surface 22. A proximal hand piece ar connector assembly 24 may be mounted on the proximal end PE of the sheath body 12 to facilitate manipuiation~of the proximal end PE of the sheath body 12 and to receive and register against the hand piece 26 of any catheter which is inserted through the torqueable introduces sheath 10.
A tubular catheter engaging member 28 is formed or mounted withir_ the lumen 20 of the distal segment 18 of the i0 tubular sheath body 12. Such tubular catheter. engaging member 28 has a lumen 30 which extends longitudinally therethrough. The lumen 30 may be of any non-cylindrical or nonuniform configuration, such as "pair shape" or "egg-shape, " whereby the luminal surface or a portion thereof will engage and.prevent rotation of the catheter inserted through the sheath. An exampleyof a generally oval shaped lumen is shown in Figure la.
A plurality of elongate reinforcement members 32, formed of wire, fibers or other suitable material, are disposed within the proximal and medial segments 14, 16 of the tubular sheath body 12. These reinforcement members 32 may be helically wound about the lumen 20 of the sheath body 12 to form an overlapping braid structure 3~. OtheY
structures, such as a coil structure, may alsc be used. In particular, such overlapping braid structure 3~ may comprise two groups of individual elongate members 32 helically wound in opposite phase about the longitudinal axis LA. of the tubular ir_troducer sheath body 1 2 , and at cross over points of such groups of elongate members 32, the individual elongate members 32 of one group will be alternately passed over and under the individual elongate members 32 of the other group, so as to provide a braid structure 34 which will impart enhanced structural integrity and torque transfer to the proximal 1~ and medial 15 segments of the tubular sheath body 12. In some WO 98!46119 PCT/US98/07134 embodiments, the distal segment 18 may alsc be provided with the elongate members 32 and/or braided structure.
In embodiment of this sheath intended for coronary application, the individual elongate members 32 may preferably be formed of stainless steel of 0.001-0.005 inch diameter. Each group of elongate members 32 may consist of eight such stainless steel wire members in substar_tially parallel side-by-side relation to one ar_other. The first and second groups of elongate members 32 will be helically wound about a tubular inner liner 36, in opposite phase such that the first and second groups of elongate members will repeatedly cross over each other. At locations whereat the groups of elongate members 32 cross over each other, each individual elongate member 32 of each group may be alternately threaded over and under the ir_dividual elongate members 32 of the other' group, so as to provide an interwoven, braided structure 3a which will impart enhanced torqueability to the tubular sheath body 12. A tubular outer skin 1,5 is then formed over the wire braid structure 3~ such that the wire braid structure 3~ is captured or located between the tubular outer skin 15 and the tubular core member 36, as shown.
In at least some applications it may desirable to impart regionalized differences in rigidity or hardness to the proximal and medial segments 14, Z6 of the tubular sheath body 12. In this manner, the outer skin 15 of the proximal portion 1~ may be formed of material which i s more rigid or greater in hardness than that of the outer ski r_ 15 of the medial portion 16. For example, the outer skin 15 of the proximal portion 14 may be formed of thermoplastic, elastin (e.g., Pebax, polyurethane, silicone, polyester) or thermoset elastomer (e. g., polyurethane or flexibly epoxy) (e.g., Pebax) having a Shore D hardness of 60-72 while the outer skin 15 of the medial portion 16 may be fcrmed of polymeric material (e. g., pebax) having a lesser hardness, such as a 40-60 Shore D hardness or. the shore D scale. The . outer skin 15 of the distal portion 18 may preferably have a Shore D hardness in the range of 30-40. The relative lengths and hardness of the inner liner 36 and outer skin 15 may be varied to adjust the overall stiffness of the catheter and the locations of the transition areas between the proximal 14, medial 16 and distal 18 segments of the sheath 10.
In the preferred embodiment, shown in the drawings, the inner liner is formed of polytetrafl uoroethylere (PTFE) of consistent hardness from the proximal end PE to the distal end DE of the tubular sheath body 12.
With reference to Figures lf-1g, one type of passageway-forming catheter 40 which is useable in conjur_ction with the torqueable sheath 10 comprises an elongate pliable catheter 40 having an irregular cross sectional configuration defining an upper portion 42 through which a tissue-penetrating element 46 may pass and a lower portion 44 through which an imaging catheter (e.g., an IWS catheter) may pass.
A tissue-penetrating element 46 of the type previously described in United States Patent Application Serial No.
08/730,327 is advar_ceable out of the distal end DE oz the upper catheter portion 42 such that the tissue penetrating element 46 will diverge laterally from the longitudinal axis LA of the catheter device 40. Ir_ this manner, the tissue-per_etrating element 46 will pass through the wall of a blood vessel wherein the distal portion of the catheter device 40 is positioned so as to create an extravascular passageway extending from the blood vessel to another blood vessel or other extravascular target location.
As shown in Figure lg, when the catheter 40 is advanced through the torqueable introducer sheath 10, the upper portion 42 of the catheter body will engage the smaller diameter side of the lumen 30 of the catheter -1a_ engagement member 28, while the relatively large diameter lower catheter portion 44 will engage the opposite end of such lumen 30, and the passageway-forming catheter 40 will be thereby prevented by the catheter engaging ir_sert 28 from rotatably moving relative to the tubular body 12 of the sheath 10. In this manner, the operator may manually grasp the proximal connector 24 and may apply rotational force to the proximal connector 24, such that the rotational force will be transmitted through the tubular sheath body 12 so as to cause the distal segment.l8 of the tubular sheath body 12 to rotate in a substar_tially one to one (1:1) relation to the proximal connector 24. In this manner, the torqueable introducer sheath 10 will cause the catheter 40 which has been inserted through the sheath 10 to rotate in conjunction with the sheath 10, irrespective of whether the 'body of the catheter 40 has sufficient structural integrity to be capable of transmitting torque from its proximal end to its distal end. This construction allows the use of a passageway-forming catheter 40 which is of relatively small diameter and formed of pliable or subtle material, while the torqueable sheath ?0 may be of stronger and less pliable material capable of transmitting torque and acting as guide for insertion of the catheter 40. Additionally, the catheter engaging insert 28 may be positioned at or near the distal end of the sheath 10 so as to transmit torque to the catheter 40 at a location at or near its distal tip, thereby eliminating torque or rotational stress on the majority of the catheter shaft and eliminating the potential for kinking or buckling of the small diameter, pliable catheter body. In this manner, the use of the sheath 10 of the present inver_tion in conjunction with the catheter 40 provides for the maintenance of precise rotational control of the distal portion of the catheter 40.
ii. Anchorable Guide Catheter Referring to Figures 2-2b' there is provided an anchorable guide catheter which is useable in cor_junction with i) an imagir_g catheter such as a commercially available IVUS catheter (e. g., 29 French Ultra-Cross available from Boston Scientific, 27 Orleans Dr., Sunnyvale, California) and ii) a transvascular passageway forming catheter, one example of which is shown ir_ Figures 3a-3d of this application and other examples of which are described in U.S. Patent Applications Serial No. 08/730,327 and 08/730,496.
The anchorable guide catheter 50, comprises a pliable tubular catheter body 52 having a proximal end PE and a distal end DE. First and second lumens 54, 56 extend longitudinally through the catheter body 52. An opening 58 is formed in one side of the Catheter body 52, so as to provide an opening into the f it st lumen. 54 . A pressure exertive member such as a balloon 59 or other projectable apparatus such as a moveable foot, is mounted on the catheter body 52 at a location laterally opposite the location of the opening 58. P.n inflation fluid aperture 60 is formed in the sidewall of the catheter body 52 between the balloon 58 and the second lumen 56 such that balloon inflation fluid may pass into and out of the balloor_ 59, through the second lumen 56.
A proximal connector assembly 62 is mour_ted or_ the proximal end PE of the catheter body 52. Such proximal connector assembly 62 has a side arm port 64 in communication with the second lumen 56 such that balloon inflation fluid may be ir_jected or withdrawn through the side arm port 64 to cause al ternate inflation and deflation of the balloon 59. Also, the proximal connector assembly 62 has a proximal port 66 through which any elongate member of suitable size and configuration, such as the imaging (IWS) catheter, a passageway forming catheter 40, or other catheters equipped for introducing channel connectors, channel sizers, lumen blockers, etc. as described in Applicant's earlier-filed United States Patent Application Serial Nos. 08/730,327 and 08/730,490', may be advanced through the first lumen 54 of the catheter body 52. The first lumen 54 of the catheter body 52 may be of a shape or configuration which is analogous to one or both of the catheters which are to be inserted through the first lumen 54 such that when such IWS catheter, passageway forming catheter 70 or other elongate member 15 inserted into the first lumen 54, the outer surfaces) thereof will engage the inner surface of the first lumen 54 such that the T_VLTS
catheter, passageway forming catheter 70 or other elongate member will be prevented from rotatably moving relative to ~S the body of the catheter 52, and the operator will thereby maintain precise control over the rotational orientation of these apparatus. Tn particular, as shown in Figures 2b-2c, the first lumen 54 may have an inner lumenal surface 64 of a "D" shape.
Referring to Figures 3a-3d, a particular passageway forming catheter 70 which is useable in conjunction with the anchorable guide catheter 50 may comprise a pliable catheter body 72 having at least a distal portion 7~-_ having a generally D-shaped outer surface 76 which is of substantially the same size and configuration as the D-shaped luminal surface 64 of the first lumen 54. A tissue penetrating element 78 extends through the pliable catheter body ?2 ar_d is connected to a trigger 80 formed or_ the proximal hand piece 82 of the catheter device 70 such that, when the trigger 80 is actuated, the tissue penetrating element 78 will pass out of a side opening 80 formed in the D-shaped portion of the catheter body 72 such t_nat the tissue penetrating element 78 will diverge laterally from the longitudinal axis LA of the catheter body 72, in this manner, the tissue penetrating element 78 may be utilized to form an extravascular passageway which extends through the wall of the blood vessel into which the catheter 70 is inserted, to another blood vessel or other target location within the body.
Referring back to Figures 2a-2c' , the anchorable guide catheter 50 is initially inserted into the vasculature and advanced to a position where the distal end DE of the balloon catheter body 52 and side oper_ing 58 are located adjacent the location at which it is desired to form an extravascular passageway. An imaging catheter 80, such as an IVL1S catheter, is inserted through the proximal por t 66 , and is advanced through the first lumen 54 until the imaging catheter 80 is in a position relative to the side opening 58 of the catheter body 52 to provide an image of anatomical structures located in alignment with such side opening 58. Thereafter, the guide catheter body 52 may be manually rotated until the image received thrcugh the imaging catheter 58 indicates that the opening 58 is directly aligned with the location. at which the extravascular passageway is to be formed. In this regard, the catheter body 52 is of a torqueable construction, and may have the same dual-layer braided construction as described hereabove with respect to the torqueable sheath 10. In this manner, the anchorable guide catheter 50 may be manually rotated by the operator to effect precise rotational positioning of the opening 58 of the balloon anchorable guide catheter within the vasculature or other luminal anatomical structure within which the guide catheter SO is inserted.
After the opening 58 of the balloon anchorable guide catheter 50 has been precisely rotationally positioned so that a passageway forming catheter 70 subsequently inserted through the guide catheter 50 will be appropriately aimed at the target anatomical location, the balloon 59 of the guide catheter 50 will be inflated (or the other pressure exertive member will be actuated) to engage the surrounding luminal anatomical wall and to hold the distal portion of the guide catheter 50 in substantially fixed longitudinal and rotational position/orientation. In this regard, the material in which the balloon 59 is formed may be fractionally textured or coated with adhesive or otherwise modified with a friction producing outer surface to er_hance its friction against the luminal wall. In this manner the balloon 59 will soundly engage the surrounding luminal wall IO to hold the distal portion of the guide catheter 50 in fixed position.
Thereafter, the imaging catheter 80 will be extracted from the first lumen 54, and a passageway-forming catheter such as that shown in Figures 3a-3d Gnd described hereabove, will then be inserted through the lumen 5a. The passageway forming catheter 70 ' may be advanced ur_ti 1 the distal end DE of the passageway forming catheter body 72 abuts against the distal end surface 82 oz the first lumen 54 of the guide catheter 50. When so inserted, the D-shaped outer surface 76 of the distal portion 7~ of the passageway forming catheter body 72 will be in abutment with the D-shaped luminal surface 64 of the First lumen 54 of the guide catheter body 52, as shown in Figure 2c'. In instances where the proximal portion (i.e., that portion proximal to the distal portion 7a) of the passageway forming catheter body 72 is not of the same D-shaped configuration, such proximal portion may simply reside within the D-shaped first lumen 54 ir_ the manner shown in Figure 2b. Thus, it is not necessary that the entire length of the passageway-forming catheter body 72 have the D-shaped outer surface 76, but only that a distal portion 72 thereof have the D-shaped outer surface 76 so as to fractionally engage the D-shaped luminal surTace 6a of the first lumen 54 in the manner shown.
Because the anchoring balloon 59 has beer_ inflated, the guide catheter body 52 will be prevented from rotating within the vasculature and will be held in a substantially fixed rotational orientation such that the side opening 58 is in direct alignment with the other blood vessel or target location to which the extravascul ar passageway is to extend. Thus, after the passageway-forming catheter 70 has been' inserted into the first lumen 54 in the above-described manner, the triggering member 80 may be actuated to cause the tissue penetrating element 78 to pass out of the passageway forming catheter body 72, through the side opening 58 of the guide catheter,, through the wall of the blood vessel in which the guide catheter 50 is located, and into another blood vessel or other extravascular target location. Ir_ some embodiments, the tissue penetrating element 78 may comprise a tubular member having a guidewi re lumen 81 extending longitudinally therethrouah. When such guidewire lumen. 81 is present, a guidewire 79 may optionally be advanced through the tissue penetrating element 78 and into the other blood vessel or extravascular target location, after the tissue-penetrating element 78 has been advanced thereinto. After such guidewire 79 has been advanced into the other blood vessel or extravascular target location, the tissue penetrating element 78 may be retracted into the body of the passageway forming catheter 70, and the passageway forming catheter 70 and balloon anchorable guide catheter 50 may be extracted from the body, leaving the guidewire 79 in place to guide other devices or operative instruments through the newly created extravascular passageway.
iii. Passaaeway-Forming Catheter Device Having Toraueable Proximal Portion Figures 4a-4e show another passageway-forming catheter device 100 of the present invention, which generally comprises an elongate catheter body 102 with definable proximal 104, medial 106 and distal 108 segments of varying flexibility and torque strength.
The proximal segment 104 and medial segment 106 of the catheter body 102 incorporate reinforcement members, such as a reinforcement member braid 110, which will impart S structural integrity to the proximal segment 104 and medial segment 106, and will enhance the ability of the proximal segment 104 and medial segment 106 to transmit torcrue from the proximal end of the catheter body 102. ~r_ some embodiments, the distal segment 108 may also incorporate such reinforcement members and/or braid 110. The reinforcement members and braid may be similar to or the same as that described in detail hereabove ir_ reference to Figure 1.
As shown in Figure 4a, the proximal segment 104 may be of greater diameter than the medial segment 106. In this manner, the proximal segment 104 may comprise a cylindrical, dual lumen core member 140a of a first diameter D1 about which the reinforcement members or wire braid 110 are wrapped. An outer jacket 142a is then formed about the reinforcement members or wire braid 110, as shown in Figure 4b.
The mid-portion 106 comprises a cylindrical core member 140b of diameter D2, about which the reinforcement members or wire braid 11 0 are wrapped. A cyli ndri cal outer jacket 142b is also formed about the mid-portion 106 of the catheter body 102, and is continuous with the outer surface of the distal portion 108, as showr_ in Figure 4a.
It would be appreciated that the individual portions or members which make up each segment of 104, 106, 108 of the catheter body 102 may be formed of materials whi ch have different physical properties (e. g., hardness, flexural.
properties, etc.) so as to bring about the desire~a regionalized variations in pliability and torque strength the catheter body 102. For example, in a presently preferred embodiment, the cylindrical core member 140a of the proximal portion 104 is formed of a polymer material of a first hardness (e.g., Pebax of 63E Shore Hardness) and the cylindrical core member 140b of the mid-portion 106 is formed of a polymer material having a different hardness (e.g., Pebax of 40D Shore Hardness). The outer jacket 142 a of the proximal portion 104 is formed of another polymeric material having yet a different hardness (e. g., Pebax 70D Shore Hardness) and the outer jacket 142d of the mid-portion 106 is formed of polymeric material having the same or similar hardness of that of the mid-portion 106 (e. g., Pebax of 40D Shore Hardness) other polymeric materials which may be used to form por~ions or members o the catheter body 102 include nylon, polyurethane, polyester, polyvinyl chloride (PVC) etc.
The catheter body 102 has a bottom portion BP and an upper portion UP. A curved or~slanted frontal surface is formed on the distal end of the upper portion. UP.
A first lumen 130 extends longitudinally through the catheter body from the proximal end to the distal end of the upper portion of the catheter body, and terminates distally at the distal outlet aperture 134.
A second lumen 132 al so extends longitudinally through the catheter body from the proximal end thereof to a closed end wall or plug at the distal end of the lower portion LP
of the catheter body 102. A proximal connector 136 is mounted on the proximal end of the catheter body. A
proximal connector 136 has a proximal end port 134 and a side arm port 138. The proximal end port 134 is in communication with the first lumen 130 of the catheter body 102, and the side arm port 138 i s in communication with the second lumen 132 of the catheter body 102. A tissue-penetrating element 150 extends through the first lumen 130. This tissue penetrating element 150 may be any suitable type of tissue penetrating element member, device, or flow of energy, as previously described in United States Patent Application Serial No. 08/730,324, of which this application is a continuation-in-part. In embodiments wherein the tissue penetrating element 150 is an advanceable member or device, a handpiece of the type shown in Figure 3a-3b may be mounted on the proximal end port 134 such that the trigger 80 is connected to the tissue penetrating element 150 and is useable to alternately advance and retract the tissue penetrating element 150, out of/into the outlet aperture 134.
An imaging catheter, such as an intravascular ultrasound (IWS) catheter may be inserted through one of the ports 134, 338 of the proximal connector 136 connected to the second lumen 132. In this manner the imaging catheter (IWS) may be advanced through the second lumen 132 such that a distal portion of the imaging catheter extends into or out of and beyond the distal extent of the second lumen 3.32, thereby placing the imaging transducer or image receiving apparatus at a vantage point which is distal to the outlet aperture 134.
Such imaging catheter may then be utilized to image anatomical structures which are situated adjacent to in the vicinity of the outlet aperture 134, and to view the passage of the tissue-penetrating element 150 out of the outlet aperture 134 and through/into the adjacent anatomical structure.
iv. A Deflectable Catheter System for Formincs ,~.xtralumi.nal,, passageways Figures 7-7b show another type of catheter system which may be utilized to form interstitial passageways between a luminal anatomical structure (e. g., a blood vessel) within which the catheter is positioned and another target anatomical location (e. g., another blood vessel, chamber of the heart, organ, tumor, etc.}.
As shown in Figure ~, the system 1000 comprises a deflectable tipped catheter 110 which is useable in combination with an imaging catheter 112 (e.g., an IWS
r catheter? and a tissue penetrating element 114 (e.g., a sharp-tipped elongate member, or a flow of tissue-penetrating energy).
The deflectable tip catheter 110 comprises an elongate pliable catheter body 1016 having a deflectable distal end DE and a proximal end PE which is connected to a handpiece 2018 .
A presently preferred construction of the handpiece 1118 is shown in Figure 7a, and a presently preferred to construction of the distal end DE of the catheter body 1016 is shown in Figure 7b.
A working lumen 1020 extends longitudinally through the catheter body 1016 and through an opening 1022 in the distal end DE of the catheter body 1016. A secondary lumen 1026 extends longitudinally through the catheter body 1016, at an off center location along one side oL the catheter body. Such secondary lumen 1026 terminates within the catheter body near the distal end thereof, and is thus a blind lumen. A pull wire 1024 extends longitudinally through the secondary lumen 1026 and the distal end 1028 of the pull wire 1024 is anchored or attached to the catheter body at a location within the catheter body, near the distal end thereof. The pull wire 1024 is axially moveable within the secondary Lumen 1026 such that, when the pull wire 1024 is retracted in the proximal direction, it will cause the distal end DE of the catheter body 1016 to deflect in lateral direction, toward the side on which the secondary lumen 1026 is formed, as shown in Figure 7b.
The handpiece 1018 comprises a rear body portion 1030 and a forward body portion 1032 a knob 1034 is formed on the forward body portion 1032. The proximal end of the forward body portion 1032 is received within ar_ inner bore 1036 of the rear body portion 1030 and is slidably retractable and advanceable within such bore 1036. A
tubular member 1038 is positioned axially within the bore 136 of the rear body portion 1030 and extends through a portion of the forward body portion 132 as shown. This tube member 1038 is attached and anchored within the handpiece 1018 by way of a nut 1039. The catheter body 1016 extends through the tubular member 1038 and the proximal end PE of the catheter body 1016 is ar_chored within the rear body portion 1030, as shown. A slot 1040 is formed in the side of the tube member 1038. The pull wire 1014 extends through a small hole formed in the side of the catheter body 1016 within the forward body portion 1032 and through the slot 1040. The proximal end of the pull wire 1024 is attached to a set screw 1042 mounted in the side of the forward body portion 1032. Pn O-ring lo4b is mounted within an annular groove formed ir_ the proximal portion of the forward body portion 1032 such that the O-ring will ride against the inner surface of the bore 1036 of the rear body portion 130 as the forward body portion 1032 is advanced and retracted therewithin.
In operation, when it is desired to cause the distal end DE of the catheter body 1016 to deflect laterally, the operator will grasp the knob 1034 of the forward body portion 1032 and will proximally retract the forward body portion 1032 into the bore 1036 of the rear body portion 1030, while the catheter body 1016 remains axially stationary due to its affixation to the proximal body portion 1030. In this manner, the pull wire 1024 will be proximally retracted within the secondary lumen 1026 and will cause the distal end DE of the catheter body 1016 to deflect in the desired lateral directior_, as shown. Such deflection of the distal end DE of the catheter body 1016 may be utilized to cause the distal end outlet aperture 1022 to be specifically di rected or aimed at the lumi nal wall of a luminal anatomical structure within which the catheter body 1016 is inserted.
A first frusto conical bore 1050 is formed within. an ,.
insert member 1052 located in the rear body portion 1030, and within which the proximal end PE of the catheter body 116 is extended. This frusto conical bore 1050 leads directly into the proximal end of the working lumen 1020 of the catheter body 1016 and will Tacilitate distally directed advancement of a guidewire, imaging catheter 1012, tissue penetrating element 1014, or other elongate apparatus through the main lumen 1020 of the catheter body 1016.
Ar_other insert member 105 having an opposite redirected frusto conical bore 1050 is also mounted withi.~.
the bore 1036 of the rear body portion 1030, proximal to the first insert member 1052. This oppositely directed frusto conical bore 1056 will serve to guide and center the proximal end of a guidewire or similar elongate apparatus over which the catheter body 116 may be advanced such that it passes out of the proximal end PE c' the catheter body 116.
Optionally, a hemostasis valve and/or gripping apparatus 1060 may be mounted on the proxi mal erd of the rear body portion 130, immediately adjacent the proximal end opening 1062 of the bore 136 through which the guidewire(s), imaging catheter 1012, tissue penetrating elerrient 101a or other elongate apparatus may be passed.
In a preferred mode of operation, the catheter body 1016 is initially inserted into a luminal anatomical structure such that the distal end DE of the catheter body 1016 is located generally adjacent a site at which an interstitial passageway is to be formed through the wall of the luminal anatomical structure within which the catheter body 1016 is positioned. The imaging catheter 1012 (e. g., an IWS catheter) is advanced through the proximal opening 1062, through the frusto conical bore 1050, ar_d through the working lumen 1020 of the catheter body 1016 ux~tll the transducer or image-receiving element o~ the imaging catheter 1012 is appropriately positioned to image the side wall of the luminal anatomical structure within which the catheter body 1016 is inserted and/or the target anatomical location to which the interstitial passageway is desired to extend. In many instanced, this will reauire that a distal portion of the imaging catheter 1012 protrudes slightly out of and beyond the di stal end opening 1022 oz the working lumen 1020. With the image catheter'1012 in its operative position, it may be utilized to precisely locate the distal end DE of the catheter body 1016 in the desired longitudinal location and rotational orientation which will cause the distal end opening 1022 to be in alignment with the specific site on the wall of the luminal anatomical structure through which the passageway is to be zormed. T_r_ this manner, one or more imageable markers cr other aiming/positioning systems as 'described ir_ this patent application or in applicant's related patent applications may be incorporated into the system 1000 to facilitate precise aiming and positioning of the distal end DE of the catheter body 1016.
After the distal end DE of the catheter body 1016 has been longitudinally and rotationally positioned/oriented, the imaging catheter 1012 will be extracted and removed, and the tissue-penetrating element lOla will then be advanced through the proximal opening 1062, through the frusto conical bore 1050, and through the working lumer_ 1020 until the tissue-penetrating elemer_t is near the distal end opening 1022 but still contained within the working lamer. 1020. Thereafter, the operator will grasp the knob 1034 of the handpiece 1018 and will retract the forward body portion 1032 of the handpiece rearwardly, into the rear body porticn 1030. This will cause the pull wire 102 to retract and will cause the distal end DE o~ the catheter to become laterally deflected such that the distal end opening 1022 is positioned in direct alignment with the site on the wall of the luminal anatomical structure through which the passageway is to be formed. Thereafter, the tissue-penetrating element lOla will be further advanced out of the distal end opening 1022 of the catheter body 1016, through the wall of the luminal anatomical structure, and through any intervening tissue, until the tissue-penetrating element 1012 emerges into the intended target anatomical location.
Thereafter, the tissue-penetrating element 101~-_ may be retracted through the working lumen 1020 and removed.
Thereafter, one or more secondary apparatus (e. g., channel connector delivery catheters, channel enlarging/modifying catheters, blocker catheters, etc.), may be advanced through the working lumen 1020 of the catheter to perform any desired modifications of the interstitial passageway or delivery of ancillary devices to facilitate flow of blood or biological fluids through the passageway, as desired.
Thereafter, when the procedure has been completed, the operator may again grasp the knob 1034 of the forward body portion 1032 and may distally advance the forward body portion. to its original position, thereby allowing the distal end DE of the catheter body 1016 to return to its substantially straight, non-deflected cor_figuratior..
Those skilled in the art will appreciate that various modifications or changes may be made to the above-described system 1000 without departing from the intended spirit and scope of the invention. For example, although the preferred embodiment has beer_ shown with a single wcrking lumen 1020 extending through the deflectable catheter 1010, a plurality of such lumens may be formed to allow multiple components (e. g., the imaging catheter 112 and the tissue penetrating element 101 and/or a guidewire (not shown) to extend through the catheter body 1016 simultaneously.
However, in many applications it will be desirably to minimize the diameter of the catheter body 1010' and to maximize its pliability or flexibility, thereby rendering it desirable to utilize a single lumen 1020 in such applications.
Optionally, a side port 1057 may be formed in the rear body portion 1030 to permit infusion/withdrawal of fluid through the working lumen 1020 of the catheter 1000.
v_ Markers and Related Apparatus for Positionina/Aimin~
The Passageway Forming Catheters F figures 4d-6c show vari ous markers and other apparatus which may be incorporated into any of the passageway forming catheters described in this patent application. or any other suitable catheter, to provide a means for visually determir_ir_g (e. g., by intracorporeal imaging such as intravascular ultrasound, or by extracorporeal imaging such as fluoroscopy) the precise positioning and rotati oval orientation of the distal portion of the catheter and/or for precisely aiming the tissue-penetrating element so that it will create the desired interstitial passageway as i t is passed out of the passageway-forming catheter.
In particular, Figures 4d-4e show markers which are particularly suitable for use on passageway-forming catheters which have a stepped or slanted distal end configuration, such as that of the torqueable catheters shown in Figure 4a. The remaining showings of Figures 4g-6c show markers and guidance/aiming apparatus which are useable with passageway-forming catheters which have various distal end configuration..
Referring to Figure 4d, there is showr_ a distal portion of a passageway-forming catheter 100 hereupon a generally U-shaped marker 180 is mounted on the upper surface of the lower catheter body, distal to the tissue penetrating outlet opening 134. The longitudinal midline of the marker 180 is in alignment with the path which will be followed by the tissue penetrating element 150 as it is ,.
advanced out of the opening 134 in the catheter 100. In this manner, an imaging apparatus such as an IWS catheter positioned withir_ the lower catheter body portion. at a vantage point distal to the distal end of the t~ssue-penetrating element outlet opening 134, may be utilized to er_sur2 that the marker 180 is in direct alignment with the target tissue prior to advancement of the tissue penetrating element 150. out of the opening 134.
Figure 4e shows a passageway forming catheter 100 having a marker strip 182 mounted on the upper portion. of the lower catheter body, distal to the location of the tissue-penetrating element outlet opening 134. This marker strip 182 creates an image artifact which extends out radially to allow *point* in a specific direction which corresponds to the path of the tissue penetrating element.
The longitudinal midline of t?z,~s marker strip 182 is in alignment with the path which will be followed by the tissue-penetrating element 150 as it passes out o. the opening 134. In this manner, an imaging apparatus such as an IWS catheter positioned within the lower catheter body portion at a vantage point distal to the distal end of the tissue-penetrating element outlet opening 13x, may be utilized to ensure that the marker strip 184 is ir_ direct alignment with the target tissue, prior to advancement of the tissue penetrating elemer_t 150 out of the opening 134.
Figure 4f shows a wire marker 186 mounted on the distal portion of a passageway-forming catheter 100 which has an optional imaging window 101 formed in the lower catheter body, distal to the tissue-penetrating element outlet opening 13x. The details of this imaging window were previously described in applicant's earlier-filed United States Patent Application Serial No. 08/730,x96.
The wins marker,186 comprises a single, elor_gate wire which is attached at its opposite ends, to the proximal and distal boarders of the window 101. The elongate wire WO 98/46119 PCT/US98/0'7134 marker 186 is preferably in the center of the window 101 and in alignment with the path which will be followed by the tissue penetrating element 150 as it is advanced out of the opening 134 in the catheter 100. 2n this manner, an imaging apparatus such as an IVLTS catheter positioned within the lower catheter body portion so as to obtain an image through the imagir_g window 101, may be utilized to ensure that the marker wire 186 is ir.~ direct alignment with the target tissue prior to advancement o~ the tissue penetrating element 150 out of the opening 134.
Figure 4g shows another passageway-forming catheter 100' which has an imaging lumen 300 through which ar_ imaging catheter may be advanced, and a working lumen 302 through which a tissue-penetrating element 150 may pass, such working lumen 302 terminating distally in an outlet opening 134 formed in the side~of the catheter 100' at a spaced distance proximal to the distal er_d of the imaging lumen 300, as shown. A pliable distal tip member 189 is mounted on the distal end of the catheter 100', and the imaging lumen 300 extends through such tip member 189 and terminates in a distal opening formed therein.
Additionally, a hollow passageway 191 extends longitudinally through such tip member 189 in direct alignment with the main portion of the working lumen. 302.
An imagable marking wire member 188, preferably formed of a combination of platinum and stainless steel, extends through the hollow passageway 191 in the tip member 189, and is surrounded 1 aterally by a gap or space 193 within such passageway 191, as shown. The proximal end of this wire member 188 is embedded in a mass of imagable material 190 located within the body of the catheter 100'. Such mass of imagable materi ai 190 is preferably a mixture of tungsten and a plastic (e.g., Pebax) or platinum. The distal er_d of the wire member 188 protrudes out of and beyond the distal end of the catheter body, as shown.
Figures 4h-4h' show another passageway-forming catheter 100" comprising an elongate pliable catheter body having an imaging lumen 300 and a working lumen 302. Pn imaging apparatus, such as IVt7S catheter, is advanceable through the imaging lumen 300. A tissue penetrating element (not shown) is passable through the working lumen 302 and out of the outlet aperture 134. A marker wire lumen 314 extends through a distal portion of the catheter 100" between a proximal opening 316 formed in the upper wall of the imaging lumen 300, and a distal outlet aperture 318 formed in the distal end of the catheter 100" , above the distal end outlet 320 of the imaging lumen. 300. =.
marker wire 310 is disposed within the imaging wire lumer_ 314. A proximal bulb 322 is formed on the prOXimal end of the marker wire 310, and an optional distal bulb 324 may be formed on the distal end therebf. Initially, the marker wire 310 is fully retracted into the marker wire lumen 3i4 such that its distal tip and any distal bulb 324 is wholly contained within the body of the catheter 100" , and with the proximal bulb 322 protruding slightly into the imaging lumen 300. The marker wire may be spring loaded or otherwise biased to this proximally retracted position.
Thereafter, when an IVL1S catheter is advanced through the imaging lumen 300, the distal end oT the advancing IWS
catheter will drive the proximal bulb 322 of the marker wire 310 into a proximal cavity 326 formed at the proximal end of the marker wire lumen 314, thereby advancir_g the marker wire 310 such that a portion of the marker wire and its distal bulb 322 extends out of the distal end outlet aperture 318 and protrudes beyond the distal end of the catheter 100" , as shown in Figure 4h. The distal bulb 322 and a longitudinal axis of the marker wire 310 are ir.
direct with the path which will be followed by a tissue-penetrating element (not shown) as it passes out of the outlet aperture 134. Thus, when the distal bulb 322 of the distally advanced marker wire 310 is ir_ direct alignment with the target tissue on the image received by the IVLTS
catheter, such will ensure that when the ti ssue penetrating element is advanced out the outlet aperture 1 3~ , it will be properly aimed and will advance into the target tissue, as desired.
Figures 4i and 4i' show another passageway-forming catheter 100' ' ' having an imaging lumen which terminates ir~
a distal outlet aperture 320 and a working lumen which terminates in a side outlet aperture 134. An imaging catheter, such as an IWS is advanceable through the imaging lumen, and a tissue-penetrating elemer_t (not shown) is advanceable out of the side outlet aperture 134.
In the particular embodiment shown. in Figure 4i, an arcuate wire marker 330 is mounted on the distal end of the catheter 100' ' ' , ir~ a generally i~orizorta 1 plane, above the distal out end outlet 320 of the imaging lumen 300. This arcuate wire marker 330 may be imaged by the transducer of an imaging catheter which protrudes out of the distal end outlet 320, and a specific, region of the artifact or image produced by the arcuate wire marker 330 may be fused, ai med or aligned with the target tissue, taking into account the distance between the catheter 100 and the target tissue, thereby ensuring that when. the tissue penetratir_g element (not shown) is advanced out of aperture 134 it will extend into the intended target anatomical location or tissue.
In the alternative embodiment shown in Figure 4i', there is provided a 3-legged wire marker 332 rnour_ted or. the distal end of the catheter 100" '. Such 3-legged wire marker 332 comprises bottom legs 334 formed of single wire strands and ar_ upper leg 336 formed cf a singl a wire strand additionally having an outer wire coil formed therearound.
The single wire strand and the outer wire coil may be formed of different materials. The upper leg 336 is in direct longitudinal alignment with the half which will be followed by the tissue penetrating element as i t passes out of the side outlet aperture 1 34 of the catheter 100" ' . In this manner, when an imaging catheter such as an IVUS is advanced out of the distal end opening 320 of the imaging lumen, it may be utilized to directly align the upper leg 336 of the three-legged wire marker 322 with the intended target tissue, thereby insuring that when the tissue penetrating element is passed out of the side outlet aperture 134, it will form the desired passageway into the target tissue.
Figures 4j-4j' show a passageway forming catheter 100" ' having the same configuration as that of Figures 4i-4i', but wherein a deflectable wire marker 340 is mounted on the end of the catheter 100" ', as shown. Such deflectable wire marker 340 preferably comprises a singe wire strand having an additional wire coil formed therearound. This deflectable wire marker 340 has a top end 342 which is attached to the bodv of the catheter 100" ' at a site which is in direct longitudinal alignment with the side outlet aperture 134. Wher_ the deflectable wire marker 3Q0 is in its non-deflected position (Figure 4j) its bottom end 344 will protrude downwardly over the distal end outlet 320 of the imaging lumen 300. Thus, when an imaging catheter such as an IWS catheter is advanced through the imaging lumen 300 and out of the distal end outlet aperture 320 it will abut against the bottom portion of the deflectable wire marker 340, thereby causing the deflectable wire marker 340 to assume a deflected positior_ as shown in Figures 4j'. When the deflectable wire marker 340 is in such deflected position, the longitudinal axis of the deflectable wire marker 340 will be in direct aligr_ment with the path which will be followed by the tissue penetrating element (not shown) as it is passed out of the side outlet aperture 134. In this manner, the imaging catheter (IVI1S) may be utilized to directly align the WO 98/46119 PCT/US9810?134 _3g_ longitudinal axis of the deflectable wire marker 3~-_0 with the target tissue, thereby insuring that when the tissue penetrating element is passed out of the side outlet aperture 134 it will form the desired interstitial passageway into the target tissue.
Figure 4k shows the same tissue-penetrating catheter 100" ' wherein a secondary guidewire lumen 348 extends longitudinally through the body of the catheter 100" ', from a proximal aperture 350 formed ir_ the distal curved surface of the working lumer_ 302 to a distal guidewire outlet aperture 352 formed in the distal end of the catheter body, as shown. In this embodiment, the tissue penetrating element 150' comprises an elongate member having a sharpened distal end and a hollow guidewire lumer_ extending longitudinally therethrough. A guidewire 356 is advancable through the guidewire lumen or the tissue penetrating element 150'. When the tissue penetrating element 150 is retracted into the working lumen 302 as shown in Figure 4k, the guidewire 356 may be advanced out of the distal end of the tissue penetrating element 150, through the secondary guidewire lumen 348, wherein it will act as a marker which may be imaged by a imaging apparatus (e . g . , an IWS catheter) passed through the imagi ng luT,er_ 300. The longitudinal axis of the guidewire 356, when.
positioned within the secondary guidewire lumen 3~8, will be in direct alignment with the path which will be followed by the tissue penetrate ng element 150 as it i s advanced out of the side outlet aperture 134.
The showing of Figure 4k also incorporates a separate image-enhancing means whereby energy (e. g., ultrasonic vibration) may be imparted to the tissue penetrating elemer_t 150' as it is advanced out of the side outlet aperture 134 to render the distal portion of the tissue penetrating element 150' more easily visible by the imaging apparatus (e. g., IWS catheter) positioned in the imaging lumen 300. This is accomplished by an energy emitting member 370, such as an ultrasound generating device is mounted in the wall of the catheter 100" ', about the side outlet aperture 134. A connector wire 372 extends longitudinally through the catheter 100" ' to its proximal end, to permit the energy-emitting apparatus 370 to be connected to an appropriate source of energy. As the tissue penetrating element 150' is advanced out of the side outlet aperture 134, the energy emitting apparatus 370 is energized via the connector wire 372, thereby .imparting energy to the distal portion of the tissue penetrating element and enhancing its visibility by the imaging apparatus positioned within the imaging lumen 300. One example of an ultrasound emitting chip which may be used as the energy emitting apparatus 370 such as a piezoelectric crystal of the type generally known in the art as a PZT
crystal (lead-zirconate titanate).
Figure 41 shows a passageway-forming catheter 100" ' of the same general configuration shown in Figures 4i-4k, but wherein at least a portion of the imaging lumen 30o is of non-round configuration. In the preferred embodiment shown, the imaging lumen 300 is . of rectangular configuration having a longitudinal groove 373 extending along the upper surface thereof, as shown. A
correspondingly shaped engagement member 378 is formed on the catheter 374 and such engagement member incorporates a longitudinal tongue 379 which fits slidably into the corresponding groove 373. In this manner, the catheter 374 can be inserted only in the desired rotational orientation, as shown. A phased array imaging catheter 37~ having a phased array imaging transducer 376 mounted thereon is advanceable through the imaging lumen 300 of the catheter 100 " '. The irregularly shaped or non-round engagement member 378 formed on the outer surface of the phased array imaging catheter 374 and is configured to fractionally engage the wall of the imaging lumen 300 to prevent the phased array imaging catheter 374 from rotating within the imaging lumen 300. An electronic marker is formed within.
the circuitry of the phased array imaging catheter 374 so as to mark a desired location L which is in direct alignment with the outlet aperture 134 of the catheter 100" ' when the phased array imaging catheter 374 is ron-rotatably inserted into the imaging lumen 300. girl this manner, the electronically marked location L may be placed in direct alignment with the target tissue viewed on the image received through the phased array imaging catheter 374, thereby insuring that the outlet aperture 134 is also in alignment with the target tissue. It should be appreciated, that as an alternative to internally or electronical ly marking the desired location L on the phased array transducer 376, various imagable markers may be formed on the body of the catheter 100" ' to mark the rotation of the outlet aperture 13a, examples os such imagable markers being described hereabove and shown ir_ Figure 4d-4k.
One example of an electrical system which may be utilized to electronically mark a desired locaticn L or. the image received from the phased array transducer 376 is shown, in schematic fashion, in Figure 41'. With reverence to Figure 41 and 41' , the phased array trar_sctucer 376 0 the phased array imaging catheter 374 has a plural i ty o~
individual crysta 1 s 900 formed at spaced-apart 1 ocations on the transducer 376. Wires 902 extend from each of the individual crystals 900 of the phased array transducer 376, through the body of the phased array imaging catheter 374 and out of the proximal end thereof. One of these individual wires 902a is separated from remair_ir_g wires 902b, and the remaining wires 902b extend directly into a monitoring console 904 which produces the viewable image from the phased array transducer 376. The selected wire 902a is connected to a switch 906. Wher_ the switch 906 is in its open posi tion, the signal received from the selected wire 902a will be shunted through a bypass circuit 908 which rejoins the remaining wires 902b prior to entry into the monitoring console 904. In this manner, when the switch 906 is open, the signal received from the selected wire 902a will bypass the signal modifying apparatus 903 and will rejoin the signals received from the remaining wires 902b to provide an image on the image monitoring console 904 which is unchanged and unmarked. .~iowever, when the switch 906 is closed, the signal received from the selected wire 902a will pass through a signal modifying apparatus 903. This signal modifying apparatus 903 may simply be an open switch which terminate the signal, thereby providing a void in place of the image which would be displayed from the individual crystal 90C from which the selected wire 902a extends. Alternatively, such signal modifying apparatus 903 may be a saturation apparatus which will produce white noise, or a color imparting apparatus which will tint or color the image received from the selected wire 902a. In either case, the image which subsequently appears on the image monitoring console 904 from the selected crystal 900 from which the selected wire 902a extends will be visually discernable by the operator and will provide a marking of the desired location L on the phased array imaging transducer 976.
Figures 4m and 4m' the presently preferred embodiment comprising a catheter 100" " wherein a segment of the catheter body is cut away, with a plurality (e. g., (three (3)) struts 402, 404, 406 formed a connectior_ between a proximal portion 408 of the catheter 100" " and a distal portion 410 thereof, so as to form an imaging cage wherein the imaging catheter (e.g., IVL1S) may be positicned. The top strut member 404 is of elongate configuration, and it longitudinal axis is directly aligned with the side outlet _88_ aperture 134 through which the tissue penetrating element will pass . In this mar_ner, when an imagir_g catheter is passed through the imaging lumen 300 such that its imaging transducer is located within ar distal to the oben area 400, such imaging catheter may be utilized to directly image the upper strut 404 and the catheter body 100' ' ' ' may be rotated until the upper strut 404 is in direct alignment with the image of the intended target tissue, thereby insuring that when the tissue penetrating el emer_t passes out of the side outlet aperture 134 it will form the desired interstitial passageway into the target tissue.
Optionally, a pliable, hollow tip member 412 may be mounted on the distal end of the catheter 100" " . In the embodiment shown in Figure 4m the optional tip member 412 is a frusto conical configuration, while in the embodiment of Figure 4m' the tip member~412' is of hemispherical configuration. It will be appreciated that this cage-like structure may be formed in many ways including by EDN
technology or by forming the struts 402, 406, 408 of individual wires.
Any of the above-described markers shown in Figures 4d-4m' may incorporate regions thereon or discrete markings formed thereon, each such region or discrete marking being correlated to a specific range or distance from the catheter 100 to the anatomical target location. In this manner, the imaging apparatus (e.g., IVL7S catheter? may be selectively used to align a specific region or distance-correlated marking on the marker with the target anatomical locations, based on the operator's knowledge, estimate or .calculation of the range or distance from the catheter 100 to the target anatomical location. Additior_ally or alternatively, in embodiments wherein the imaging apparatus is mounted on a catheter which is insertable through an imaging lumen 300 in the passageway-forming catheter 100, the passageway forming catheter 100 may be provided with length markings or friction-producing regions within the imaging lumen 300 to provide increased resistance or some other tactile sensation whereby the operator may judge the length of the imaging catheter (e. g., IVLTS catheter) which has been advanced through the imaging lumen 300 and the present location of the imaging transducer or other image receiving apparatus thereon. In this manner, the operator may precisely position the imaging transducer or image receiving apparatus at a specific location (e.g.,, extended out of the distal end oper_ing 320 and immediately distal to the distal end of the catheter 100) which provides the optimal vantage point for visualization of the target anatomical structure and marker, and for resultant aiming of the marker by rotational and longitudinal adjustment of the catheter 100.
Any of the imageable markers described herein, including but limited to those shown in Figures 4d-am, may be formed of materials which affect the form of energy which is sensed by the imaging apparatus or catheter (e. g., ultrasound being received by an IVtTS catheter) to modify or enhance the artifact created by the marker. For example, any of these markers may be formed of material (e. g., soft plastic having low acoustic impedance) which is absorptive of the ultrasound or other energy form received by the imaging apparatus and, therefore, will appear as a void or black area on the image screen. Similarly, these markers may be formed of material (e.g., metals or alloys such as stainless steel, beryllium, or Nitinol) which is partially internally reflective of the energy form so as to give rise to an artifact (e.g., a streak or ray) which appears to emanate from in one or more directions from the exact location of the marker. In this manner, the marker may be positioned at a precise location and may be formed of material which is partially internally reflective such that an artifact (e. g., a ray or streak) is formed on the image screen which directly correlates to the path which will be followed by the tissue-penetrating element, such artifact (e. g., ray or streak? being useful to er_able the operator to determine the precise path which will be followed by the tissue penetrating element. In other applicatior_s, the marker may be formed of material which is reflective of the energy form such that a bright spot or exaggerated area will appear on the image screen wher_ such marker is surrounded by tissue or other matter which is less then totally reflective of the energy form. Thus, in addition to the above-described methods for modifying the markers by applying energy (e.g., ultrasound) to the body of the marker, the exact form of the image or artifact produced by the marker may also be altered or optimized by forming the marker of a particular material of varied acoustic impedance, ranging from air or~fluid filled cavities, to solid materials, to produce a range of marker effects on the image produced.
Figure 5 shows an alternative positioning-aiming system which is useable to facilitate precise positioning and aiming of the passageway forming catheter 100a. In this system, a signal emitting apparatus 500 is positioned in the target area (e. g., within a second blood vessel BVZ) and a signal receiving apparatus 502 is mounted within the passageway-forming catheter 100a located within in a first blood vessel BV1. The sigr_al emitting apparatus 500 comprises a signal emitting wire 504 having a tubular shield 506 surrounding the shaft of the wire such that only a distal portion 508 of the wire 504 extends out of the distal end of the shielding tube 506. The shielding tube 506 may comprise any suitable electromagnetic shielding material, and is preferably formed of a pliable plastic tube having an aluminum braid formed therein. Those ski 1 led in the art wi 1 1 appreciate that the signal emi tting wire 504 may be attached to an extracorporealiy located _a1_ signal generating apparatus capable of passing ar~
electromagnetic signal through the wire 504. Such electromagnetic signal may be a 20 Khz signal.
The signal receiving apparatus 502 is preferably formed within the wall of the passageway forming catheter 100a laterally outboard of the working lumen 302 through which the tissue penetrating element is passed, and in direct alignment with the tissue penetrating element outlet aperture 134 formed in the side of the catheter 100a.
30 Optionally, the catheter 100a may also include an imaging lumen 300 through which and imaging catheter (e. g., an IVUS
catheter) may be passed. However, tr~ose skilled in the art will appreciate that in many applications the signal emitting apparatus 500 and signal receiving apparatus 502 will be operable to control the precise positioning and rotational orientation of the catheter 100a, and such imaging lumen 300 may be unnecessary.
The signal receiving apparatus 502 formed in the passageway-forming catheter 10.0a comprises a signal receiving wire 520 having a tubular shielding apparatus 512 formed therearound. The tubular shielding apparatus 512 surrounds the shaft of the receiving wire 514 and G short distal portion 514 of the receiving wire 510 extends out of and beyond the distal end of the tubular shield 512. The tubular shield 512 may be formed in the same manner as the above-described tubular shield 506 of sigr_al emitting apparatus 500. The exposed distal portion= 51~-_ of the signal receiving wire 510 is located immediately adjacent, and in longitudinal al ignment with the side outlet aperture 134. In this manner, an electro magnetic sigr_al may be emitted through the signal emitting apparatus S00 after it has been positioned within- the second blood vessel BVz or other target tissue. The longitudinal positioning and rotational orientation of the passageway-forming catheter 100a inserted withir_ the first blood vessel Bvl may then be adjusted until the signal rece-ved by the signal receiving apparatus 502 of the catheter 100a is at its t~e''u-k intensity, thereby indicating that the exposed distal portion 514 of the receiving wire 510 has been positioned at its closest possible point to the exposed distal portion 508 of the signal emitting wire 504. This wi?1 ensure that the passageway forming catheter 100a is longitudinally positioned at the closest straigrt-lined point from the signal emitting apparatus 500 located with~n the second l0 blood vessel BVZ or other target tissue, and .that the catheter 100a has been rotated to a rotational orier_tation wherein the outlet aperture 134 is directly aimed at the signal emitting apparatus 500 located within the second blood vessel BVz or other target tissue . It wi 11 be Further appreciated by those skilled in the art that various types of energy-emitting signals may be utilized into, such that the signal emitting apparatus 500 lccated within the second blood vessel BVZ or target tissue is an "active" element and the signal receiving apparatus 502 associated with the passageway forming catheter 100a is a "passive" or receiving element. The types oz signals which may be utilized include, but are not necessarily limited to, electromagnetic signals (as specifically described hereabove), sonic signals (e. g., doppler), ultrasonic signals, high inter_sity light, laser, radiozrequer_cy, etc.
Figure 5a shows another positioning/aiming system which is wholly incorporated into the passageway-formi ng catheter 100b. A signal emitting or "active" component 520, such as a piezoelectric crystal is mounted upon or formed within the catheter 100b so to emit a signal or fl ow of energy which will strike, er_ter or be reflected from the target tissue T. A passive or receiving apparatus, such as another piezoelectri c crystal may be mounted at a second location within or upor_ the catheter 100d so as to receive a reflected signal or returning signal from the target r ,.
_a3_ tissue T. The positior_ oz the passive or receivir_g apparatus 522 relative to the active or emitting apparatus 520 is known, and may be utilized to precisely determir_e the longitudinal position and rotation orientation of the catheter 100b. In this manner, this positioning/aiming system may be utilized to effect precise longitudinal positioning and rotational orientation of the catheter such that when the tissue penetrating element is passed out of the outlet aperture 134, it will extend ir_to the target tissue T, as desired. Those skilled ir_ the art will appreciate that, as an alternative to the passive receiving apparatus 522, or in addition thereto, an optional imaging lumen 300 may extend through the body of the catheter 100b such that an imaging catheter (e.g., IVL1S catheter or receivir_g catheter carrying the passive receiving apparatus 522 may be passed through such'lumen 300 and utilized to alternatively cr Gdditionally facilitate the positioning and rotational orientation of the catheter 100b.
Figure 5b shows yet another alternative positioning/aiming system wherein a signal emitting crystal 530 is positioned on or within the catheter 100c so as to emit a signal (e.g., ultrasound or sound waves) in a direction which is specifically aligned with the path which will be followed by the tissue penetrating element as it passes out of the side outlet aperture 13a ar_ imaging catheter. An imaging catheter (e. g., an IVT1S cGtheter) positioned within the imaging lumen 300 is utilized to receive the signal from the crystal 530 after it has reflected front the target tissue T, thereby discerning the specific point of impingement X on the target tissue T
where it is struck by the energy being emitted by the signal emitting crystal 530. In this mar_ner, the imaging catheter positioned within the imaging lumen 300 may be utilized, to precisely position and aim the outlet aperture 134 of the passageway-forming catheter at the energy impingement point X on the target tissue T, thereby insuring that, when the tissue. penetrating element is advanced out of the outlet aperture 134, it will extend into the target tissue T at a desired site.
Further referring to Figure 5b, the signal emitting crystal S30 may be alternatively utilized as a signal receiving crystal, such that it will receive re=lected ultrasound from the IVLS, as indicated by the dotted arrows on Figure Sb. Since the signal receiving crystal 530 is specifically positioned and oriented in relation to the outlet 134 and/or path of the tissue penetrating element 150, such receipt of the IVL1S ultrascund by the signal receiving crystal 530 will enable the operator to precisely position and rotatior_ally orient the catheter such that the tissue penetrating element 150 will pass directly into the target tissue T, in parallel -to the path of reflected ultrasound received by the signal receiving crystal 530.
Figure Sc shows yet another positior~ing/aimir_g system wherein the passageway-forming catheter 100d has a working lumen 302 which terminates in a side outlet aperture 134 and through which a tissue-penetrating element 500 in the nature of an elongate member S40 havir_g a sharpened distal end may be advanced through such working lamer- 302 Gnd out of the side outlet aperture 134 of the catheter 100d. The elongate member 540 in this embodiment is equipped with a sensor apparatus 548 positioned Gt or rear the sharpened distal end of the elongate member 540. A connector wire 550 may extend longitudinally through the elongate member 540 to permit the sensor 548 to send a signal through the shaft of the member 540 to an extracorporeai locatior_ at which such signal may be processed and/or monitored. The sensor 548 may be any suitable type o= sensor which will sense the presence and/or location of the inter_ded target tissue T. Parameters or variables which may be ser_sed by the sensor 548 include temperature, pulse, flow, or other r characteristics of the target tissue T, capable of being mechanically, electronically or optically sensed.
Additionally or alternatively, an energy emitting or "active" apparatus, such as the energy emitting apparatus 500 described hereabove with reference tc Figure 5, may be positioned within the target tissue T and the sensor 5~3 formed on the tissue penetrating member 5~0 may be adapted to receive and sense energy emitted by the active energy emitting member located within the target tissue T. In this manner, the tissue penetrating member 540 serves its own sensing function and enables the operator to control the longitudinal and rotational position of t he catheter 100d prior to or during the advancemen~. o. the tissue penetrating member 540 out of the outle~ aperture 13~ and ir_to the target tissue T. It will be apprecia~ed by those skilled in the art, when a tissue penetrating member S~0 having an onboard sensor 5~8 of the type desc=ibed here'n 1S utl.llZed, SLCh W111 ellminate the need f0'' anV Other extracorporeal or intracorpcreal imagir_g cr sensing apparatus for aiding in positioning or rotational orientation of the catheter 100b. Alterr_atively, the catheter 100b may also be provided with c~her onboard aiming/positioning apparatus or an imaging lumen 300 as described in reference to various other embodiments shown in Figures a-5.
Figure 5d shows another aiming/positicnins system which is similar to that shown in Figure 5b, but wherein the emitting member 530 (e. g., ar_ ultrasound emitting piezoelectric crystal) is aimed downwardly at the transducer or receiving port of the imaging catheter (e. g., IWS catheter) , ar_d the emitting member 530 is specifically positioned relative to the outlet openir_g 13~ so as to provide an imageable marking at the outlet opening 13~. In this manner, the imaging catheter (IVLJS catheter) may be used to specifically site and identify the location of the .y. .__.___ __ ____~__",~___""~y1 ~~...
3~ rotationally move the catheter until the signal received WO 9$/46119 PCTIUS98/07134 outlet aperture 134, thereby facilitating longitudinal positioning and rotational aiming of the catheter prior to deployment of the tissue penetrating meiaber 150.
Figure Se shows one embodiment of a system 790 which may be utilized to facilitate optimization or peaking of the signal received from a sensor or receiving component r~hich is utilized to position and aim the catheter, such as those described hereabove and identified by reference numerals 502, 522, 530 and 598. In this system 794, the wire 510, 521, 531, 550 through which a signal is received from the receiving coiaponent 502, 522, 530, 548 is connected to a switch 818. When the switch 818 is open, the signal received will not enter the system 790.
However, when the switch 818 is closed, the signal received from the receiving or sensing component 502, 522, 530, 548 will enter a signal conditioning and filtering component 880 wherein the signal will undergo condit~.oning and filtering. Thereafter this signal will pass through a rectifier 810 wherein the signal will be rectified, and through a leaky integrator 812 of the type well known in the art. Such leaky integrator 812 may comprise a capacitor and a resistor in parallel. The integrated signal from the leaky integrator 812 may then pass into an analog to digital convertor 814, if desired, whereby it will be converted to a digital signal, and such digital signal will then be fed to a display 816 of a type suitable for indicating the relative intensity of the signal received. Such display may be an LED or multiple light display, whereby a column or array of lights are provided and the intensity of the signal received is indicated by the height of the column or the number of lights in the array which are lit at any given time.
In this manner, the system 790 shaven in Figure 5d may be utilized to enable the operator to longitudinally and rotationally move the catheter until the signal received from the receiving component or sensor 502, 522, 530, 5~8 has been peaked or optimized, thereby indicating that the catheter is properly positioned such that the tissue penetrating element will extend from the outlet 130 into the target anatomical location T.
Figures 6-6c show other catheter marking schemes which may be used in conjunction with an extracorporeal imaging apparatus 118, such as a fluoroscope, positioned adjacent a mammalian body MB. In the showing o~ Figure 6, a to catheter 100 has been advanced into the blood vessel Bv"
and such catheter is marked with one of the marking schemes of this embodiment of the present inventior_. Figures o'a-6c show the manner in which the marking scheme o~ the catheter 100 will appear on the fluoroscopy screen 120 as the catheter is rotated within the blood vessel BV..
Referring to Figure 6a, there is provided a marking scheme which comprises a first radio-opaque linear marking 122 on one side of the catheter body, and a second radio-opaque linear marking 122b. The second linear marking 122b is located directly and 180° opposite the first linear marking 122a, but slightly more distal to the first marking 122a. An additional rotation indicating indicia 200, comprising the letter "R° formed of radio-opaque or other imagable material, is formed to the right of the first linear marking 122a. As shown in Figure 6a, when. the catheter is in its desired rotational orier_tatior_, the first ar_d second linear markings 122a and 122b will appear next to and in linear aligr_mert with one another on the fluoroscopy screen 120. When such markings 122a and 122b are viewed from the right side RS of the catheter body the rotational marking indicia 200 will appear as the letter "R". However, when the catheter is rotated 180° such that the fluoroscope 118 views the catheter from the left side ZS of the catheter body, the rotational marking indicia 200 will appear as the inverted mirror image of the letter "R" , thereby inforrraing the operator that the catheter is rotated 180° from the desired rotational orientation.
Figure 6b shows a similar markir_g scheme wherein the rotational marking indicia 200 is formed adjacent a radio s opaque circle 24 formed on the right side RS of the catheter body such that, when the catheter bcdy is in its desired rotational position, a radio-opaque dot 126 formed on the left side LS of the catheter body will appear within the circle 124 on the fluoroscopy screen 120, and the rotational marking indicia 200 will appear as the letter "R" to the right of the radio-opaque circle 124. However, when the catheter body is rotated 180° such that the fluoroscope 118 is viewing the left side LS of the catheter body, the rotational marking indicia 200 will appear as the inverted mirror image of the 1 etter "R" or the ? ef t side of the circular markir_g indicia 124, as illustrated in Figure 6b.
Similarly, as shown in Figure 6c, the catheter X00 may be provided with two (2) through holes 128a, 128b formed in direct linear alignment with one another o:. opposite sides of the catheter 100. Adjacent one of the through holes is an imageable marker in the form of the letter "R". When the catheter 100 is rotated such that the through holes 128a, 128b are in direct alignment with the extracorporeal imaging apparatus 118, both through holes 128a, 128b will appear as a single aperture on the image provided on the image viewing apparatus 120. However, when the through holes 128a, 128b are not in direct alignment with one another, they will appear as separate images on the image viewing apparatus 120. In this manner, these through holes 128x, 128b may be utilized to discerr_ the correct rotational orientation of the catheter using an extracorporeal imaging apparatus 118. Similarly, as described hereabove, the letter R will appear differently depending or_ which side of the catheter 100 is closest to the imaging apparatus 118, thereby avoiding any possible inadvertent 180° mis-rotation of the catheter.
vi. Apparatus For Preventing Inadvertent De~lovment of Tissue Penetrating Element Figure 8 shows another embodiment of the catheter l0oe which incorporates apparatus for preventing inadvertent deployment of the tissue-penetrating element 150. Ir_ this catheter 100e, a lumen closure member 548 is pivotally mounted on one side of the working lumer_ 302 through which the tissue penetrating element 150 will pass sucr. that, when in an upwardly pivoted position, such member 548 will block the lumen and prevent inadvertent advancement of the tissue penetrating element out of the opening 134. A
balloon 544 or other pressure exerting member is mounted within the body of the catheter~l00e, adjacent the blocking member 548 in the embodiment shown, a balloon inflation lumen 546 extends through the catheter to permit alternate inflation and deflation of the balloon. In this manner, when the balloon 544 is inflated, as shown in Figure 8, the member 548 will pivot upwardly so as to block the working lumen 302 in a manner which will prevent inadvertent deployment of the tissue penetrating element 150.
Alternately, when the balloon 544 is deflated, the member 548 will pivot downwardly thereby restoring the working lumen 302 to an oper_ configuration through which the tissue-penetrating element 150 may pass.
Figure 8' shows another embodiment of the catheter 100e which incorporates apparatus for stabilizing the catheter within a vessel after proper orientation has been confirmed. This apparatus also prevents inadvertent deployment of the tissue penetrating element 150 in combination with the stabilization. Ir_ this catheter 100e, a lumen closure member 548' is pivotally mounted near the working lumen 302 through which the tissue penetrating element 150 will pass . The lumer_ cl osure member 548' is biased or spring loaded by spring member 998 such that when the balloon, 544' or other pressure exerting member is deflated, lumen 302 is blocked preventing inadvertent advancement of the tissue penetrating element out of the opening 134 . A balloon inflation 1 umer_ 546 extends through the catheter to permit al ternate inflation and deflation of the ball oor_. After proper orientation of the catheter 100e has been confirmed, the balloon is inflated which causes a portior_ of the balloon to exit the side of the catheter through exit port 999 which secures the catheter in place within the vessel, 997 as is shown in Figure 8" .
Simultar_eous with anchoring the catheter ir_ place, inflation of the balloon causes lumen closure member 548' to pivot thereby opening the working lumen 302 to allow advancement of the tissue penetYating element 150.
Materials, construction and treatments of the balloon, 544' may be made to prevent undesired movement or dislodgment in the vessel during its inflated state.
Treatment may include surface modificatior_, Dacron, or other means.
It should be appreciated that the general concept of combining ar_ anchoring device which is deployed after confirmation of proper orientation of the tissue penetrating element which simultaneously or nearly thereafter, removes a safety device previously in place to prevent inadvertent advancement of the tissue penetrating element, can be accomplished in other ways not completely described above.
It will be appreciated by those skilled in the art that the invention has beer. described hereabove with reference to certain presently preferred embodiments and examples only, and no effort has been made to exhaustively describe all possible embodiments and examples in which the invention may take physical form. Furthermore, it will be appreciated that each of the specific components and elements of the above-described embodiments and examples may be combined or used in conjunction with any of the other components shown in relation to other embodiments or examples, to the extent such recombination of elements or components may be accomplished without rendering the device, apparatus, or system unusable for its intended purpose. Furthermore, various additions, deletions, modifications, and alterations may be made to the above-described embodiments and examples without departing from the intended spirit and scope o~ the inventior_.
Accordingly it is intended that all such variations, recombination, additions, deletions ar_d modifications be included within the scope of the following claims.
Claims (39)
1. A torqueable sheath which is insertable into a mammalian body and useable to rotationally position of the distal end of a catheter which has been inserted through the sheath; said sheath comprising:
a pliable tubular sheath body having a proximal end, a distal end and a hollow lumen extending longitudinally therethrough, said tubular sheath body having sufficient torque strength to transfer torque from the proximal end thereof to the distal end thereof, such that the distal end or the sheath body will rotate in substantial correlation with the proximal end of the sheath body;
a catheter engaging surface formed within the lumen of the sheath body, said catheter engaging surface being operative to engage the catheter when the catheter has been inserted through the sheath, such that i) the catheter will be prevented from rotating independently of the introduces sheath, but ii) at least the distal end of the catheter will be caused to rotate in unison with the sheath.
a pliable tubular sheath body having a proximal end, a distal end and a hollow lumen extending longitudinally therethrough, said tubular sheath body having sufficient torque strength to transfer torque from the proximal end thereof to the distal end thereof, such that the distal end or the sheath body will rotate in substantial correlation with the proximal end of the sheath body;
a catheter engaging surface formed within the lumen of the sheath body, said catheter engaging surface being operative to engage the catheter when the catheter has been inserted through the sheath, such that i) the catheter will be prevented from rotating independently of the introduces sheath, but ii) at least the distal end of the catheter will be caused to rotate in unison with the sheath.
2. The torqueable sheath of Claim 1 wherein said tubular sheath body is formed of a polymeric material having reinforcement members disposed therein to increase the torque strength of said polymeric material.
3. The torqueable sheath of Claim 2 wherein said reinforcement members are formed into a braid.
4. The torqueable sheath of Claim 3 wherein said braid is formed of first and second groups oz elongate members, each of said groups of elongate members being made up of a plurality or individual elongate members arranged in substantially parallel, side-by-side relation to one another, said first group being wound about the lumen of the sheath body in a clockwise direction, and said second group being helically wound about the lumen of the sheath body in a counterclockwise direction, such that the elongate members of the first group cross wits the elongate members of the second group at a plurality of cross-over locations, the individual elongate members of the first group being alternately passed over and under the individual elongate members of the second group at said cross-over locations, so as to form .a tubular braid about the lumen of said sheath body.
5. An achorable guide catheter which is insertable into a luminal anatomical structure, said guide catheter comprising:
a elongate catheter body having at least one lumen extending longitudinally therethrough;
an opening formed at a first location in said catheter body, in communications with said at least one lumen;
a pressure exerting member formed on said catheter body, said pressure exerting member being engageable with the luminal anatomical structure to prevent the first location of the catheter body from moving within the luminal anatomical structure.
a elongate catheter body having at least one lumen extending longitudinally therethrough;
an opening formed at a first location in said catheter body, in communications with said at least one lumen;
a pressure exerting member formed on said catheter body, said pressure exerting member being engageable with the luminal anatomical structure to prevent the first location of the catheter body from moving within the luminal anatomical structure.
6. The anchorable guide catheter of Claim 5 wherein said pressure exerting member is a balloon, and wherein said balloon is inflatable such that it will engage the luminal anatomical structure to prevent the first location of the catheter from moving within said luminal anatomical structure.
7. The anchorable guide catheter of Claim 6 wherein said balloon includes a friction enhancing treatment upon a surface of the balloon which engages the luminal anatomical structure.
8. The anchorable guide catheter of Claim 7 wherein said friction enhancing treatment on said balloon. is selected from the group of friction enhancing treatments consisting of:
texturing;
adhesive; and, woven fabric.
9. The anchorable guide catheter of Claim 5 further comprising:
at least one engagement surface associated with said first lumen, said at least one engagement surface being operative to engage a second catheter which has been inserted through said first lumen such that said second catheter is thereby prevented from rotating independently of said balloon-anchorable guide catheter.
7. The anchorable guide catheter of Claim 6 wherein said balloon includes a friction enhancing treatment upon a surface of the balloon which engages the luminal anatomical structure.
8. The anchorable guide catheter of Claim 7 wherein said friction enhancing treatment on said balloon. is selected from the group of friction enhancing treatments consisting of:
texturing;
adhesive; and, woven fabric.
9. The anchorable guide catheter of Claim 5 further comprising:
at least one engagement surface associated with said first lumen, said at least one engagement surface being operative to engage a second catheter which has been inserted through said first lumen such that said second catheter is thereby prevented from rotating independently of said balloon-anchorable guide catheter.
7. The anchorable guide catheter of Claim 9 in combination with at least a) an imaging catheter and b) a passageway-forming catheter having a tissue-penetrating element which is passable through the wall of the luminal anatomical structure within which the balloon-anchorable guide catheter is positioned, said anchorable guide catheter being useable in conjunction with said imaging catheter and said passageway-forming catheter to form said passageway through the wall of the luminal anatomical structure, at a predetermined location, by the following steps:
i) transluminally advancing the guide catheter into said luminal anatomical structure until the opening of the guide catheter is near the location on the luminal anatomical structure through which said passageway is to be formed;
ii) inserting the imaging catheter into a lumen of the guide catheter such that the imaging catheter will image anatomical structures which are in alignment with the opening of the guide catheter;
iii) moving the guide catheter until the image obtained by the imaging catheter indicates that the opening of the guide catheter is in alignment with the site at which the extravascular passageway is to be formed;
iv) causing the pressure exerting member to engage the luminal anatomical structure 10 as to hold the first location of the guide catheter in substantially fixed position;
v) removing the imaging catheter from the first lumen of the guide catheter;
vi) inserting the passageway-forming catheter into a lumen of the guide catheter such that the passageway-forming catheter engages the at least one engagement surface of the guide catheter;
vii) causing the tissue-penetrating element to pass out of the passageway-forming catheter, through the opening of the guide catheter, and through the wall of the luminal anatomical structure, thereby forming said passageway.
i) transluminally advancing the guide catheter into said luminal anatomical structure until the opening of the guide catheter is near the location on the luminal anatomical structure through which said passageway is to be formed;
ii) inserting the imaging catheter into a lumen of the guide catheter such that the imaging catheter will image anatomical structures which are in alignment with the opening of the guide catheter;
iii) moving the guide catheter until the image obtained by the imaging catheter indicates that the opening of the guide catheter is in alignment with the site at which the extravascular passageway is to be formed;
iv) causing the pressure exerting member to engage the luminal anatomical structure 10 as to hold the first location of the guide catheter in substantially fixed position;
v) removing the imaging catheter from the first lumen of the guide catheter;
vi) inserting the passageway-forming catheter into a lumen of the guide catheter such that the passageway-forming catheter engages the at least one engagement surface of the guide catheter;
vii) causing the tissue-penetrating element to pass out of the passageway-forming catheter, through the opening of the guide catheter, and through the wall of the luminal anatomical structure, thereby forming said passageway.
8. The anchorable guide catheter of Claim 7 wherein the pressure exerting member is an inflatable balloon, and wherein the step iv) comprises inflating the balloon such that the balloon will engage the luminal anatomical structure.
9. In a passageway-forming catheter of the type having i) an elongate catheter body and ii) a tissue-penetrating element which is advanceable out of a first location on the elongate catheter body so as to pass through the wall of a luminal anatomical structure and to a target location in which said catheter is positioned, and iii) an imaging means which is useable to image the target location, the improvement comprising:
a marker formed on said catheter at a second location, said second location being positioned relative to said imaging means and said first location, such that when the position and rotational orientation of the catheter is adjusted such that said marker is aimed at said target location, said tissue penetrating element will penetrate through the wall of the luminal structure and into said target location.
a marker formed on said catheter at a second location, said second location being positioned relative to said imaging means and said first location, such that when the position and rotational orientation of the catheter is adjusted such that said marker is aimed at said target location, said tissue penetrating element will penetrate through the wall of the luminal structure and into said target location.
10. The catheter of Claim 9 wherein said marker comprises:
a U-shaped member mounted on said catheter.
a U-shaped member mounted on said catheter.
11. The catheter of Claim 9 wherein said marker comprises:
an elongate, generally rectangular member mounted on said catheter.
an elongate, generally rectangular member mounted on said catheter.
12. The catheter of Claim 9 wherein said marker comprises:
a elongate wire mounted on said catheter.
a elongate wire mounted on said catheter.
13. The catheter of Claim 9 wherein said marker comprises an arcuate member attached to and extending distally from the distal end of the catheter body, said arcuate member being disposed in a plane which is substantially perpendicular to the path of the tissue-penetrating element.
14. The catheter of Claim 9 wherein said marker comprises a tripod member mounted on the distal end of the catheter, said tripod member having first second and third legs attached to said catheter and to one another, at least one of said legs being in alignment with the path Of the tissue penetrating element.
15. The catheter of Claim 9 wherein the imaging means comprises an elongate imaging lumen which extends longitudinally through the catheter body and into which an imaging apparatus is insertable and positionable so as to obtain an image of said marker and said target anatomical structure.
16. The catheter of Claim 15 wherein said imaging lumen extends longitudinally through the catheter and opens through an outlet aperture in the distal end of the catheter, and wherein said imaging apparatus is advanceable through said lumen such that the imaging apparatus protrudes out of and extends beyond the distal end of the catheter.
17. The catheter of Claim 15 wherein said imaging lumen extends longitudinally through said catheter and wherein an imaging window is formed at a second location on said catheter such that an imaging apparatus may be advanced through said imaging lumen and utilized to obtain an image of said marker and said target anatomical structure, through said imaging window.
18. The catheter of Claim 9 wherein said catheter further comprises:
a flexible tip member mounted on the distal end of the catheter, said flexible tip member having a hollow passageway extending longitudinally therethrough, and wherein said marker comprises an elongate member attached to said catheter body and extending through at least a portion of the hollow passageway formed in said elongate member.
a flexible tip member mounted on the distal end of the catheter, said flexible tip member having a hollow passageway extending longitudinally therethrough, and wherein said marker comprises an elongate member attached to said catheter body and extending through at least a portion of the hollow passageway formed in said elongate member.
19. The catheter of Claim 18 wherein said hollow passageway has a first diameter, and wherein said elongate member has a second diameter smaller than said first diameter, such that a gap surrounds said elongate member within said hollow passageway.
20. The catheter of Claim 18 wherein said elongate member protrudes beyond the distal end of said distal tip member.
21. The catheter of Claim 9 wherein said marker comprises:
a notch formed within said catheter and surrounded by a plurality of strut members, said imaging means being positionable within said notch, and at least one of said strut members being useable as said marker.
a notch formed within said catheter and surrounded by a plurality of strut members, said imaging means being positionable within said notch, and at least one of said strut members being useable as said marker.
22. The catheter of Claim 21 wherein said strut members comprise elongate wires attached to said catheter body and extending over said notch.
23. The catheter of Claim 21 wherein said notch comprises a region which is cut away from said catheter body such that there is defined a proximal catheter body portion proximal to said notch, and a distal catheter body portion distal to said notch.
24. The catheter of Claim 23 wherein an imaging catheter lumen extends longitudinally through said catheter body, and wherein said imaging means comprises an imaging catheter which is advanceable through said imaging catheter lumen and into said notch such that the image received by said imaging catheter includes the image of said at least one strut member which is useable as said marker.
25. The passageway-forming catheter of Claim 9 wherein said marker is a signal-emitting component which emits a signal which may be detected by said imaging means.
26. The passageway-forming catheter of Claim 25 wherein said energy-emitting component is a piezoelectric crystal.
27. The catheter of Claim 9 wherein the distance from said first location on said catheter to said target anatomical structure is known, and wherein said marker further comprises:
a plurality of distance-specific marker locations, each said distance-specific marker location being correlated to a known distance from said first location on said catheter to said target anatomical structure, said imaging means being thereby useable to position a selected on of said distance-correlated markings in alignment with the image of said target anatomical structure, thereby placing the catheter in optimal position and orientation to cause said tissue-penetrating element to form the desired passageway to said target anatomical structure, without extending beyond said target anatomical structure.
a plurality of distance-specific marker locations, each said distance-specific marker location being correlated to a known distance from said first location on said catheter to said target anatomical structure, said imaging means being thereby useable to position a selected on of said distance-correlated markings in alignment with the image of said target anatomical structure, thereby placing the catheter in optimal position and orientation to cause said tissue-penetrating element to form the desired passageway to said target anatomical structure, without extending beyond said target anatomical structure.
28. A system for positioning/aiming a passageway forming catheter which comprises an elongate catheter body having a tissue-penetrating element passable out of said catheter body in a lateral direction so as to create an interstitial passageway through the wall of the luminal anatomical structure within which the catheter is inserted into a target anatomical location, said apparatus comprising:
an emitting component which causes a signal to be emitted from said target anatomical location; and, a receiving component which receives said signal from said anatomical location;
one of said emitting and receiving components being located at a fixed position relative to the path which will be followed by said tissue penetrating element as said tissue penetrating element passes out of said catheter, and being thereby useable to position and orient said catheter such that said tissue-penetrating element will create the desired interstitial passageway into said target anatomical location.
an emitting component which causes a signal to be emitted from said target anatomical location; and, a receiving component which receives said signal from said anatomical location;
one of said emitting and receiving components being located at a fixed position relative to the path which will be followed by said tissue penetrating element as said tissue penetrating element passes out of said catheter, and being thereby useable to position and orient said catheter such that said tissue-penetrating element will create the desired interstitial passageway into said target anatomical location.
29. The system of Claim 28 wherein said emitting component and said receiving component are both located on said passageway-forming catheter.
30. The system of Claim 28 wherein one of said emitting component and said receiving component is located at said target anatomical location, and the other thereof is located on said passageway-forming catheter.
31. The system of Claim 28 wherein said emitting component comprises an energy-emitting member which emits a form of energy selected from the group of energy forms consisting of:
sonic energy;
ultrasonic energy;
light energy;
laser light energy;
radio frequency energy;
an electromagnetic signal;
and wherein said receiving component comprises a sensor adapted to receive said form of energy.
sonic energy;
ultrasonic energy;
light energy;
laser light energy;
radio frequency energy;
an electromagnetic signal;
and wherein said receiving component comprises a sensor adapted to receive said form of energy.
32. The system of Claim 28 wherein said emitting and receiving components are respectively positioned such that, when said emitting and receiving components are brought into direct alignment to direct alignment with one another, the passageway-forming catheter will be properly positioned to cause said tissue-penetrating element to pass from said passageway to forming catheter into said target anatomical location, and wherein said system further comprises:
apparatus for monitoring the intensity of the signal received by the receiving component, such that one may determine when the signal received by the receiving component has been peaked, thereby indicating that the emitting and receiving components have been brought into direct alignment with one another and the catheter is correctly positioned and oriented.
apparatus for monitoring the intensity of the signal received by the receiving component, such that one may determine when the signal received by the receiving component has been peaked, thereby indicating that the emitting and receiving components have been brought into direct alignment with one another and the catheter is correctly positioned and oriented.
33. The system of Claim 32 wherein said apparatus for monitoring the intensity of the signal received by the receiving component comprises in series:
a signal conditioning and filtering component;
a rectifier;
a leaky integrator;
a analog to digital converter; and, a display adapted to display the strength of the signal received by the receiving component.
a signal conditioning and filtering component;
a rectifier;
a leaky integrator;
a analog to digital converter; and, a display adapted to display the strength of the signal received by the receiving component.
34. The system of Claim 28 wherein said emitting component comprises an elongate pliable wire having an emission-preventing shield formed laterally about the length of the wire, with the distal tip of the wire extending out of and beyond said shield such that energy may be emitted by only the distal tip of the wire.
35. The system of Claim 28 adapted for use in a procedure wherein the passageway-forming catheter is transluminally advanced into a first blood vessel for the purpose of forming a passageway through the wall of said first blood vessel and into said target anatomical location, and wherein one of said emitting and receiving components is insertable into said target anatomical location. and the other thereof is mounted on said passageway-forming catheter.
36. A system for forming an interstitial passageway which extends through the wall of a luminal anatomical structure, said system comprising:
a) a deflectable catheter having an elongate pliable catheter body, a distal end, at least one lumen extending longitudinally through the catheter body, and a distal end opening through which said lumen opens at the distal end of said catheter body, a portion of said catheter body immediately adjacent the distal end thereof being alternately moveable between:
i) a straight configuration; and, ii) a curved configuration;
b) an imaging apparatus which is insertable through at least a portion of said at least one lumen of said deflectable catheter to provide an image of at least the luminal anatomical structure when said deflectable catheter is inserted into said luminal anatomical structure; and, c) a tissue-penetrating element which is advanceable through said at least one lumen of said catheter and out of said distal end opening such that, when the distal portion of the catheter is in its curved configuration within said luminal anatomical structure, the tissue-penetrating element will pass out of said distal end opening and through the wall of said luminal anatomical structure.
a) a deflectable catheter having an elongate pliable catheter body, a distal end, at least one lumen extending longitudinally through the catheter body, and a distal end opening through which said lumen opens at the distal end of said catheter body, a portion of said catheter body immediately adjacent the distal end thereof being alternately moveable between:
i) a straight configuration; and, ii) a curved configuration;
b) an imaging apparatus which is insertable through at least a portion of said at least one lumen of said deflectable catheter to provide an image of at least the luminal anatomical structure when said deflectable catheter is inserted into said luminal anatomical structure; and, c) a tissue-penetrating element which is advanceable through said at least one lumen of said catheter and out of said distal end opening such that, when the distal portion of the catheter is in its curved configuration within said luminal anatomical structure, the tissue-penetrating element will pass out of said distal end opening and through the wall of said luminal anatomical structure.
37. The system of Claim 36 wherein said catheter further comprises:
a marker formed on said catheter at a first location, said marker being positioned at a known location on said catheter and being imagable by said imaging apparatus when said imaging apparatus is inserted into said at least one lumen of said catheter, said marker being thereby useable to facilitate selected rotation orientation of said catheter within said luminal anatomical structure such that, when the distal portion of the catheter is moved to its curved configuration, the distal opening of the catheter will be aimed at a desired location on said luminal anatomical structure.
a marker formed on said catheter at a first location, said marker being positioned at a known location on said catheter and being imagable by said imaging apparatus when said imaging apparatus is inserted into said at least one lumen of said catheter, said marker being thereby useable to facilitate selected rotation orientation of said catheter within said luminal anatomical structure such that, when the distal portion of the catheter is moved to its curved configuration, the distal opening of the catheter will be aimed at a desired location on said luminal anatomical structure.
38. The system of Claim 36 wherein said system further comprises:
d) a passageway modifying apparatus which is passable through said at least one lumen of said catheter and out of said distal opening, said passageway modifying apparatus being useable to modify a passageway which has been initially formed by said tissue-penetrating element.
d) a passageway modifying apparatus which is passable through said at least one lumen of said catheter and out of said distal opening, said passageway modifying apparatus being useable to modify a passageway which has been initially formed by said tissue-penetrating element.
39. The system of Claim 38 wherein said passageway modifying apparatus is selected from the group of passageway modifying apparatus consisting of:
an apparatus for closing said passageway;
an apparatus for stenting said passageway;
an apparatus for enlarging said passageway;
an apparatus for cauterizing said passageway;
an apparatus for placing a channel connector within said passageway;
NOT FURNISHED UPON FILING
an apparatus for closing said passageway;
an apparatus for stenting said passageway;
an apparatus for enlarging said passageway;
an apparatus for cauterizing said passageway;
an apparatus for placing a channel connector within said passageway;
NOT FURNISHED UPON FILING
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/837,294 | 1997-04-11 | ||
US08/837,294 US6302875B1 (en) | 1996-10-11 | 1997-04-11 | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
PCT/US1998/007134 WO1998046119A1 (en) | 1997-04-11 | 1998-04-10 | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2285001A1 true CA2285001A1 (en) | 1998-10-22 |
Family
ID=25274080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002285001A Abandoned CA2285001A1 (en) | 1997-04-11 | 1998-04-10 | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
Country Status (10)
Country | Link |
---|---|
US (4) | US6302875B1 (en) |
EP (2) | EP0964636B1 (en) |
JP (1) | JP4019112B2 (en) |
AT (2) | ATE370699T1 (en) |
AU (1) | AU749373B2 (en) |
CA (1) | CA2285001A1 (en) |
DE (2) | DE69838287T2 (en) |
ES (1) | ES2293679T3 (en) |
IL (1) | IL132197A0 (en) |
WO (1) | WO1998046119A1 (en) |
Families Citing this family (455)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6375615B1 (en) * | 1995-10-13 | 2002-04-23 | Transvascular, Inc. | Tissue penetrating catheters having integral imaging transducers and their methods of use |
US6302875B1 (en) | 1996-10-11 | 2001-10-16 | Transvascular, Inc. | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
US6283983B1 (en) | 1995-10-13 | 2001-09-04 | Transvascular, Inc. | Percutaneous in-situ coronary bypass method and apparatus |
US6726677B1 (en) * | 1995-10-13 | 2004-04-27 | Transvascular, Inc. | Stabilized tissue penetrating catheters |
US20050171478A1 (en) * | 1998-01-13 | 2005-08-04 | Selmon Matthew R. | Catheter system for crossing total occlusions in vasculature |
US6231546B1 (en) * | 1998-01-13 | 2001-05-15 | Lumend, Inc. | Methods and apparatus for crossing total occlusions in blood vessels |
AU768005B2 (en) | 1998-03-31 | 2003-11-27 | Transvascular, Inc. | Tissue penetrating catheters having integral imaging transducers |
US6238401B1 (en) | 1998-07-31 | 2001-05-29 | Zuli Holdings Ltd. | Apparatus and method for selectively positioning a device and manipulating it |
US6641610B2 (en) | 1998-09-10 | 2003-11-04 | Percardia, Inc. | Valve designs for left ventricular conduits |
US6254564B1 (en) * | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
US6261304B1 (en) | 1998-09-10 | 2001-07-17 | Percardia, Inc. | Delivery methods for left ventricular conduit |
US6196230B1 (en) | 1998-09-10 | 2001-03-06 | Percardia, Inc. | Stent delivery system and method of use |
ATE322230T1 (en) * | 1998-09-10 | 2006-04-15 | Percardia Inc | TMR DEVICE |
US6290728B1 (en) | 1998-09-10 | 2001-09-18 | Percardia, Inc. | Designs for left ventricular conduit |
US7314477B1 (en) | 1998-09-25 | 2008-01-01 | C.R. Bard Inc. | Removable embolus blood clot filter and filter delivery unit |
US8177762B2 (en) | 1998-12-07 | 2012-05-15 | C. R. Bard, Inc. | Septum including at least one identifiable feature, access ports including same, and related methods |
AU736964B2 (en) | 1998-12-09 | 2001-08-09 | Cook Medical Technologies Llc | Hollow, curved, superelastic medical needle |
US6855123B2 (en) | 2002-08-02 | 2005-02-15 | Flow Cardia, Inc. | Therapeutic ultrasound system |
US8506519B2 (en) | 1999-02-16 | 2013-08-13 | Flowcardia, Inc. | Pre-shaped therapeutic catheter |
US7892246B2 (en) | 1999-07-28 | 2011-02-22 | Bioconnect Systems, Inc. | Devices and methods for interconnecting conduits and closing openings in tissue |
US6253768B1 (en) | 1999-08-04 | 2001-07-03 | Percardia, Inc. | Vascular graft bypass |
US6302892B1 (en) | 1999-08-04 | 2001-10-16 | Percardia, Inc. | Blood flow conduit delivery system and method of use |
US6638237B1 (en) | 1999-08-04 | 2003-10-28 | Percardia, Inc. | Left ventricular conduits and methods for delivery |
DE19938775A1 (en) * | 1999-11-02 | 2001-02-22 | Bisping Hans Juergen | Temporary or permanent medical catheter has electrode elements as sleeves open at both ends or at one end with cap covering other opening aperture(s) that reduce surface area |
US7887556B2 (en) * | 2000-12-20 | 2011-02-15 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US6299622B1 (en) | 1999-08-19 | 2001-10-09 | Fox Hollow Technologies, Inc. | Atherectomy catheter with aligned imager |
US6638233B2 (en) * | 1999-08-19 | 2003-10-28 | Fox Hollow Technologies, Inc. | Apparatus and methods for material capture and removal |
US7708749B2 (en) | 2000-12-20 | 2010-05-04 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US8328829B2 (en) | 1999-08-19 | 2012-12-11 | Covidien Lp | High capacity debulking catheter with razor edge cutting window |
US7713279B2 (en) | 2000-12-20 | 2010-05-11 | Fox Hollow Technologies, Inc. | Method and devices for cutting tissue |
US6605053B1 (en) | 1999-09-10 | 2003-08-12 | Percardia, Inc. | Conduit designs and related methods for optimal flow control |
US6527752B1 (en) * | 1999-09-24 | 2003-03-04 | Cook Urological, Inc. | Embryo transfer catheter |
US6361555B1 (en) * | 1999-12-15 | 2002-03-26 | Advanced Cardiovascular Systems, Inc. | Stent and stent delivery assembly and method of use |
US6497676B1 (en) | 2000-02-10 | 2002-12-24 | Baxter International | Method and apparatus for monitoring and controlling peritoneal dialysis therapy |
US6579243B2 (en) * | 2000-03-02 | 2003-06-17 | Scimed Life Systems, Inc. | Catheter with thermal sensor for detection of vulnerable plaque |
US6953560B1 (en) | 2000-09-28 | 2005-10-11 | Advanced Cardiovascular Systems, Inc. | Barriers for polymer-coated implantable medical devices and methods for making the same |
US6716444B1 (en) | 2000-09-28 | 2004-04-06 | Advanced Cardiovascular Systems, Inc. | Barriers for polymer-coated implantable medical devices and methods for making the same |
US6482184B1 (en) * | 2000-09-29 | 2002-11-19 | Advanced Infusion, Inc. | Attachable catheter |
US6976973B1 (en) * | 2000-10-12 | 2005-12-20 | Baxter International Inc. | Peritoneal dialysis catheters |
US6506178B1 (en) * | 2000-11-10 | 2003-01-14 | Vascular Architects, Inc. | Apparatus and method for crossing a position along a tubular body structure |
AU2002226347A1 (en) * | 2000-11-24 | 2002-06-18 | Innovacell Biotechnologie Gmbh | Ultrasonic probe comprising a positioning device for examination devices and operation devices |
US7699790B2 (en) | 2000-12-20 | 2010-04-20 | Ev3, Inc. | Debulking catheters and methods |
DE60144107D1 (en) | 2000-12-20 | 2011-04-07 | Fox Hollow Technologies Inc | REDUCTION CATHETER |
US7927784B2 (en) | 2000-12-20 | 2011-04-19 | Ev3 | Vascular lumen debulking catheters and methods |
US6663662B2 (en) | 2000-12-28 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Diffusion barrier layer for implantable devices |
US6645195B1 (en) * | 2001-01-05 | 2003-11-11 | Advanced Cardiovascular Systems, Inc. | Intraventricularly guided agent delivery system and method of use |
US7357794B2 (en) * | 2002-01-17 | 2008-04-15 | Medtronic Vascular, Inc. | Devices, systems and methods for acute or chronic delivery of substances or apparatus to extravascular treatment sites |
IL157120A0 (en) * | 2001-02-06 | 2004-02-08 | Transvascular Inc | Methods and apparatus for guided transluminal interventions using vessel wall penetrating catheters and other apparatus |
US8214015B2 (en) * | 2001-02-06 | 2012-07-03 | Medtronic Vascular, Inc. | In vivo localization and tracking of tissue penetrating catheters using magnetic resonance imaging |
DE10105592A1 (en) | 2001-02-06 | 2002-08-08 | Achim Goepferich | Placeholder for drug release in the frontal sinus |
US6989004B2 (en) | 2001-02-28 | 2006-01-24 | Rex Medical, L.P. | Apparatus for delivering ablation fluid to treat lesions |
AU2002250170B2 (en) | 2001-02-28 | 2006-08-10 | Rex Medical, L.P. | Apparatus for Delivering Ablation Fluid to Treat Lesions |
US7087040B2 (en) | 2001-02-28 | 2006-08-08 | Rex Medical, L.P. | Apparatus for delivering ablation fluid to treat lesions |
US7245959B1 (en) * | 2001-03-02 | 2007-07-17 | Scimed Life Systems, Inc. | Imaging catheter for use inside a guiding catheter |
US20030032936A1 (en) * | 2001-08-10 | 2003-02-13 | Lederman Robert J. | Side-exit catheter and method for its use |
US7892247B2 (en) * | 2001-10-03 | 2011-02-22 | Bioconnect Systems, Inc. | Devices and methods for interconnecting vessels |
WO2003030744A1 (en) * | 2001-10-09 | 2003-04-17 | Jomed Nv | Coronary bypass apparatus and method |
WO2003105670A2 (en) | 2002-01-10 | 2003-12-24 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US9204956B2 (en) | 2002-02-20 | 2015-12-08 | C. R. Bard, Inc. | IVC filter with translating hooks |
US7141041B2 (en) * | 2003-03-19 | 2006-11-28 | Mercator Medsystems, Inc. | Catheters having laterally deployable needles |
US20040082859A1 (en) | 2002-07-01 | 2004-04-29 | Alan Schaer | Method and apparatus employing ultrasound energy to treat body sphincters |
US9955994B2 (en) | 2002-08-02 | 2018-05-01 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US8133236B2 (en) * | 2006-11-07 | 2012-03-13 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US7604608B2 (en) | 2003-01-14 | 2009-10-20 | Flowcardia, Inc. | Ultrasound catheter and methods for making and using same |
US6942677B2 (en) | 2003-02-26 | 2005-09-13 | Flowcardia, Inc. | Ultrasound catheter apparatus |
US7137963B2 (en) | 2002-08-26 | 2006-11-21 | Flowcardia, Inc. | Ultrasound catheter for disrupting blood vessel obstructions |
US7220233B2 (en) | 2003-04-08 | 2007-05-22 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
US7335180B2 (en) | 2003-11-24 | 2008-02-26 | Flowcardia, Inc. | Steerable ultrasound catheter |
US20040044329A1 (en) * | 2002-08-29 | 2004-03-04 | Trudell Leonard A. | Catheter for cardiac injection and method for delivery of therapeutic agents to specified tissues |
US7351247B2 (en) | 2002-09-04 | 2008-04-01 | Bioconnect Systems, Inc. | Devices and methods for interconnecting body conduits |
EP1402819B1 (en) * | 2002-09-25 | 2006-02-15 | B-K Medical ApS | Catheter for insertion into the human body |
US8317816B2 (en) | 2002-09-30 | 2012-11-27 | Acclarent, Inc. | Balloon catheters and methods for treating paranasal sinuses |
AU2003297190A1 (en) * | 2002-12-16 | 2004-07-22 | Edrich Vascular Devices, Inc. | Endovascular stapler |
US7547304B2 (en) * | 2002-12-19 | 2009-06-16 | Gore Enterprise Holdings, Inc. | Guidewire-centering catheter tip |
JP2006520786A (en) | 2003-03-14 | 2006-09-14 | シネクサス, インコーポレイテッド | Sinus delivery of sustained-release therapeutic agents |
US7715896B2 (en) | 2003-03-21 | 2010-05-11 | Boston Scientific Scimed, Inc. | Systems and methods for internal tissue penetration |
US20050049675A1 (en) * | 2003-03-28 | 2005-03-03 | Board Of Regents, The University Of Texas System | Medical devices and related methods |
US20040193034A1 (en) * | 2003-03-28 | 2004-09-30 | Lawrence Wasicek | Combined long rail/short rail IVUS catheter |
US8246640B2 (en) | 2003-04-22 | 2012-08-21 | Tyco Healthcare Group Lp | Methods and devices for cutting tissue at a vascular location |
RU2238043C1 (en) * | 2003-06-30 | 2004-10-20 | Шкарубо Алексей Николаевич | Device for setting medical instruments |
IES20030531A2 (en) * | 2003-07-17 | 2005-09-21 | Medtronic Vascular Connaught | Methods and devices for placing a fistula device in fluid communication with a target vessel |
US8753262B2 (en) * | 2003-07-29 | 2014-06-17 | Hoya Corporation | Internal treatment apparatus having circumferential side holes |
US7758510B2 (en) | 2003-09-19 | 2010-07-20 | Flowcardia, Inc. | Connector for securing ultrasound catheter to transducer |
US20050070874A1 (en) * | 2003-09-30 | 2005-03-31 | Hikaru Matsuda | System and method for injecting liquid drug containing biological material |
US20060259137A1 (en) * | 2003-10-06 | 2006-11-16 | Jason Artof | Minimally invasive valve replacement system |
WO2005046528A1 (en) * | 2003-10-06 | 2005-05-26 | 3F Therapeutics, Inc. | Minimally invasive valve replacement system |
US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
US8014849B2 (en) * | 2003-11-21 | 2011-09-06 | Stryker Corporation | Rotational markers |
HRP20030990A2 (en) * | 2003-11-27 | 2006-02-28 | Branko Breyer Ivo Čikeš | System for guidance and control of minimum invasive delivery of therapy with medical agents |
US7637904B2 (en) * | 2003-12-19 | 2009-12-29 | Vance Products Incorporated | Catheter with snap on feature |
US8764729B2 (en) | 2004-04-21 | 2014-07-01 | Acclarent, Inc. | Frontal sinus spacer |
US9089258B2 (en) | 2004-04-21 | 2015-07-28 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US8864787B2 (en) | 2004-04-21 | 2014-10-21 | Acclarent, Inc. | Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis |
US20070167682A1 (en) | 2004-04-21 | 2007-07-19 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US9351750B2 (en) | 2004-04-21 | 2016-05-31 | Acclarent, Inc. | Devices and methods for treating maxillary sinus disease |
US7361168B2 (en) | 2004-04-21 | 2008-04-22 | Acclarent, Inc. | Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders |
US7720521B2 (en) * | 2004-04-21 | 2010-05-18 | Acclarent, Inc. | Methods and devices for performing procedures within the ear, nose, throat and paranasal sinuses |
US7803150B2 (en) | 2004-04-21 | 2010-09-28 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US9101384B2 (en) | 2004-04-21 | 2015-08-11 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat |
US7410480B2 (en) | 2004-04-21 | 2008-08-12 | Acclarent, Inc. | Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders |
US7654997B2 (en) | 2004-04-21 | 2010-02-02 | Acclarent, Inc. | Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat |
US8702626B1 (en) | 2004-04-21 | 2014-04-22 | Acclarent, Inc. | Guidewires for performing image guided procedures |
US9554691B2 (en) | 2004-04-21 | 2017-01-31 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US7419497B2 (en) | 2004-04-21 | 2008-09-02 | Acclarent, Inc. | Methods for treating ethmoid disease |
US8747389B2 (en) | 2004-04-21 | 2014-06-10 | Acclarent, Inc. | Systems for treating disorders of the ear, nose and throat |
US9399121B2 (en) | 2004-04-21 | 2016-07-26 | Acclarent, Inc. | Systems and methods for transnasal dilation of passageways in the ear, nose or throat |
US8146400B2 (en) | 2004-04-21 | 2012-04-03 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US20060063973A1 (en) | 2004-04-21 | 2006-03-23 | Acclarent, Inc. | Methods and apparatus for treating disorders of the ear, nose and throat |
US20060004323A1 (en) | 2004-04-21 | 2006-01-05 | Exploramed Nc1, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures |
US8894614B2 (en) | 2004-04-21 | 2014-11-25 | Acclarent, Inc. | Devices, systems and methods useable for treating frontal sinusitis |
US7559925B2 (en) | 2006-09-15 | 2009-07-14 | Acclarent Inc. | Methods and devices for facilitating visualization in a surgical environment |
US8932276B1 (en) | 2004-04-21 | 2015-01-13 | Acclarent, Inc. | Shapeable guide catheters and related methods |
US20190314620A1 (en) | 2004-04-21 | 2019-10-17 | Acclarent, Inc. | Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures |
US20070208252A1 (en) * | 2004-04-21 | 2007-09-06 | Acclarent, Inc. | Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses |
US10188413B1 (en) | 2004-04-21 | 2019-01-29 | Acclarent, Inc. | Deflectable guide catheters and related methods |
US7462175B2 (en) | 2004-04-21 | 2008-12-09 | Acclarent, Inc. | Devices, systems and methods for treating disorders of the ear, nose and throat |
US20050267520A1 (en) * | 2004-05-12 | 2005-12-01 | Modesitt D B | Access and closure device and method |
US20050278013A1 (en) * | 2004-05-26 | 2005-12-15 | Matthew Rust | Method for endovascular bypass stent graft delivery |
US7276064B2 (en) | 2004-05-27 | 2007-10-02 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Side-port sheath for catheter placement and translation |
US7678133B2 (en) * | 2004-07-10 | 2010-03-16 | Arstasis, Inc. | Biological tissue closure device and method |
US7704267B2 (en) | 2004-08-04 | 2010-04-27 | C. R. Bard, Inc. | Non-entangling vena cava filter |
US7540852B2 (en) | 2004-08-26 | 2009-06-02 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
GB0419954D0 (en) | 2004-09-08 | 2004-10-13 | Advotek Medical Devices Ltd | System for directing therapy |
US8545488B2 (en) * | 2004-09-17 | 2013-10-01 | The Spectranetics Corporation | Cardiovascular imaging system |
US8628519B2 (en) | 2004-09-17 | 2014-01-14 | The Spectranetics Corporation | Rapid exchange bias laser catheter design |
US7794473B2 (en) | 2004-11-12 | 2010-09-14 | C.R. Bard, Inc. | Filter delivery system |
US20060111704A1 (en) * | 2004-11-22 | 2006-05-25 | Rox Medical, Inc. | Devices, systems, and methods for energy assisted arterio-venous fistula creation |
US7713210B2 (en) | 2004-11-23 | 2010-05-11 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for localizing an ultrasound catheter |
US8221343B2 (en) | 2005-01-20 | 2012-07-17 | Flowcardia, Inc. | Vibrational catheter devices and methods for making same |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US8267954B2 (en) | 2005-02-04 | 2012-09-18 | C. R. Bard, Inc. | Vascular filter with sensing capability |
US9474888B2 (en) | 2005-03-04 | 2016-10-25 | C. R. Bard, Inc. | Implantable access port including a sandwiched radiopaque insert |
US7947022B2 (en) | 2005-03-04 | 2011-05-24 | C. R. Bard, Inc. | Access port identification systems and methods |
US8029482B2 (en) | 2005-03-04 | 2011-10-04 | C. R. Bard, Inc. | Systems and methods for radiographically identifying an access port |
JP5484674B2 (en) | 2005-03-04 | 2014-05-07 | シー・アール・バード・インコーポレーテッド | Access port and identification method |
WO2006107957A2 (en) | 2005-04-04 | 2006-10-12 | Sinexus, Inc. | Device and methods for treating paranasal sinus conditions |
US7794413B2 (en) | 2005-04-19 | 2010-09-14 | Ev3, Inc. | Libraries and data structures of materials removed by debulking catheters |
EP2308547B1 (en) * | 2005-04-27 | 2014-09-17 | C.R. Bard, Inc. | High pressure access port with septum |
US10307581B2 (en) | 2005-04-27 | 2019-06-04 | C. R. Bard, Inc. | Reinforced septum for an implantable medical device |
WO2006116613A1 (en) * | 2005-04-27 | 2006-11-02 | C.R. Bard, Inc. | Infusion apparatuses |
US20070016062A1 (en) | 2005-05-04 | 2007-01-18 | Byong-Ho Park | Multiple transducers for intravascular ultrasound imaging |
AU2006247355B2 (en) | 2005-05-12 | 2013-01-10 | Arstasis, Inc. | Access and closure device and method |
MX2007013932A (en) | 2005-05-12 | 2008-01-28 | Bard Inc C R | Removable embolus blood clot filter. |
US8613754B2 (en) | 2005-05-12 | 2013-12-24 | C. R. Bard, Inc. | Tubular filter |
DE102005022345A1 (en) * | 2005-05-13 | 2006-11-16 | Siemens Ag | Method for creation of image of vessel and obtaining information about speed of blood flow, comprises use of ultrasonic catheter |
US8951225B2 (en) | 2005-06-10 | 2015-02-10 | Acclarent, Inc. | Catheters with non-removable guide members useable for treatment of sinusitis |
US7691086B2 (en) * | 2005-06-14 | 2010-04-06 | Tengiz Tkebuchava | Catheter for introduction of medications to the tissues of a heart or other organ |
US20070038097A1 (en) * | 2005-07-22 | 2007-02-15 | Crawford Alan D | Introducer |
CA2616818C (en) | 2005-08-09 | 2014-08-05 | C.R. Bard, Inc. | Embolus blood clot filter and delivery system |
WO2007025230A2 (en) * | 2005-08-25 | 2007-03-01 | Fluid Medical, Inc. | Tubular compliant mechanisms for ultrasonic imaging systems and intravascular interventional devices |
EP1924315B1 (en) | 2005-09-12 | 2019-12-04 | Bridgepoint Medical, Inc. | Endovascular devices |
US7918870B2 (en) | 2005-09-12 | 2011-04-05 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US8083727B2 (en) | 2005-09-12 | 2011-12-27 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US11020141B2 (en) | 2005-09-12 | 2021-06-01 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US8025655B2 (en) | 2005-09-12 | 2011-09-27 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US8114113B2 (en) | 2005-09-23 | 2012-02-14 | Acclarent, Inc. | Multi-conduit balloon catheter |
EP1943938B9 (en) * | 2005-11-04 | 2016-09-21 | Olympus Corporation | Endoscope system |
MX344147B (en) | 2005-11-18 | 2016-12-07 | Bard Inc C R | Vena cava filter with filament. |
US7989207B2 (en) * | 2006-02-17 | 2011-08-02 | Tyco Healthcare Group Lp | Testing lumenectomy samples for markers of non-vascular diseases |
US9282984B2 (en) | 2006-04-05 | 2016-03-15 | Flowcardia, Inc. | Therapeutic ultrasound system |
US20130190676A1 (en) | 2006-04-20 | 2013-07-25 | Limflow Gmbh | Devices and methods for fluid flow through body passages |
US9511214B2 (en) | 2006-05-02 | 2016-12-06 | Vascular Access Technologies, Inc. | Methods of transvascular retrograde access placement and devices for facilitating therein |
US10188496B2 (en) | 2006-05-02 | 2019-01-29 | C. R. Bard, Inc. | Vena cava filter formed from a sheet |
US20070270679A1 (en) * | 2006-05-17 | 2007-11-22 | Duy Nguyen | Deflectable variable radius catheters |
US8190389B2 (en) | 2006-05-17 | 2012-05-29 | Acclarent, Inc. | Adapter for attaching electromagnetic image guidance components to a medical device |
EP2021846B1 (en) | 2006-05-19 | 2017-05-03 | Koninklijke Philips N.V. | Ablation device with optimized input power profile |
US20070276419A1 (en) | 2006-05-26 | 2007-11-29 | Fox Hollow Technologies, Inc. | Methods and devices for rotating an active element and an energy emitter on a catheter |
CA2655158A1 (en) | 2006-06-05 | 2007-12-13 | C.R. Bard Inc. | Embolus blood clot filter utilizable with a single delivery system or a single retrieval system in one of a femoral or jugular access |
US20070289596A1 (en) * | 2006-06-14 | 2007-12-20 | Campbell Shannon E | Endotracheal cuff and technique for using the same |
US9023075B2 (en) * | 2006-06-30 | 2015-05-05 | Cvdevices, Llc | Devices, systems, and methods for lead delivery |
US8535707B2 (en) | 2006-07-10 | 2013-09-17 | Intersect Ent, Inc. | Devices and methods for delivering active agents to the osteomeatal complex |
US9867530B2 (en) * | 2006-08-14 | 2018-01-16 | Volcano Corporation | Telescopic side port catheter device with imaging system and method for accessing side branch occlusions |
US9820688B2 (en) | 2006-09-15 | 2017-11-21 | Acclarent, Inc. | Sinus illumination lightwire device |
JP4943796B2 (en) * | 2006-09-29 | 2012-05-30 | テルモ株式会社 | Medical device |
US20080086112A1 (en) * | 2006-10-06 | 2008-04-10 | National Health Research Institute (An Institution Of Taiwan, R.O.C.) | Microdevice for detecting, activating and delivering molecules |
US8388680B2 (en) | 2006-10-18 | 2013-03-05 | Guided Delivery Systems, Inc. | Methods and devices for catheter advancement and delivery of substances therethrough |
US8246643B2 (en) | 2006-11-07 | 2012-08-21 | Flowcardia, Inc. | Ultrasound catheter having improved distal end |
US9265912B2 (en) | 2006-11-08 | 2016-02-23 | C. R. Bard, Inc. | Indicia informative of characteristics of insertable medical devices |
US9642986B2 (en) | 2006-11-08 | 2017-05-09 | C. R. Bard, Inc. | Resource information key for an insertable medical device |
US9060802B2 (en) | 2006-11-21 | 2015-06-23 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US10888354B2 (en) | 2006-11-21 | 2021-01-12 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US11298511B2 (en) | 2006-11-21 | 2022-04-12 | Bridgepoint Medical, Inc. | Endovascular devices and methods for exploiting intramural space |
US8439687B1 (en) | 2006-12-29 | 2013-05-14 | Acclarent, Inc. | Apparatus and method for simulated insertion and positioning of guidewares and other interventional devices |
US8257382B2 (en) * | 2007-03-29 | 2012-09-04 | Boston Scientific Limited | Lumen reentry devices and methods |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8118757B2 (en) | 2007-04-30 | 2012-02-21 | Acclarent, Inc. | Methods and devices for ostium measurement |
US8052651B2 (en) * | 2007-05-03 | 2011-11-08 | Kimberly-Clark Worldwide, Inc. | Apparatus and method for securing a catheter within an anatomy |
US8485199B2 (en) | 2007-05-08 | 2013-07-16 | Acclarent, Inc. | Methods and devices for protecting nasal turbinate during surgery |
ES2651269T3 (en) | 2007-06-20 | 2018-01-25 | Medical Components, Inc. | Venous reservoir with molded indications and / or radiopacas |
US8864675B2 (en) | 2007-06-28 | 2014-10-21 | W. L. Gore & Associates, Inc. | Catheter |
US8852112B2 (en) | 2007-06-28 | 2014-10-07 | W. L. Gore & Associates, Inc. | Catheter with deflectable imaging device and bendable electrical conductor |
US8285362B2 (en) * | 2007-06-28 | 2012-10-09 | W. L. Gore & Associates, Inc. | Catheter with deflectable imaging device |
WO2009012395A1 (en) | 2007-07-19 | 2009-01-22 | Innovative Medical Devices, Llc | Venous access port assembly with x-ray discernable indicia |
EP3311877A1 (en) | 2007-07-19 | 2018-04-25 | Medical Components, Inc. | Venous access port assembly with x-ray discernable indicia |
WO2009018583A1 (en) | 2007-08-02 | 2009-02-05 | Bio Connect Systems | Implantable flow connector |
US20130197546A1 (en) | 2007-08-02 | 2013-08-01 | Bioconnect Systems, Inc. | Implantable flow connector |
FR2920084B1 (en) * | 2007-08-24 | 2010-08-20 | Endocontrol | IMAGING SYSTEM FOR MONITORING A SURGICAL TOOL IN AN OPERATIVE FIELD |
US8632556B2 (en) | 2007-10-22 | 2014-01-21 | Bridgepoint Medical, Inc. | Methods and devices for crossing chronic total occlusions |
US9579496B2 (en) | 2007-11-07 | 2017-02-28 | C. R. Bard, Inc. | Radiopaque and septum-based indicators for a multi-lumen implantable port |
AU2008335138A1 (en) | 2007-12-11 | 2009-06-18 | Cornell University | Method and apparatus for sealing an opening in the side wall of a body lumen |
EP3791826A1 (en) | 2007-12-18 | 2021-03-17 | Intersect ENT, Inc. | Self-expanding devices |
US10206821B2 (en) | 2007-12-20 | 2019-02-19 | Acclarent, Inc. | Eustachian tube dilation balloon with ventilation path |
US20100286626A1 (en) * | 2007-12-21 | 2010-11-11 | Petersen Scott R | Longitudinally incompressible, laterally flexible interior shaft for catheter |
US20110160682A1 (en) * | 2008-01-31 | 2011-06-30 | Franano F Nicholas | Medical device |
US8337425B2 (en) | 2008-02-05 | 2012-12-25 | Bridgepoint Medical, Inc. | Endovascular device with a tissue piercing distal probe and associated methods |
WO2009100129A2 (en) | 2008-02-05 | 2009-08-13 | Chad John Kugler | Crossing occlusions in blood vessels |
US8784440B2 (en) | 2008-02-25 | 2014-07-22 | Covidien Lp | Methods and devices for cutting tissue |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
BR112012021347A2 (en) | 2008-02-26 | 2019-09-24 | Jenavalve Tecnology Inc | stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
US8182432B2 (en) | 2008-03-10 | 2012-05-22 | Acclarent, Inc. | Corewire design and construction for medical devices |
US8016842B2 (en) * | 2008-03-25 | 2011-09-13 | Medtronic Vascular, Inc. | Methods for treating vulnerable plaque |
US20090254105A1 (en) * | 2008-04-04 | 2009-10-08 | Medtronic Vascular, Inc. | Anastomotic connectors |
US20090259174A1 (en) * | 2008-04-15 | 2009-10-15 | Medtronic Vascular, Inc. | Methods and devices for treating vulnerable atherosclerotic plaque |
EP3165184B1 (en) | 2008-04-28 | 2021-12-01 | Bridgepoint Medical, Inc. | Apparatus for crossing occlusions in blood vessels |
CA2723810C (en) | 2008-05-07 | 2015-06-30 | Guided Delivery Systems, Inc. | Deflectable guide |
WO2009146458A2 (en) | 2008-05-30 | 2009-12-03 | Gore Enterprise Holdings, Inc. | Real time ultrasound catheter probe |
CN102159126A (en) * | 2008-07-21 | 2011-08-17 | 阿尔斯塔西斯公司 | Devices, methods, and kits for forming tracts in tissue |
AU2009274128A1 (en) * | 2008-07-21 | 2010-01-28 | Arstasis, Inc. | Devices and methods for forming tracts in tissue |
US8979888B2 (en) | 2008-07-30 | 2015-03-17 | Acclarent, Inc. | Paranasal ostium finder devices and methods |
EP2320832A4 (en) | 2008-08-01 | 2015-07-29 | Intersect Ent Inc | Methods and devices for crimping self-expanding devices |
CN103623498B (en) | 2008-09-18 | 2015-12-30 | 阿克拉伦特公司 | Be used for the treatment of the method and apparatus of otorhinolaryngology disease |
WO2010045226A2 (en) | 2008-10-13 | 2010-04-22 | Fox Hollow Technologies, Inc. | Devices and methods for manipulating a catheter shaft |
EP2346553B1 (en) | 2008-10-31 | 2022-01-19 | C.R. Bard, Inc. | Systems and methods for identifying an access port |
US8088103B2 (en) * | 2008-11-03 | 2012-01-03 | Advanced Catheter Therapies, Inc. | Occlusion perfusion catheter |
US8932271B2 (en) | 2008-11-13 | 2015-01-13 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
US11890443B2 (en) | 2008-11-13 | 2024-02-06 | C. R. Bard, Inc. | Implantable medical devices including septum-based indicators |
JP5789195B2 (en) * | 2008-12-08 | 2015-10-07 | シリコンバレー メディカル インスツルメンツ インコーポレイテッド | Catheter system for image guidance |
ITRM20080697A1 (en) * | 2008-12-30 | 2010-06-30 | Roberto Gandini | CATHETER FOR EMBULISATION WITH A TRANSCAVAL APPROACH OF A TYPE I AND II ENDOLEAK AFTER THE ENDOVASCULAR TREATMENT OF AN ABDOMINAL AURALISM. |
US8974445B2 (en) | 2009-01-09 | 2015-03-10 | Recor Medical, Inc. | Methods and apparatus for treatment of cardiac valve insufficiency |
US20100198192A1 (en) | 2009-01-20 | 2010-08-05 | Eugene Serina | Anchor deployment devices and related methods |
CA2750222C (en) | 2009-01-22 | 2018-02-27 | Cornell University | Method and apparatus for restricting flow through the wall of a lumen |
US20100191168A1 (en) | 2009-01-29 | 2010-07-29 | Trustees Of Tufts College | Endovascular cerebrospinal fluid shunt |
EP2395935A1 (en) | 2009-02-12 | 2011-12-21 | Koninklijke Philips Electronics N.V. | System for determining the orientation of a catheter |
CA2753260A1 (en) * | 2009-02-24 | 2010-09-02 | George Klein | Anchoring catheter sheath |
US20100241155A1 (en) | 2009-03-20 | 2010-09-23 | Acclarent, Inc. | Guide system with suction |
US7978742B1 (en) | 2010-03-24 | 2011-07-12 | Corning Incorporated | Methods for operating diode lasers |
US8435290B2 (en) | 2009-03-31 | 2013-05-07 | Acclarent, Inc. | System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx |
KR101323553B1 (en) | 2009-04-29 | 2013-10-29 | 코비디엔 엘피 | Methods and devices for cutting and abrading tissue |
US8206306B2 (en) * | 2009-05-07 | 2012-06-26 | Hitachi Aloka Medical, Ltd. | Ultrasound systems and methods for orthopedic applications |
JP5702365B2 (en) * | 2009-05-07 | 2015-04-15 | 日立アロカメディカル株式会社 | Ultrasound system for orthopedic applications |
JP5281195B2 (en) | 2009-05-14 | 2013-09-04 | コヴィディエン リミテッド パートナーシップ | Atherotomy catheter that can be easily cleaned and method of use |
AU2010248992B2 (en) | 2009-05-15 | 2014-11-27 | Intersect Ent, Inc. | Expandable devices and methods therefor |
AU2010248821A1 (en) * | 2009-05-15 | 2011-12-01 | Arstasis, Inc. | Devices, methods and kits for forming tracts in tissue |
US8439962B2 (en) * | 2009-05-28 | 2013-05-14 | Mahesh S. MULUMUDI | Endoprothesis stent delivery system and method of using the same |
WO2010144483A1 (en) * | 2009-06-08 | 2010-12-16 | Trireme Medical, Inc. | Side branch balloon |
US8226566B2 (en) | 2009-06-12 | 2012-07-24 | Flowcardia, Inc. | Device and method for vascular re-entry |
US20120095291A1 (en) * | 2009-07-06 | 2012-04-19 | Kiyokazu Nakajima | Endoscope overtube |
US8409236B2 (en) | 2009-08-21 | 2013-04-02 | Vascular Access Technologies, Inc. | Methods of transvascular retrograde access placement and devices for facilitating the placement |
US20120265233A1 (en) | 2009-08-28 | 2012-10-18 | Lea Waisman | Inverted balloon neck on catheter |
CA2774958A1 (en) * | 2009-09-22 | 2011-03-31 | Arstasis, Inc. | Devices, methods, and kits for forming tracts in tissue |
WO2011039752A2 (en) | 2009-10-03 | 2011-04-07 | Noam Livneh | Transdermal antenna |
JP2013510652A (en) | 2009-11-17 | 2013-03-28 | シー・アール・バード・インコーポレーテッド | Overmolded access port including locking feature and identification feature |
US8496677B2 (en) | 2009-12-02 | 2013-07-30 | Covidien Lp | Methods and devices for cutting tissue |
IN2012DN04977A (en) | 2009-12-11 | 2015-09-25 | Tyco Healthcare | |
EP2523612A1 (en) * | 2010-01-11 | 2012-11-21 | Arstasis, Inc. | Device for forming tracts in tissue |
EP2539009B1 (en) | 2010-02-26 | 2019-07-17 | The Board of Trustees of The Leland Stanford Junior University | Systems for endoluminal valve creation |
US10117564B2 (en) | 2010-04-16 | 2018-11-06 | Hitachi Healthcare Americas Corporation | Ultrasound and detachable instrument for procedures |
CN103002833B (en) | 2010-05-25 | 2016-05-11 | 耶拿阀门科技公司 | Artificial heart valve and comprise artificial heart valve and support through conduit carry interior prosthese |
BR112012031907A2 (en) | 2010-06-14 | 2020-08-04 | Covidien Lp | material removal device. |
EP2582314B1 (en) | 2010-06-15 | 2019-12-18 | Avenu Medical, Inc. | Intravascular arterial to venous anastomosis and tissue welding catheter |
CA2804524C (en) | 2010-06-15 | 2018-04-10 | Caymus Medical, Inc. | Systems and methods for creating arteriovenous (av) fistulas |
US9247942B2 (en) | 2010-06-29 | 2016-02-02 | Artventive Medical Group, Inc. | Reversible tubal contraceptive device |
WO2012002944A1 (en) | 2010-06-29 | 2012-01-05 | Artventive Medical Group, Inc. | Reducing flow through a tubular structure |
US8652033B2 (en) * | 2010-09-23 | 2014-02-18 | Karl Storz Endovision, Inc. | Video stylet with directable tip |
US9155492B2 (en) | 2010-09-24 | 2015-10-13 | Acclarent, Inc. | Sinus illumination lightwire device |
US8685050B2 (en) | 2010-10-06 | 2014-04-01 | Rex Medical L.P. | Cutting wire assembly for use with a catheter |
US8685049B2 (en) | 2010-11-18 | 2014-04-01 | Rex Medical L.P. | Cutting wire assembly for use with a catheter |
US9282991B2 (en) | 2010-10-06 | 2016-03-15 | Rex Medical, L.P. | Cutting wire assembly with coating for use with a catheter |
US8932315B2 (en) | 2010-10-18 | 2015-01-13 | W. L. Gore & Associates, Inc. | Systems and methods for percutaneous occlusion crossing |
US9149277B2 (en) | 2010-10-18 | 2015-10-06 | Artventive Medical Group, Inc. | Expandable device delivery |
US9023040B2 (en) | 2010-10-26 | 2015-05-05 | Medtronic Advanced Energy Llc | Electrosurgical cutting devices |
KR101518147B1 (en) | 2010-10-28 | 2015-05-06 | 코비디엔 엘피 | Material removal device and method of use |
CA2817213C (en) | 2010-11-11 | 2016-06-14 | Covidien Lp | Flexible debulking catheters with imaging and methods of use and manufacture |
EP2640280B1 (en) * | 2010-11-16 | 2022-03-16 | TVA Medical, Inc. | Devices for forming a fistula |
US8702736B2 (en) | 2010-11-22 | 2014-04-22 | Rex Medical L.P. | Cutting wire assembly for use with a catheter |
USD676955S1 (en) | 2010-12-30 | 2013-02-26 | C. R. Bard, Inc. | Implantable access port |
USD682416S1 (en) | 2010-12-30 | 2013-05-14 | C. R. Bard, Inc. | Implantable access port |
WO2012114334A1 (en) | 2011-02-24 | 2012-08-30 | Ilan Ben Oren | Hybrid catheter for endoluminal intervention |
EP2693981A4 (en) | 2011-04-01 | 2015-07-01 | Univ Cornell | Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen |
US20120289987A1 (en) | 2011-04-20 | 2012-11-15 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for endoluminal valve creation |
US9138230B1 (en) | 2011-04-29 | 2015-09-22 | Avenu Medical, Inc. | Systems and methods for creating arteriovenous (AV) fistulas |
US20120316589A1 (en) * | 2011-06-07 | 2012-12-13 | Cook Medical Technologies Llc | Balloon catheter with raised elements and visual marker |
US8852165B2 (en) * | 2011-06-16 | 2014-10-07 | II Edward G. Mackay | Endoluminal drug delivery devices and methods |
US8956376B2 (en) | 2011-06-30 | 2015-02-17 | The Spectranetics Corporation | Reentry catheter and method thereof |
WO2013003757A2 (en) | 2011-06-30 | 2013-01-03 | The Spectranetics Corporation | Reentry catheter and method thereof |
US8998936B2 (en) | 2011-06-30 | 2015-04-07 | The Spectranetics Corporation | Reentry catheter and method thereof |
JP5806407B2 (en) | 2011-09-01 | 2015-11-10 | コヴィディエン リミテッド パートナーシップ | Catheter with helical drive shaft and manufacturing method |
WO2013055703A1 (en) | 2011-10-07 | 2013-04-18 | Cornell University | Method and apparatus for restricting flow through an opening in a body lumen while maintaining normal flow |
WO2013055917A1 (en) | 2011-10-12 | 2013-04-18 | Volcano Corporation | Rotational shape-memory actuators and associated devices, systems, and methods |
US8951276B2 (en) | 2011-11-04 | 2015-02-10 | Avenu Medical, Inc. | Systems and methods for percutaneous intravascular access and guidewire placement |
US9603615B2 (en) | 2012-01-18 | 2017-03-28 | C.R. Bard, Inc. | Vascular re-entry device |
US10292807B2 (en) | 2012-02-07 | 2019-05-21 | Intervene, Inc. | Systems and methods for endoluminal valve creation |
AU2013216809B2 (en) | 2012-02-08 | 2017-05-11 | Avenu Medical, Inc. | Intravascular arterial to venous anastomosis and tissue welding catheter |
EP2633876B1 (en) | 2012-03-02 | 2014-09-24 | Cook Medical Technologies LLC | Dilation cap for endoluminal device |
US10434293B2 (en) | 2012-04-15 | 2019-10-08 | Tva Medical, Inc. | Implantable flow connector |
US9314600B2 (en) | 2012-04-15 | 2016-04-19 | Bioconnect Systems, Inc. | Delivery system for implantable flow connector |
US20130317438A1 (en) | 2012-05-25 | 2013-11-28 | Arstasis, Inc. | Vascular access configuration |
US20130317481A1 (en) | 2012-05-25 | 2013-11-28 | Arstasis, Inc. | Vascular access configuration |
US9623217B2 (en) | 2012-05-30 | 2017-04-18 | Vascular Access Techonlogies, Inc. | Transvascular access methods |
WO2013181397A1 (en) * | 2012-05-30 | 2013-12-05 | Vascular Access Technologies, Inc. | Transvascular access device and method |
EP2879596A2 (en) | 2012-08-02 | 2015-06-10 | Flowcardia, Inc. | Ultrasound catheter system |
US9033917B2 (en) | 2012-08-15 | 2015-05-19 | Abbott Cardiovascular Systems Inc. | Needle catheter for delivery of agents directly into vessel wall |
US9532844B2 (en) | 2012-09-13 | 2017-01-03 | Covidien Lp | Cleaning device for medical instrument and method of use |
CN104394752B (en) * | 2012-09-19 | 2016-08-24 | 奥林巴斯株式会社 | Plug assistive device |
CA2883209A1 (en) * | 2012-09-28 | 2014-04-03 | Rox Medical, Inc. | Methods, systems and devices for treating hypertension |
US9486276B2 (en) | 2012-10-11 | 2016-11-08 | Tva Medical, Inc. | Devices and methods for fistula formation |
US9763817B2 (en) | 2012-10-29 | 2017-09-19 | Cook Medical Technologies Llc | Delivery system with curved preloaded catheter |
US9943329B2 (en) | 2012-11-08 | 2018-04-17 | Covidien Lp | Tissue-removing catheter with rotatable cutter |
US9549666B2 (en) | 2012-11-10 | 2017-01-24 | Curvo Medical, Inc. | Coaxial micro-endoscope |
US9233225B2 (en) | 2012-11-10 | 2016-01-12 | Curvo Medical, Inc. | Coaxial bi-directional catheter |
JP6175511B2 (en) | 2012-11-14 | 2017-08-02 | アベヌ メディカル インコーポレイテッドAvenu Medical,Inc. | A device to create an arteriovenous fistula |
US20140163421A1 (en) * | 2012-12-06 | 2014-06-12 | Volcano Corporation | Reinforced Catheter Transition With Flexible Tip Portion |
US9301774B2 (en) | 2013-01-07 | 2016-04-05 | Cook Medical Technologies Llc | Lumen reentry mechanism and method |
US9655754B2 (en) * | 2013-01-10 | 2017-05-23 | Trivascular, Inc. | Systems and methods for guidewire crossover for bifurcated prostheses |
EP2943151B1 (en) | 2013-01-10 | 2017-07-19 | Intervene, Inc. | System for endoluminal valve creation |
US9095344B2 (en) | 2013-02-05 | 2015-08-04 | Artventive Medical Group, Inc. | Methods and apparatuses for blood vessel occlusion |
US8984733B2 (en) | 2013-02-05 | 2015-03-24 | Artventive Medical Group, Inc. | Bodily lumen occlusion |
US10835367B2 (en) | 2013-03-08 | 2020-11-17 | Limflow Gmbh | Devices for fluid flow through body passages |
JP6609479B2 (en) | 2013-03-08 | 2019-11-20 | リムフロウ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Method and system for providing or maintaining fluid flow through a body passage |
US9351698B2 (en) | 2013-03-12 | 2016-05-31 | Lightlab Imaging, Inc. | Vascular data processing and image registration systems, methods, and apparatuses |
US9623211B2 (en) | 2013-03-13 | 2017-04-18 | The Spectranetics Corporation | Catheter movement control |
US9272121B2 (en) * | 2013-03-13 | 2016-03-01 | Invatec S.P.A. | Side lumen reentry catheters and related methods |
US9757200B2 (en) | 2013-03-14 | 2017-09-12 | The Spectranetics Corporation | Intelligent catheter |
EP3636227A1 (en) | 2013-03-14 | 2020-04-15 | Intersect ENT, Inc. | Systems and devices for treating a sinus condition |
US10758308B2 (en) | 2013-03-14 | 2020-09-01 | The Spectranetics Corporation | Controller to select optical channel parameters in a catheter |
EP3566740A1 (en) | 2013-03-14 | 2019-11-13 | TVA Medical, Inc. | Fistula formulation/formation devices |
US20140276086A1 (en) * | 2013-03-14 | 2014-09-18 | Volcano Corporation | Deflectable ivus catheter |
US11642169B2 (en) | 2013-03-14 | 2023-05-09 | The Spectranetics Corporation | Smart multiplexed medical laser system |
US9833221B2 (en) * | 2013-03-15 | 2017-12-05 | Lightlab Imaging, Inc. | Apparatus and method of image registration |
US9629684B2 (en) | 2013-03-15 | 2017-04-25 | Acclarent, Inc. | Apparatus and method for treatment of ethmoid sinusitis |
US9433437B2 (en) | 2013-03-15 | 2016-09-06 | Acclarent, Inc. | Apparatus and method for treatment of ethmoid sinusitis |
US10149968B2 (en) | 2013-06-14 | 2018-12-11 | Artventive Medical Group, Inc. | Catheter-assisted tumor treatment |
US9737308B2 (en) | 2013-06-14 | 2017-08-22 | Artventive Medical Group, Inc. | Catheter-assisted tumor treatment |
US9636116B2 (en) | 2013-06-14 | 2017-05-02 | Artventive Medical Group, Inc. | Implantable luminal devices |
US9737306B2 (en) | 2013-06-14 | 2017-08-22 | Artventive Medical Group, Inc. | Implantable luminal devices |
US9301777B2 (en) | 2013-07-29 | 2016-04-05 | Invatec S.P.A. | Occlusion bypassing apparatuses and methods for bypassing an occlusion in a blood vessel |
US9308356B2 (en) | 2013-07-29 | 2016-04-12 | Invatec S.P.A. | Occlusion bypassing apparatuses and methods for bypassing an occlusion in a blood vessel |
US10070866B1 (en) | 2013-08-01 | 2018-09-11 | Avenu Medical, Inc. | Percutaneous arterial to venous anastomosis clip application catheter system and methods |
US9364642B2 (en) | 2013-08-14 | 2016-06-14 | Invatec S.P.A. | Balloon catheter systems and methods for bypassing an occlusion in a blood vessel |
US9320874B2 (en) | 2013-08-15 | 2016-04-26 | Invatec S.P.A. | Catheter systems with a blocking mechanism and methods for bypassing an occlusion in a blood vessel |
JP6562919B2 (en) | 2013-08-15 | 2019-08-21 | インテュイティブ サージカル オペレーションズ, インコーポレイテッド | System and method for medical treatment confirmation |
JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
WO2015048565A2 (en) | 2013-09-27 | 2015-04-02 | Intervene, Inc. | Visualization devices, systems, and methods for informing intravascular procedures on blood vessel valves |
KR101485558B1 (en) | 2013-11-05 | 2015-01-22 | 동국대학교 산학협력단 | Pullback system |
US10307135B2 (en) | 2013-11-20 | 2019-06-04 | Advanced Access Solutions, Inc. | Intravascular ultrasound needle guide |
US10286190B2 (en) | 2013-12-11 | 2019-05-14 | Cook Medical Technologies Llc | Balloon catheter with dynamic vessel engaging member |
US9713456B2 (en) | 2013-12-30 | 2017-07-25 | Acist Medical Systems, Inc. | Position sensing in intravascular imaging |
US11260160B2 (en) | 2014-01-14 | 2022-03-01 | Philips Image Guided Therapy Corporation | Systems and methods for improving an AV access site |
JP2017509366A (en) * | 2014-01-14 | 2017-04-06 | ボルケーノ コーポレイション | Catheter assembly for vascular access site creation |
CN105916457A (en) | 2014-01-14 | 2016-08-31 | 火山公司 | Devices and methods for forming vascular access |
JP6389526B2 (en) | 2014-01-14 | 2018-09-12 | ボルケーノ コーポレイション | System and method for assessing hemodialysis arteriovenous fistula maturation |
US10874409B2 (en) | 2014-01-14 | 2020-12-29 | Philips Image Guided Therapy Corporation | Methods and systems for clearing thrombus from a vascular access site |
US9737696B2 (en) | 2014-01-15 | 2017-08-22 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
EP3094365B1 (en) | 2014-01-15 | 2021-12-08 | Tufts Medical Center, Inc. | Endovascular cerebrospinal fluid shunt |
EP2898920B1 (en) | 2014-01-24 | 2018-06-06 | Cook Medical Technologies LLC | Articulating balloon catheter |
FR3017044A1 (en) * | 2014-01-31 | 2015-08-07 | Jacques Seguin | DEVICE FOR TREATING PULMONARY ARTERIAL HYPERTENSION |
US9855402B2 (en) | 2014-02-15 | 2018-01-02 | Rex Medical, L.P. | Apparatus for delivering fluid to treat renal hypertension |
US9446222B2 (en) | 2014-03-05 | 2016-09-20 | Invatec S.P.A. | Catheter assemblies and methods for stabilizing a catheter assembly within a subintimal space |
US10772672B2 (en) | 2014-03-06 | 2020-09-15 | Avenu Medical, Inc. | Systems and methods for percutaneous access and formation of arteriovenous fistulas |
US10695534B2 (en) | 2014-03-14 | 2020-06-30 | Tva Medical, Inc. | Fistula formation devices and methods therefor |
JP5954747B2 (en) * | 2014-03-20 | 2016-07-20 | 朝日インテック株式会社 | catheter |
EP3122266B1 (en) | 2014-03-24 | 2018-06-06 | Intervene, Inc. | Devices and systems for controlled hydrodissection of vessel walls |
US10363043B2 (en) | 2014-05-01 | 2019-07-30 | Artventive Medical Group, Inc. | Treatment of incompetent vessels |
US10987168B2 (en) | 2014-05-29 | 2021-04-27 | Spectranetics Llc | System and method for coordinated laser delivery and imaging |
US9545263B2 (en) | 2014-06-19 | 2017-01-17 | Limflow Gmbh | Devices and methods for treating lower extremity vasculature |
WO2015200702A1 (en) | 2014-06-27 | 2015-12-30 | Covidien Lp | Cleaning device for catheter and catheter including the same |
EP3169249B1 (en) * | 2014-07-15 | 2018-11-28 | Koninklijke Philips N.V. | Devices for intrahepatic shunts |
US10456557B2 (en) | 2014-08-14 | 2019-10-29 | Invatec S.P.A. | Occlusion bypassing apparatus with varying flexibility and methods for bypassing an occlusion in a blood vessel |
WO2016027502A1 (en) * | 2014-08-21 | 2016-02-25 | オリンパス株式会社 | Hard mirror set |
WO2016033374A1 (en) | 2014-08-27 | 2016-03-03 | Tva Medical, Inc. | Cryolipopysis devices and methods therefor |
US10499813B2 (en) | 2014-09-12 | 2019-12-10 | Lightlab Imaging, Inc. | Methods, systems and apparatus for temporal calibration of an intravascular imaging system |
US9981119B2 (en) * | 2014-10-29 | 2018-05-29 | Edwards Lifesciences Corporation | Bi-directional cannula |
WO2016070147A1 (en) | 2014-10-31 | 2016-05-06 | Cerevasc, Llc | Methods and systems for treating hydrocephalus |
EP3232953B1 (en) | 2014-12-16 | 2023-04-05 | Intervene, Inc. | Intravascular devices for the controlled dissection of body lumens |
US10226599B2 (en) * | 2014-12-23 | 2019-03-12 | C.R. Bard, Inc. | Inflatable medical device and related sheath |
US10646274B2 (en) | 2014-12-30 | 2020-05-12 | Regents Of The University Of Minnesota | Laser catheter with use of reflected light and force indication to determine material type in vascular system |
US10646118B2 (en) | 2014-12-30 | 2020-05-12 | Regents Of The University Of Minnesota | Laser catheter with use of reflected light to determine material type in vascular system |
US10646275B2 (en) | 2014-12-30 | 2020-05-12 | Regents Of The University Of Minnesota | Laser catheter with use of determined material type in vascular system in ablation of material |
US10603040B1 (en) | 2015-02-09 | 2020-03-31 | Tva Medical, Inc. | Methods for treating hypertension and reducing blood pressure with formation of fistula |
EP3265004B1 (en) | 2015-03-05 | 2023-06-28 | Ancora Heart, Inc. | Devices of visualizing and determining depth of penetration in cardiac tissue |
US10314667B2 (en) | 2015-03-25 | 2019-06-11 | Covidien Lp | Cleaning device for cleaning medical instrument |
US20160287223A1 (en) * | 2015-04-01 | 2016-10-06 | Boston Scientific Scimed, Inc. | Pulmonary biopsy devices |
JP6767388B2 (en) | 2015-05-01 | 2020-10-14 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Devices and methods to reduce the proportion of pacemakers in heart valve replacement |
US10109058B2 (en) | 2015-05-17 | 2018-10-23 | Lightlab Imaging, Inc. | Intravascular imaging system interfaces and stent detection methods |
US10646198B2 (en) | 2015-05-17 | 2020-05-12 | Lightlab Imaging, Inc. | Intravascular imaging and guide catheter detection methods and systems |
US10222956B2 (en) | 2015-05-17 | 2019-03-05 | Lightlab Imaging, Inc. | Intravascular imaging user interface systems and methods |
US9996921B2 (en) | 2015-05-17 | 2018-06-12 | LIGHTLAB IMAGING, lNC. | Detection of metal stent struts |
CN108024785B (en) * | 2015-06-15 | 2021-03-09 | 新宁研究院 | Intravascular imaging catheter and method of use |
US10292721B2 (en) | 2015-07-20 | 2019-05-21 | Covidien Lp | Tissue-removing catheter including movable distal tip |
WO2017019634A1 (en) | 2015-07-25 | 2017-02-02 | Lightlab Imaging, Inc. | Intravascular data visualization method |
JP6531999B2 (en) | 2015-08-21 | 2019-06-19 | アベニュ メディカル インコーポレイテッド | Systems and methods for forming a percutaneous arteriovenous fistula |
US11324548B2 (en) * | 2015-08-21 | 2022-05-10 | Baylis Medical Company Inc. | Transvascular electrosurgical devices and systems and methods of using the same |
US10172632B2 (en) | 2015-09-22 | 2019-01-08 | Medtronic Vascular, Inc. | Occlusion bypassing apparatus with a re-entry needle and a stabilization tube |
US10327791B2 (en) | 2015-10-07 | 2019-06-25 | Medtronic Vascular, Inc. | Occlusion bypassing apparatus with a re-entry needle and a distal stabilization balloon |
US10314664B2 (en) | 2015-10-07 | 2019-06-11 | Covidien Lp | Tissue-removing catheter and tissue-removing element with depth stop |
US9789294B2 (en) | 2015-10-07 | 2017-10-17 | Edwards Lifesciences Corporation | Expandable cardiac shunt |
JP6820612B2 (en) | 2015-10-30 | 2021-01-27 | セレバスク,インコーポレイテッド | Hydrocephalus treatment system and method |
EP3378036B1 (en) | 2015-11-18 | 2021-08-04 | Lightlab Imaging, Inc. | X-ray image feature detection and registration systems and methods |
JP6898927B2 (en) | 2015-11-23 | 2021-07-07 | ライトラボ・イメージング・インコーポレーテッド | Detection and verification of shadows in intravascular images |
JP6894440B2 (en) | 2016-01-15 | 2021-06-30 | ティーブイエー メディカル, インコーポレイテッド | Devices and methods for forming fistulas |
AU2017207507B2 (en) | 2016-01-15 | 2021-11-11 | Tva Medical, Inc. | Devices and methods for advancing a wire |
US10874422B2 (en) | 2016-01-15 | 2020-12-29 | Tva Medical, Inc. | Systems and methods for increasing blood flow |
US10646247B2 (en) | 2016-04-01 | 2020-05-12 | Intervene, Inc. | Intraluminal tissue modifying systems and associated devices and methods |
US10813644B2 (en) | 2016-04-01 | 2020-10-27 | Artventive Medical Group, Inc. | Occlusive implant and delivery system |
JP7027331B2 (en) | 2016-04-14 | 2022-03-01 | ライトラボ・イメージング・インコーポレーテッド | Identification of blood vessel branches |
US11684420B2 (en) | 2016-05-05 | 2023-06-27 | Eximo Medical Ltd. | Apparatus and methods for resecting and/or ablating an undesired tissue |
EP4183371A1 (en) | 2016-05-13 | 2023-05-24 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US10631754B2 (en) | 2016-05-16 | 2020-04-28 | Lightlab Imaging, Inc. | Intravascular absorbable stent detection and diagnostic methods and systems |
WO2017201287A1 (en) | 2016-05-19 | 2017-11-23 | Acist Medical Systems, Inc. | Position sensing in intravascular processes |
EP3457946B1 (en) | 2016-05-19 | 2023-05-03 | Acist Medical Systems, Inc. | Position sensing in intravascular processes |
CA3037525A1 (en) * | 2016-09-25 | 2018-03-29 | Tva Medical, Inc. | Vascular stent devices and methods |
CA3043175A1 (en) | 2016-11-11 | 2018-05-17 | Avenu Medical, Inc. | Systems and methods for percutaneous intravascular access and guidewire placement |
US20180140321A1 (en) | 2016-11-23 | 2018-05-24 | C. R. Bard, Inc. | Catheter With Retractable Sheath And Methods Thereof |
EP3551085A1 (en) * | 2016-12-07 | 2019-10-16 | Boston Scientific Scimed, Inc. | Systems for real-time biopsy needle and target tissue visualization |
US10617854B2 (en) | 2016-12-09 | 2020-04-14 | Vascular Access Technologies, Inc. | Trans-jugular carotid artery access methods |
US11596726B2 (en) | 2016-12-17 | 2023-03-07 | C.R. Bard, Inc. | Ultrasound devices for removing clots from catheters and related methods |
US10758256B2 (en) | 2016-12-22 | 2020-09-01 | C. R. Bard, Inc. | Ultrasonic endovascular catheter |
US11654224B2 (en) | 2016-12-30 | 2023-05-23 | Vascular Access Technologies, Inc. | Methods and devices for percutaneous implantation of arterio-venous grafts |
WO2018138658A1 (en) | 2017-01-27 | 2018-08-02 | Jenavalve Technology, Inc. | Heart valve mimicry |
US10582983B2 (en) | 2017-02-06 | 2020-03-10 | C. R. Bard, Inc. | Ultrasonic endovascular catheter with a controllable sheath |
CN108392294B (en) | 2017-02-07 | 2020-05-19 | 先健科技(深圳)有限公司 | Puncture device and anchoring device |
US20200100776A1 (en) * | 2017-02-09 | 2020-04-02 | Intuitive Surgical Operations, Inc. | System and method of accessing encapsulated targets |
US10926060B2 (en) | 2017-03-02 | 2021-02-23 | Covidien Lp | Flexible tip catheter |
EP4299086A2 (en) | 2017-04-10 | 2024-01-03 | LimFlow GmbH | Devices for treating lower extremity vasculature |
CN113143413B (en) | 2017-05-03 | 2022-06-21 | 美敦力瓦斯科尔勒公司 | Tissue removal catheter with guidewire isolation bushing |
US11690645B2 (en) | 2017-05-03 | 2023-07-04 | Medtronic Vascular, Inc. | Tissue-removing catheter |
US11179516B2 (en) | 2017-06-22 | 2021-11-23 | Baxter International Inc. | Systems and methods for incorporating patient pressure into medical fluid delivery |
CN111065342B (en) * | 2017-08-15 | 2023-07-04 | 皇家飞利浦有限公司 | Intracavity ultrasound device for diagnostic imaging and therapy |
NL2019909B1 (en) * | 2017-11-14 | 2019-05-20 | Academisch Ziekenhuis Leiden | SYSTEM, METHOD AND CATHETER FOR PITUITARY AND BRAIN IMPLANTATION |
US11033248B2 (en) | 2018-02-28 | 2021-06-15 | Gyrus Acmi, Inc. | Orientation pins for device using radial ultrasound |
US11013900B2 (en) | 2018-03-08 | 2021-05-25 | CereVasc, Inc. | Systems and methods for minimally invasive drug delivery to a subarachnoid space |
US10470797B1 (en) | 2018-07-17 | 2019-11-12 | SlipStream, LLC | Systems and methods for vascular access |
US11883232B2 (en) * | 2018-09-11 | 2024-01-30 | Olympus Medical Systems Corporation | Radial ultrasound capsule and system |
WO2020076833A1 (en) | 2018-10-09 | 2020-04-16 | Limflow Gmbh | Devices and methods for catheter alignment |
US11259834B2 (en) * | 2018-10-30 | 2022-03-01 | Biosense Webster (Israel) Ltd. | Brain aneurysm tool with a wire deflection mechanism |
TWI679996B (en) * | 2019-02-01 | 2019-12-21 | 佳世達科技股份有限公司 | Ultrasound needle positioning system and ultrasound needle positioning method |
US20220192502A1 (en) * | 2019-04-17 | 2022-06-23 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Endovascular orifice detection device for accurate fenestrated stent graft deployment |
US11819236B2 (en) | 2019-05-17 | 2023-11-21 | Medtronic Vascular, Inc. | Tissue-removing catheter |
US11497552B2 (en) | 2019-07-09 | 2022-11-15 | Juad, Inc. | Apparatus, systems and methods for transvascular access to the brain |
EP3998969A4 (en) | 2019-07-15 | 2023-08-02 | Ancora Heart, Inc. | Devices and methods for tether cutting |
US11602388B2 (en) * | 2019-08-21 | 2023-03-14 | Veran Medical Technologies, Inc. | Ablation monitoring system and method |
WO2021046577A1 (en) * | 2019-09-04 | 2021-03-11 | Hbip Limited Liability Company | Indwelling double or triple lumen urinary catheter |
CA3150143A1 (en) | 2019-09-13 | 2021-03-18 | Thomas D. Pate | Systems, devices, and methods for forming an anastomosis |
EP4033955A4 (en) * | 2019-09-25 | 2023-10-04 | Kin F. Chan | Imaging catheter, imaging system, and methods of operation thereof |
EP4051174A4 (en) | 2019-11-01 | 2023-11-22 | LimFlow GmbH | Devices and methods for increasing blood perfusion to a distal extremity |
US11857738B2 (en) * | 2019-12-16 | 2024-01-02 | Biosense Webster (Israel) Ltd. | Stabilized coronary sinus catheter handle |
CN111317543B (en) * | 2020-03-23 | 2022-10-25 | 南阳市中心医院 | Multi-functional strutting clearing device of neural intervention |
US11471651B2 (en) * | 2020-06-22 | 2022-10-18 | Medtronic, Inc. | Balloon catheter including a guidewire tube with a friction-increasing outer coating |
EP4171723A4 (en) | 2020-06-30 | 2023-12-13 | Vonova Inc. | Transcatheter electroctode array and use thereof |
US20220117468A1 (en) * | 2020-10-15 | 2022-04-21 | American Endoscopic Innovations, LLC | Endoscopic System With Attached Instruments |
US20220117584A1 (en) * | 2020-10-20 | 2022-04-21 | GE Precision Healthcare LLC | System And Method Of Signal Processing For Ultrasound Arrays With Mechanically Adjustable Transducer Shapes |
US11872357B2 (en) | 2020-11-09 | 2024-01-16 | Agile Devices, Inc. | Devices for steering catheters |
DE102021106856A1 (en) | 2021-03-19 | 2022-09-22 | Martin-Luther-Universität Halle-Wittenberg | Balloon dilatation catheter with two working channels for the use of two guide wires, in particular for endosonographically guided tissue puncture and placement of plastic stents in the upper GI tract |
EP4312707A1 (en) * | 2021-03-24 | 2024-02-07 | Simpson Interventions, Inc. | Chronic total occlusion treatment system using low refractive index materials |
WO2023057057A1 (en) * | 2021-10-06 | 2023-04-13 | Clearstream Technologies Limited | A catheter system for forming a fistula |
Family Cites Families (418)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1010406A (en) | 1909-07-15 | 1911-11-28 | Howard Robard Hughes | Roller-drill. |
US1018291A (en) | 1911-05-09 | 1912-02-20 | Single Service Package Corp Am | Machine for making metal tubes. |
US1018433A (en) | 1911-06-28 | 1912-02-27 | Hoechst Ag | Brown vat dyestuff and process of making same. |
US3752162A (en) | 1972-04-10 | 1973-08-14 | Dow Corning | Artificial cutaneous stoma |
US3941127A (en) * | 1974-10-03 | 1976-03-02 | Froning Edward C | Apparatus and method for stereotaxic lateral extradural disc puncture |
SU891076A1 (en) | 1979-03-19 | 1981-12-23 | Казахский Институт Клинической И Экспериментальной Хирургии | Method of shunting coronary arteriae |
US4578061A (en) * | 1980-10-28 | 1986-03-25 | Lemelson Jerome H | Injection catheter and method |
US4445892A (en) | 1982-05-06 | 1984-05-01 | Laserscope, Inc. | Dual balloon catheter device |
RU1822750C (en) | 1982-07-26 | 1993-06-23 | Смоленский государственный медицинский институт | Method of thoracic-coronary shunting |
US5370675A (en) | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US4582067A (en) | 1983-02-14 | 1986-04-15 | Washington Research Foundation | Method for endoscopic blood flow detection by the use of ultrasonic energy |
US4774949A (en) | 1983-06-14 | 1988-10-04 | Fogarty Thomas J | Deflector guiding catheter |
US5190546A (en) | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US5423878A (en) | 1984-03-06 | 1995-06-13 | Ep Technologies, Inc. | Catheter and associated system for pacing the heart |
US4618600A (en) | 1984-04-19 | 1986-10-21 | Biotechnology Research Associates, J.V. | Novel polypeptide diuretic/vasodilators |
US4552554A (en) | 1984-06-25 | 1985-11-12 | Medi-Tech Incorporated | Introducing catheter |
US4602624A (en) | 1984-10-11 | 1986-07-29 | Case Western Reserve University | Implantable cuff, method of manufacture, and method of installation |
US4649936A (en) | 1984-10-11 | 1987-03-17 | Case Western Reserve University | Asymmetric single electrode cuff for generation of unidirectionally propagating action potentials for collision blocking |
US4669465A (en) * | 1984-12-10 | 1987-06-02 | Gv Medical, Inc. | Laser catheter control and connecting apparatus |
US4824436A (en) | 1985-04-09 | 1989-04-25 | Harvey Wolinsky | Method for the prevention of restenosis |
FR2592791A1 (en) | 1986-01-14 | 1987-07-17 | Ire Celltarg Sa | PHARMACEUTICAL COMPOSITION CONTAINING A LOCAL ANESTHETIC AND / OR A CENTRAL ANALGESIC ENCAPSULATED IN LIPOSOMES |
US4794931A (en) | 1986-02-28 | 1989-01-03 | Cardiovascular Imaging Systems, Inc. | Catheter apparatus, system and method for intravascular two-dimensional ultrasonography |
US5000185A (en) * | 1986-02-28 | 1991-03-19 | Cardiovascular Imaging Systems, Inc. | Method for intravascular two-dimensional ultrasonography and recanalization |
US4709698A (en) | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
US4739768B2 (en) | 1986-06-02 | 1995-10-24 | Target Therapeutics Inc | Catheter for guide-wire tracking |
US4808153A (en) * | 1986-11-17 | 1989-02-28 | Ultramed Corporation | Device for removing plaque from arteries |
GB8704930D0 (en) * | 1987-03-03 | 1987-04-08 | Davy Mckee Sheffield | Manipulator for metal ingots |
NL8700632A (en) | 1987-03-17 | 1988-10-17 | Stichting Biomedical Engineeri | Medical spark erosion catheter - removes blockages in blood vessels using ultrasonic transducer to aid accurate placement |
US4986262A (en) * | 1987-03-31 | 1991-01-22 | Kabushiki Kaisha Toshiba | Measuring endoscope |
DE3710913A1 (en) | 1987-04-01 | 1988-10-13 | Manfred Wolfgang Dr Helzel | PUNCTURE CATHETER |
DE8717643U1 (en) * | 1987-05-12 | 1989-09-21 | Foerster, Ernst, Dr.Med. Dr.Rer.Nat. | |
US4817613A (en) | 1987-07-13 | 1989-04-04 | Devices For Vascular Intervention, Inc. | Guiding catheter |
US4769005A (en) | 1987-08-06 | 1988-09-06 | Robert Ginsburg | Selective catheter guide |
JPH01139081A (en) | 1987-11-27 | 1989-05-31 | Olympus Optical Co Ltd | Apparatus for radiating laser beam |
US4890623A (en) | 1988-03-14 | 1990-01-02 | C. R. Bard, Inc. | Biopotential sensing device and method for making |
US4924863A (en) * | 1988-05-04 | 1990-05-15 | Mmtc, Inc. | Angioplastic method for removing plaque from a vas |
DE68925757T2 (en) | 1988-06-13 | 1996-09-05 | Samuel Shiber | Atherectomy system with a guidewire |
WO1989012460A1 (en) * | 1988-06-16 | 1989-12-28 | Bactex, Inc. | Haemophilus influenzae pilus vaccines |
US4955377A (en) | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
JP2619941B2 (en) * | 1988-10-31 | 1997-06-11 | オリンパス光学工業株式会社 | Hyperthermia probe |
AU4945490A (en) | 1989-01-06 | 1990-08-01 | Angioplasty Systems Inc. | Electrosurgical catheter for resolving atherosclerotic plaque |
US5779698A (en) | 1989-01-18 | 1998-07-14 | Applied Medical Resources Corporation | Angioplasty catheter system and method for making same |
US5087244A (en) | 1989-01-31 | 1992-02-11 | C. R. Bard, Inc. | Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen |
US4976711A (en) | 1989-04-13 | 1990-12-11 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US4936281A (en) * | 1989-04-13 | 1990-06-26 | Everest Medical Corporation | Ultrasonically enhanced RF ablation catheter |
US4997431A (en) | 1989-08-30 | 1991-03-05 | Angeion Corporation | Catheter |
US5114403A (en) * | 1989-09-15 | 1992-05-19 | Eclipse Surgical Technologies, Inc. | Catheter torque mechanism |
US5220924A (en) | 1989-09-28 | 1993-06-22 | Frazin Leon J | Doppler-guided retrograde catheterization using transducer equipped guide wire |
US5055109A (en) | 1989-10-05 | 1991-10-08 | Advanced Cardiovascular Systems, Inc. | Torque transmitting assembly for intravascular devices |
US5024234A (en) * | 1989-10-17 | 1991-06-18 | Cardiovascular Imaging Systems, Inc. | Ultrasonic imaging catheter with guidewire channel |
US5344395A (en) | 1989-11-13 | 1994-09-06 | Scimed Life Systems, Inc. | Apparatus for intravascular cavitation or delivery of low frequency mechanical energy |
US5061245A (en) * | 1990-01-19 | 1991-10-29 | Waldvogel Chester W | Arterial bypass tool |
US5084006A (en) | 1990-03-30 | 1992-01-28 | Alza Corporation | Iontopheretic delivery device |
US5236413B1 (en) | 1990-05-07 | 1996-06-18 | Andrew J Feiring | Method and apparatus for inducing the permeation of medication into internal tissue |
US5558093A (en) * | 1990-05-18 | 1996-09-24 | Cardiovascular Imaging Systems, Inc. | Guidewire with imaging capability |
US5035702A (en) * | 1990-06-18 | 1991-07-30 | Taheri Syde A | Method and apparatus for providing an anastomosis |
US5190528A (en) | 1990-10-19 | 1993-03-02 | Boston University | Percutaneous transseptal left atrial cannulation system |
US5254112A (en) * | 1990-10-29 | 1993-10-19 | C. R. Bard, Inc. | Device for use in laser angioplasty |
US5389096A (en) * | 1990-12-18 | 1995-02-14 | Advanced Cardiovascular Systems | System and method for percutaneous myocardial revascularization |
CA2094250A1 (en) | 1990-12-10 | 1992-06-11 | Joshua Makower | Device and method for interstitial laser energy delivery |
JP3041967B2 (en) | 1990-12-13 | 2000-05-15 | ソニー株式会社 | Digital signal coding device |
US5054492A (en) | 1990-12-17 | 1991-10-08 | Cardiovascular Imaging Systems, Inc. | Ultrasonic imaging catheter having rotational image correlation |
US5380316A (en) | 1990-12-18 | 1995-01-10 | Advanced Cardiovascular Systems, Inc. | Method for intra-operative myocardial device revascularization |
US5827315A (en) | 1994-01-04 | 1998-10-27 | Yoon; Inbae | Safety penetrating instrument with penetrating member protected after penetration to predetermined depth |
US6524274B1 (en) | 1990-12-28 | 2003-02-25 | Scimed Life Systems, Inc. | Triggered release hydrogel drug delivery system |
US5102402A (en) | 1991-01-04 | 1992-04-07 | Medtronic, Inc. | Releasable coatings on balloon catheters |
US5997497A (en) | 1991-01-11 | 1999-12-07 | Advanced Cardiovascular Systems | Ultrasound catheter having integrated drug delivery system and methods of using same |
ES2098333T3 (en) | 1991-01-31 | 1997-05-01 | Baxter Int | AUTOMATIC INSTILATION PUMP WITH SUBSTITUTE MEMORY CARTRIDGES. |
US5409453A (en) * | 1992-08-12 | 1995-04-25 | Vidamed, Inc. | Steerable medical probe with stylets |
US5330496A (en) | 1991-05-06 | 1994-07-19 | Alferness Clifton A | Vascular catheter assembly for tissue penetration and for cardiac stimulation and methods thereof |
US5743875A (en) * | 1991-05-15 | 1998-04-28 | Advanced Cardiovascular Systems, Inc. | Catheter shaft with an oblong transverse cross-section |
US5193546A (en) * | 1991-05-15 | 1993-03-16 | Alexander Shaknovich | Coronary intravascular ultrasound imaging method and apparatus |
US6309379B1 (en) | 1991-05-23 | 2001-10-30 | Lloyd K. Willard | Sheath for selective delivery of multiple intravascular devices and methods of use thereof |
WO1993000868A1 (en) * | 1991-07-04 | 1993-01-21 | Earl Ronald Owen | Tubular surgical implant |
US5452733A (en) * | 1993-02-22 | 1995-09-26 | Stanford Surgical Technologies, Inc. | Methods for performing thoracoscopic coronary artery bypass |
US5370649A (en) | 1991-08-16 | 1994-12-06 | Myriadlase, Inc. | Laterally reflecting tip for laser transmitting fiber |
JP3530528B2 (en) | 1991-11-08 | 2004-05-24 | ボストン サイエンティフィック リミテッド | Ablation electrode with insulated temperature sensing element |
US5704361A (en) | 1991-11-08 | 1998-01-06 | Mayo Foundation For Medical Education And Research | Volumetric image ultrasound transducer underfluid catheter system |
US5713363A (en) | 1991-11-08 | 1998-02-03 | Mayo Foundation For Medical Education And Research | Ultrasound catheter and method for imaging and hemodynamic monitoring |
US5325860A (en) | 1991-11-08 | 1994-07-05 | Mayo Foundation For Medical Education And Research | Ultrasonic and interventional catheter and method |
US5358514A (en) | 1991-12-18 | 1994-10-25 | Alfred E. Mann Foundation For Scientific Research | Implantable microdevice with self-attaching electrodes |
US5697882A (en) | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US5419767A (en) | 1992-01-07 | 1995-05-30 | Thapliyal And Eggers Partners | Methods and apparatus for advancing catheters through severely occluded body lumens |
WO1993015676A1 (en) * | 1992-02-05 | 1993-08-19 | Angelase, Inc. | Laser catheter with movable integral fixation wire |
MX9300607A (en) * | 1992-02-06 | 1993-10-01 | American Med Syst | APPARATUS AND METHOD FOR INTERSTITIAL TREATMENT. |
US5251640A (en) * | 1992-03-31 | 1993-10-12 | Cook, Incorporated | Composite wire guide shaft |
US5306250A (en) | 1992-04-02 | 1994-04-26 | Indiana University Foundation | Method and apparatus for intravascular drug delivery |
US5300068A (en) | 1992-04-21 | 1994-04-05 | St. Jude Medical, Inc. | Electrosurgical apparatus |
US5331947A (en) * | 1992-05-01 | 1994-07-26 | Shturman Cardiology Systems, Inc. | Inflatable sheath for introduction of ultrasonic catheter through the lumen of a fiber optic endoscope |
US5599300A (en) | 1992-05-11 | 1997-02-04 | Arrow Precision Products, Inc. | Method for electrosurgically obtaining access to the biliary tree with an adjustably positionable needle-knife |
US5271402A (en) * | 1992-06-02 | 1993-12-21 | Hewlett-Packard Company | Turbine drive mechanism for steering ultrasound signals |
US5325845A (en) * | 1992-06-08 | 1994-07-05 | Adair Edwin Lloyd | Steerable sheath for use with selected removable optical catheter |
US5772590A (en) | 1992-06-30 | 1998-06-30 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire |
US5538504A (en) | 1992-07-14 | 1996-07-23 | Scimed Life Systems, Inc. | Intra-extravascular drug delivery catheter and method |
US5484400A (en) | 1992-08-12 | 1996-01-16 | Vidamed, Inc. | Dual channel RF delivery system |
US5542916A (en) | 1992-08-12 | 1996-08-06 | Vidamed, Inc. | Dual-channel RF power delivery system |
US5486161A (en) * | 1993-02-02 | 1996-01-23 | Zomed International | Medical probe device and method |
US5556377A (en) * | 1992-08-12 | 1996-09-17 | Vidamed, Inc. | Medical probe apparatus with laser and/or microwave monolithic integrated circuit probe |
US5312341A (en) | 1992-08-14 | 1994-05-17 | Wayne State University | Retaining apparatus and procedure for transseptal catheterization |
WO1994007446A1 (en) | 1992-10-05 | 1994-04-14 | Boston Scientific Corporation | Device and method for heating tissue |
US5383460A (en) | 1992-10-05 | 1995-01-24 | Cardiovascular Imaging Systems, Inc. | Method and apparatus for ultrasound imaging and atherectomy |
US5634899A (en) | 1993-08-20 | 1997-06-03 | Cortrak Medical, Inc. | Simultaneous cardiac pacing and local drug delivery method |
CA2107741C (en) | 1992-10-07 | 2000-06-27 | Peter T. Keith | Ablation devices and methods of use |
DE4235506A1 (en) | 1992-10-21 | 1994-04-28 | Bavaria Med Tech | Drug injection catheter |
US5287861A (en) | 1992-10-30 | 1994-02-22 | Wilk Peter J | Coronary artery by-pass method and associated catheter |
US5409019A (en) | 1992-10-30 | 1995-04-25 | Wilk; Peter J. | Coronary artery by-pass method |
US5429144A (en) | 1992-10-30 | 1995-07-04 | Wilk; Peter J. | Coronary artery by-pass method |
US5634901A (en) | 1992-11-02 | 1997-06-03 | Localmed, Inc. | Method of using a catheter sleeve |
CA2109980A1 (en) | 1992-12-01 | 1994-06-02 | Mir A. Imran | Steerable catheter with adjustable bend location and/or radius and method |
US5256141A (en) | 1992-12-22 | 1993-10-26 | Nelson Gencheff | Biological material deployment method and apparatus |
US5487730A (en) * | 1992-12-30 | 1996-01-30 | Medtronic, Inc. | Balloon catheter with balloon surface retention means |
US5373849A (en) | 1993-01-19 | 1994-12-20 | Cardiovascular Imaging Systems, Inc. | Forward viewing imaging catheter |
JPH06217988A (en) * | 1993-01-26 | 1994-08-09 | Terumo Corp | Blood vessel sticking instrument |
US5381786A (en) * | 1993-02-11 | 1995-01-17 | Wayne State University | Method and apparatus for measurement of luminal dimensions |
US5797960A (en) | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
EP0617308A1 (en) | 1993-03-22 | 1994-09-28 | NCR International, Inc. | Liquid crystal display with integrated electronics |
US5523092A (en) | 1993-04-14 | 1996-06-04 | Emory University | Device for local drug delivery and methods for using the same |
US5429136A (en) * | 1993-04-21 | 1995-07-04 | Devices For Vascular Intervention, Inc. | Imaging atherectomy apparatus |
US5590654A (en) | 1993-06-07 | 1997-01-07 | Prince; Martin R. | Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent |
US5860974A (en) | 1993-07-01 | 1999-01-19 | Boston Scientific Corporation | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
WO1995001751A1 (en) * | 1993-07-01 | 1995-01-19 | Boston Scientific Corporation | Imaging, electrical potential sensing, and ablation catheters |
US5527325A (en) | 1993-07-09 | 1996-06-18 | Device For Vascular Intervention, Inc. | Atherectomy catheter and method |
US5562619A (en) * | 1993-08-19 | 1996-10-08 | Boston Scientific Corporation | Deflectable catheter |
US5746745A (en) * | 1993-08-23 | 1998-05-05 | Boston Scientific Corporation | Balloon catheter |
EP0746362B1 (en) * | 1993-08-23 | 2002-01-16 | Boston Scientific Corporation | Improved balloon catheter |
US5496307A (en) | 1993-09-10 | 1996-03-05 | S.L.T. Japan Co., Ltd. | Laser light irradiation apparatus for medical treatment |
US5571147A (en) | 1993-11-02 | 1996-11-05 | Sluijter; Menno E. | Thermal denervation of an intervertebral disc for relief of back pain |
US5599346A (en) | 1993-11-08 | 1997-02-04 | Zomed International, Inc. | RF treatment system |
JP2833456B2 (en) | 1993-11-22 | 1998-12-09 | 株式会社東芝 | Insertable ultrasound system |
US5443497A (en) * | 1993-11-22 | 1995-08-22 | The Johns Hopkins University | Percutaneous prosthetic by-pass graft and method of use |
US6099524A (en) | 1994-01-28 | 2000-08-08 | Cardiac Pacemakers, Inc. | Electrophysiological mapping and ablation catheter and method |
DE4408108A1 (en) | 1994-03-10 | 1995-09-14 | Bavaria Med Tech | Catheter for injecting a fluid or a drug |
US5485840A (en) | 1994-03-15 | 1996-01-23 | Bauman; Robert P. | Method of precise guidance for directional atherectomy using ultrasound |
US5588962A (en) | 1994-03-29 | 1996-12-31 | Boston Scientific Corporation | Drug treatment of diseased sites deep within the body |
US5464395A (en) | 1994-04-05 | 1995-11-07 | Faxon; David P. | Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway |
US5496309A (en) | 1994-05-06 | 1996-03-05 | Trimedyne, Inc. | Catheter device utilizing a laser beam laterally directed by a high index prism in a liquid medium |
US5456694A (en) * | 1994-05-13 | 1995-10-10 | Stentco, Inc. | Device for delivering and deploying intraluminal devices |
US6009877A (en) | 1994-06-24 | 2000-01-04 | Edwards; Stuart D. | Method for treating a sphincter |
US6405732B1 (en) | 1994-06-24 | 2002-06-18 | Curon Medical, Inc. | Method to treat gastric reflux via the detection and ablation of gastro-esophageal nerves and receptors |
US5857998A (en) | 1994-06-30 | 1999-01-12 | Boston Scientific Corporation | Stent and therapeutic delivery system |
US5540236A (en) | 1994-08-05 | 1996-07-30 | Cardiovascular Imaging Systems, Incorporated | Guide wire exit port |
US5514092A (en) | 1994-08-08 | 1996-05-07 | Schneider (Usa) Inc. | Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration |
GB2293240B (en) | 1994-09-15 | 1998-05-20 | Intravascular Res Ltd | Ultrasonic visualisation method and apparatus |
US5571093A (en) | 1994-09-21 | 1996-11-05 | Cruz; Cosme | Multiple-lumen catheter |
JP3614943B2 (en) | 1994-09-29 | 2005-01-26 | オリンパス株式会社 | Endoscopic puncture needle |
US5558673A (en) | 1994-09-30 | 1996-09-24 | Vidamed, Inc. | Medical probe device and method having a flexible resilient tape stylet |
US5549601A (en) * | 1994-10-11 | 1996-08-27 | Devices For Vascular Intervention, Inc. | Delivery of intracorporeal probes |
US5817144A (en) | 1994-10-25 | 1998-10-06 | Latis, Inc. | Method for contemporaneous application OF laser energy and localized pharmacologic therapy |
US6689086B1 (en) | 1994-10-27 | 2004-02-10 | Advanced Cardiovascular Systems, Inc. | Method of using a catheter for delivery of ultrasonic energy and medicament |
US5588960A (en) | 1994-12-01 | 1996-12-31 | Vidamed, Inc. | Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence |
US5665062A (en) | 1995-01-23 | 1997-09-09 | Houser; Russell A. | Atherectomy catheter and RF cutting method |
US5728044A (en) * | 1995-03-10 | 1998-03-17 | Shan; Yansong | Sensor device for spacial imaging of endoscopes |
NL9500494A (en) * | 1995-03-13 | 1996-10-01 | Cordis Europ | Balloon catheter with light guide. |
US5636644A (en) | 1995-03-17 | 1997-06-10 | Applied Medical Resources Corporation | Method and apparatus for endoconduit targeting |
US5606974A (en) * | 1995-05-02 | 1997-03-04 | Heart Rhythm Technologies, Inc. | Catheter having ultrasonic device |
AU5727096A (en) | 1995-05-04 | 1996-11-21 | Eric R. Cosman | Cool-tip electrode thermosurgery system |
US5688237A (en) * | 1995-05-04 | 1997-11-18 | Cedars-Sinai Medical Center | Implantable catheter and method of use |
US6251104B1 (en) | 1995-05-10 | 2001-06-26 | Eclipse Surgical Technologies, Inc. | Guiding catheter system for ablating heart tissue |
WO1996035469A1 (en) | 1995-05-10 | 1996-11-14 | Cardiogenesis Corporation | System for treating or diagnosing heart tissue |
AU5741296A (en) | 1995-05-12 | 1996-11-29 | Rodney C. Perkins | Translumenal circumferential injector |
US5895355A (en) | 1995-05-23 | 1999-04-20 | Cardima, Inc. | Over-the-wire EP catheter |
US5596990A (en) | 1995-06-06 | 1997-01-28 | Yock; Paul | Rotational correlation of intravascular ultrasound image with guide catheter position |
US6149620A (en) | 1995-11-22 | 2000-11-21 | Arthrocare Corporation | System and methods for electrosurgical tissue treatment in the presence of electrically conductive fluid |
US6322558B1 (en) | 1995-06-09 | 2001-11-27 | Engineering & Research Associates, Inc. | Apparatus and method for predicting ablation depth |
US5865801A (en) | 1995-07-18 | 1999-02-02 | Houser; Russell A. | Multiple compartmented balloon catheter with external pressure sensing |
US5672174A (en) | 1995-08-15 | 1997-09-30 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US5735847A (en) | 1995-08-15 | 1998-04-07 | Zomed International, Inc. | Multiple antenna ablation apparatus and method with cooling element |
DE29513195U1 (en) | 1995-08-17 | 1996-12-19 | Schreiber Hans | Arteriovenous shunt |
US5707400A (en) | 1995-09-19 | 1998-01-13 | Cyberonics, Inc. | Treating refractory hypertension by nerve stimulation |
US6283951B1 (en) | 1996-10-11 | 2001-09-04 | Transvascular, Inc. | Systems and methods for delivering drugs to selected locations within the body |
ATE275880T1 (en) * | 1995-10-13 | 2004-10-15 | Transvascular Inc | DEVICE FOR BYPASSING ARTERIAL Narrowings AND/OR FOR PERFORMING OTHER TRANSVASCULAR PROCEDURES |
US5700282A (en) | 1995-10-13 | 1997-12-23 | Zabara; Jacob | Heart rhythm stabilization using a neurocybernetic prosthesis |
US6302875B1 (en) | 1996-10-11 | 2001-10-16 | Transvascular, Inc. | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
CA2234389A1 (en) | 1995-10-13 | 1997-04-17 | Transvascular, Inc. | A device, system and method for interstitial transvascular intervention |
US5817092A (en) | 1995-11-09 | 1998-10-06 | Radio Therapeutics Corporation | Apparatus, system and method for delivering radio frequency energy to a treatment site |
US5803083A (en) | 1995-11-09 | 1998-09-08 | Cordis Corporation | Guiding catheter with ultrasound imaging capability |
US5749848A (en) * | 1995-11-13 | 1998-05-12 | Cardiovascular Imaging Systems, Inc. | Catheter system having imaging, balloon angioplasty, and stent deployment capabilities, and method of use for guided stent deployment |
JP2001508318A (en) * | 1996-02-02 | 2001-06-26 | トランスバスキュラー インコーポレイテッド | Apparatus, systems and methods for interstitial transvascular intervention |
US5733296A (en) | 1996-02-06 | 1998-03-31 | Devices For Vascular Intervention | Composite atherectomy cutter |
US5771895A (en) | 1996-02-12 | 1998-06-30 | Slager; Cornelis J. | Catheter for obtaining three-dimensional reconstruction of a vascular lumen and wall |
ES2251018T3 (en) | 1996-02-15 | 2006-04-16 | Biosense Webster, Inc. | CATHETER WITH LUMEN. |
US6036687A (en) | 1996-03-05 | 2000-03-14 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency |
US5830224A (en) | 1996-03-15 | 1998-11-03 | Beth Israel Deaconess Medical Center | Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo |
US5843016A (en) | 1996-03-18 | 1998-12-01 | Physion S.R.L. | Electromotive drug administration for treatment of acute urinary outflow obstruction |
EP0796633B1 (en) * | 1996-03-18 | 2003-07-02 | Hiroaki Ashiya | Catheter assembly |
US5891133A (en) * | 1996-03-29 | 1999-04-06 | Eclipse Surgical Technologies, Inc. | Apparatus for laser-assisted intra-coronary transmyocardial revascularization and other applications |
US5824042A (en) * | 1996-04-05 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
US5713923A (en) | 1996-05-13 | 1998-02-03 | Medtronic, Inc. | Techniques for treating epilepsy by brain stimulation and drug infusion |
US5699805A (en) | 1996-06-20 | 1997-12-23 | Mayo Foundation For Medical Education And Research | Longitudinal multiplane ultrasound transducer underfluid catheter system |
US5944710A (en) | 1996-06-24 | 1999-08-31 | Genetronics, Inc. | Electroporation-mediated intravascular delivery |
US5983141A (en) | 1996-06-27 | 1999-11-09 | Radionics, Inc. | Method and apparatus for altering neural tissue function |
US6246912B1 (en) | 1996-06-27 | 2001-06-12 | Sherwood Services Ag | Modulated high frequency tissue modification |
US5800450A (en) * | 1996-10-03 | 1998-09-01 | Interventional Technologies Inc. | Neovascularization catheter |
WO1998016161A1 (en) | 1996-10-11 | 1998-04-23 | Transvascular, Inc. | Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures |
US5755704A (en) | 1996-10-29 | 1998-05-26 | Medtronic, Inc. | Thinwall guide catheter |
US5893885A (en) | 1996-11-01 | 1999-04-13 | Cordis Webster, Inc. | Multi-electrode ablation catheter |
US6091995A (en) | 1996-11-08 | 2000-07-18 | Surx, Inc. | Devices, methods, and systems for shrinking tissues |
US5944716A (en) | 1996-12-09 | 1999-08-31 | Scimed Life Systems, Inc. | Radio frequency transmyocardial revascularization corer |
US5954719A (en) | 1996-12-11 | 1999-09-21 | Irvine Biomedical, Inc. | System for operating a RF ablation generator |
US5724975A (en) | 1996-12-12 | 1998-03-10 | Plc Medical Systems, Inc. | Ultrasonic detection system for transmyocardial revascularization |
CA2225521C (en) | 1996-12-27 | 2004-04-06 | Eclipse Surgical Technologies, Inc. | Laser assisted drug delivery apparatus |
WO1998034558A2 (en) | 1997-02-12 | 1998-08-13 | Oratec Interventions, Inc. | Concave probe for arthroscopic surgery |
US6416510B1 (en) | 1997-03-13 | 2002-07-09 | Biocardia, Inc. | Drug delivery catheters that attach to tissue and methods for their use |
US7027869B2 (en) | 1998-01-07 | 2006-04-11 | Asthmatx, Inc. | Method for treating an asthma attack |
US6117128A (en) | 1997-04-30 | 2000-09-12 | Kenton W. Gregory | Energy delivery catheter and method for the use thereof |
US6723063B1 (en) | 1998-06-29 | 2004-04-20 | Ekos Corporation | Sheath for use with an ultrasound element |
US6024740A (en) | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US5989208A (en) | 1997-05-16 | 1999-11-23 | Nita; Henry | Therapeutic ultrasound system |
WO1999000060A1 (en) | 1997-06-26 | 1999-01-07 | Advanced Coronary Intervention | Electrosurgical catheter for resolving obstructions by radio frequency ablation |
US6161048A (en) | 1997-06-26 | 2000-12-12 | Radionics, Inc. | Method and system for neural tissue modification |
US6117101A (en) | 1997-07-08 | 2000-09-12 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6869431B2 (en) | 1997-07-08 | 2005-03-22 | Atrionix, Inc. | Medical device with sensor cooperating with expandable member |
US8257725B2 (en) | 1997-09-26 | 2012-09-04 | Abbott Laboratories | Delivery of highly lipophilic agents via medical devices |
US6231516B1 (en) | 1997-10-14 | 2001-05-15 | Vacusense, Inc. | Endoluminal implant with therapeutic and diagnostic capability |
US6917834B2 (en) | 1997-12-03 | 2005-07-12 | Boston Scientific Scimed, Inc. | Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates |
US6273886B1 (en) | 1998-02-19 | 2001-08-14 | Curon Medical, Inc. | Integrated tissue heating and cooling apparatus |
WO1999049908A1 (en) | 1998-03-31 | 1999-10-07 | University Of Cincinnati | Temperature controlled solute delivery system |
US6314325B1 (en) | 1998-04-07 | 2001-11-06 | William R. Fitz | Nerve hyperpolarization method and apparatus for pain relief |
US6219577B1 (en) | 1998-04-14 | 2001-04-17 | Global Vascular Concepts, Inc. | Iontophoresis, electroporation and combination catheters for local drug delivery to arteries and other body tissues |
US6364856B1 (en) | 1998-04-14 | 2002-04-02 | Boston Scientific Corporation | Medical device with sponge coating for controlled drug release |
US6161047A (en) | 1998-04-30 | 2000-12-12 | Medtronic Inc. | Apparatus and method for expanding a stimulation lead body in situ |
US6022901A (en) | 1998-05-13 | 2000-02-08 | Pharmascience Inc. | Administration of resveratrol to prevent or treat restenosis following coronary intervention |
US7198635B2 (en) | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
WO1999065561A1 (en) | 1998-06-19 | 1999-12-23 | Cordis Webster, Inc. | Method and apparatus for transvascular treatment of tachycardia and fibrillation |
US6322559B1 (en) | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
US6152943A (en) | 1998-08-14 | 2000-11-28 | Incept Llc | Methods and apparatus for intraluminal deposition of hydrogels |
US6123702A (en) | 1998-09-10 | 2000-09-26 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US20060240070A1 (en) | 1998-09-24 | 2006-10-26 | Cromack Keith R | Delivery of highly lipophilic agents via medical devices |
US8257724B2 (en) | 1998-09-24 | 2012-09-04 | Abbott Laboratories | Delivery of highly lipophilic agents via medical devices |
US7313444B2 (en) | 1998-11-20 | 2007-12-25 | Pacesetter, Inc. | Self-anchoring coronary sinus lead |
US6296619B1 (en) | 1998-12-30 | 2001-10-02 | Pharmasonics, Inc. | Therapeutic ultrasonic catheter for delivering a uniform energy dose |
US7481803B2 (en) | 2000-11-28 | 2009-01-27 | Flowmedica, Inc. | Intra-aortic renal drug delivery catheter |
US6749598B1 (en) | 1999-01-11 | 2004-06-15 | Flowmedica, Inc. | Apparatus and methods for treating congestive heart disease |
US7329236B2 (en) | 1999-01-11 | 2008-02-12 | Flowmedica, Inc. | Intra-aortic renal drug delivery catheter |
US7780628B1 (en) | 1999-01-11 | 2010-08-24 | Angiodynamics, Inc. | Apparatus and methods for treating congestive heart disease |
US6695830B2 (en) | 1999-01-15 | 2004-02-24 | Scimed Life Systems, Inc. | Method for delivering medication into an arterial wall for prevention of restenosis |
ES2240078T3 (en) | 1999-03-09 | 2005-10-16 | Thermage, Inc. | APPARATUS FOR TREATMENT OF FABRICS. |
US6484052B1 (en) | 1999-03-30 | 2002-11-19 | The Regents Of The University Of California | Optically generated ultrasound for enhanced drug delivery |
US6692738B2 (en) | 2000-01-27 | 2004-02-17 | The General Hospital Corporation | Delivery of therapeutic biologicals from implantable tissue matrices |
US6325797B1 (en) | 1999-04-05 | 2001-12-04 | Medtronic, Inc. | Ablation catheter and method for isolating a pulmonary vein |
US6939346B2 (en) | 1999-04-21 | 2005-09-06 | Oratec Interventions, Inc. | Method and apparatus for controlling a temperature-controlled probe |
US6245045B1 (en) | 1999-04-23 | 2001-06-12 | Alexander Andrew Stratienko | Combination sheath and catheter for cardiovascular use |
US6514236B1 (en) | 1999-04-23 | 2003-02-04 | Alexander A. Stratienko | Method for treating a cardiovascular condition |
US6595959B1 (en) | 1999-04-23 | 2003-07-22 | Alexander A. Stratienko | Cardiovascular sheath/catheter |
US6302870B1 (en) | 1999-04-29 | 2001-10-16 | Precision Vascular Systems, Inc. | Apparatus for injecting fluids into the walls of blood vessels, body cavities, and the like |
WO2000066017A1 (en) | 1999-05-04 | 2000-11-09 | Curon Medical, Inc. | Electrodes for creating lesions in tissue regions at or near a sphincter |
US7171263B2 (en) | 1999-06-04 | 2007-01-30 | Impulse Dynamics Nv | Drug delivery device |
US7840278B1 (en) | 1999-06-25 | 2010-11-23 | Puskas John D | Devices and methods for vagus nerve stimulation |
US6283947B1 (en) | 1999-07-13 | 2001-09-04 | Advanced Cardiovascular Systems, Inc. | Local drug delivery injection catheter |
US6767544B2 (en) | 2002-04-01 | 2004-07-27 | Allergan, Inc. | Methods for treating cardiovascular diseases with botulinum toxin |
JP2003510126A (en) | 1999-09-28 | 2003-03-18 | ノヴァシス メディカル インコーポレイテッド | Tissue treatment by application of energy and drugs |
US6711444B2 (en) | 1999-11-22 | 2004-03-23 | Scimed Life Systems, Inc. | Methods of deploying helical diagnostic and therapeutic element supporting structures within the body |
US6542781B1 (en) | 1999-11-22 | 2003-04-01 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements in contact with body tissue |
US6447443B1 (en) | 2001-01-13 | 2002-09-10 | Medtronic, Inc. | Method for organ positioning and stabilization |
US7706882B2 (en) | 2000-01-19 | 2010-04-27 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area |
US6623453B1 (en) | 2000-01-19 | 2003-09-23 | Vanny Corporation | Chemo-thermo applicator for cancer treatment |
US6885888B2 (en) | 2000-01-20 | 2005-04-26 | The Cleveland Clinic Foundation | Electrical stimulation of the sympathetic nerve chain |
US6514226B1 (en) | 2000-02-10 | 2003-02-04 | Chf Solutions, Inc. | Method and apparatus for treatment of congestive heart failure by improving perfusion of the kidney |
US6770070B1 (en) | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
US6558382B2 (en) | 2000-04-27 | 2003-05-06 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
EP1278471B1 (en) | 2000-04-27 | 2005-06-15 | Medtronic, Inc. | Vibration sensitive ablation apparatus |
ATE290827T1 (en) | 2000-06-13 | 2005-04-15 | Atrionix Inc | SURGICAL ABLATION PROBE FOR FORMING AN ANNUAL LESION |
US6477426B1 (en) | 2000-06-20 | 2002-11-05 | Celsion Corporation | System and method for heating the prostate gland to treat and prevent the growth and spread of prostate tumors |
US7837720B2 (en) | 2000-06-20 | 2010-11-23 | Boston Scientific Corporation | Apparatus for treatment of tissue adjacent a bodily conduit with a gene or drug-coated compression balloon |
JP4099388B2 (en) | 2000-07-13 | 2008-06-11 | プロリズム,インコーポレイテッド | A device for applying energy to the body of a living organism |
JP2004508074A (en) | 2000-08-24 | 2004-03-18 | ボルケーノ セラピューティックス, インコーポレイテッド | Thermographic catheter with flexible circuit temperature sensor |
US6850801B2 (en) | 2001-09-26 | 2005-02-01 | Cvrx, Inc. | Mapping methods for cardiovascular reflex control devices |
US6522926B1 (en) | 2000-09-27 | 2003-02-18 | Cvrx, Inc. | Devices and methods for cardiovascular reflex control |
US6985774B2 (en) | 2000-09-27 | 2006-01-10 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
US6845267B2 (en) | 2000-09-28 | 2005-01-18 | Advanced Bionics Corporation | Systems and methods for modulation of circulatory perfusion by electrical and/or drug stimulation |
US7306591B2 (en) | 2000-10-02 | 2007-12-11 | Novasys Medical, Inc. | Apparatus and methods for treating female urinary incontinence |
US7104987B2 (en) | 2000-10-17 | 2006-09-12 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
US6616624B1 (en) | 2000-10-30 | 2003-09-09 | Cvrx, Inc. | Systems and method for controlling renovascular perfusion |
US6623452B2 (en) | 2000-12-19 | 2003-09-23 | Scimed Life Systems, Inc. | Drug delivery catheter having a highly compliant balloon with infusion holes |
US6544223B1 (en) | 2001-01-05 | 2003-04-08 | Advanced Cardiovascular Systems, Inc. | Balloon catheter for delivering therapeutic agents |
EP1363700A4 (en) | 2001-01-11 | 2005-11-09 | Rita Medical Systems Inc | Bone-treatment instrument and method |
DE10103503A1 (en) | 2001-01-26 | 2002-08-14 | Fraunhofer Ges Forschung | Endoluminal expandable implant with integrated sensors |
US6623444B2 (en) | 2001-03-21 | 2003-09-23 | Advanced Medical Applications, Inc. | Ultrasonic catheter drug delivery method and device |
US6972016B2 (en) | 2001-05-01 | 2005-12-06 | Cardima, Inc. | Helically shaped electrophysiology catheter |
US7127284B2 (en) | 2001-06-11 | 2006-10-24 | Mercator Medsystems, Inc. | Electroporation microneedle and methods for its use |
US20040043030A1 (en) | 2001-07-31 | 2004-03-04 | Immunomedics, Inc. | Polymeric delivery systems |
US20030050635A1 (en) | 2001-08-22 | 2003-03-13 | Csaba Truckai | Embolization systems and techniques for treating tumors |
US7778703B2 (en) | 2001-08-31 | 2010-08-17 | Bio Control Medical (B.C.M.) Ltd. | Selective nerve fiber stimulation for treating heart conditions |
US7547294B2 (en) | 2001-09-20 | 2009-06-16 | The Regents Of The University Of California | Microfabricated surgical device for interventional procedures |
US6547803B2 (en) | 2001-09-20 | 2003-04-15 | The Regents Of The University Of California | Microfabricated surgical device for interventional procedures |
US20030082225A1 (en) | 2001-10-19 | 2003-05-01 | Mason Paul Arthur | Sterile, breathable patch for treating wound pain |
US6849075B2 (en) | 2001-12-04 | 2005-02-01 | Estech, Inc. | Cardiac ablation devices and methods |
US20030125790A1 (en) | 2001-12-27 | 2003-07-03 | Vitaly Fastovsky | Deployment device, system and method for medical implantation |
US6893436B2 (en) | 2002-01-03 | 2005-05-17 | Afx, Inc. | Ablation instrument having a flexible distal portion |
US20030171734A1 (en) | 2002-01-22 | 2003-09-11 | Endobionics, Inc. | Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia |
US7744584B2 (en) | 2002-01-22 | 2010-06-29 | Mercator Medsystems, Inc. | Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation |
US20060189941A1 (en) | 2002-01-22 | 2006-08-24 | Mercator Medsystems, Inc. | Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation |
US8133501B2 (en) | 2002-02-08 | 2012-03-13 | Boston Scientific Scimed, Inc. | Implantable or insertable medical devices for controlled drug delivery |
US20070078620A1 (en) | 2002-02-13 | 2007-04-05 | Mercator Medsystems Inc. | Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia |
US6736835B2 (en) | 2002-03-21 | 2004-05-18 | Depuy Acromed, Inc. | Early intervention spinal treatment methods and devices for use therein |
EP1487535B1 (en) | 2002-03-27 | 2012-06-20 | CVRX, Inc. | Electrode structures for use in cardiovascular reflex control |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US8145316B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US8175711B2 (en) | 2002-04-08 | 2012-05-08 | Ardian, Inc. | Methods for treating a condition or disease associated with cardio-renal function |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US7620451B2 (en) | 2005-12-29 | 2009-11-17 | Ardian, Inc. | Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach |
US8145317B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods for renal neuromodulation |
US7162303B2 (en) | 2002-04-08 | 2007-01-09 | Ardian, Inc. | Renal nerve stimulation method and apparatus for treatment of patients |
US8131371B2 (en) | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US20080213331A1 (en) | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US6978174B2 (en) | 2002-04-08 | 2005-12-20 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US7141041B2 (en) | 2003-03-19 | 2006-11-28 | Mercator Medsystems, Inc. | Catheters having laterally deployable needles |
US7070606B2 (en) | 2002-05-28 | 2006-07-04 | Mercator Medsystems, Inc. | Methods and apparatus for aspiration and priming of inflatable structures in catheters |
JP2004016333A (en) | 2002-06-13 | 2004-01-22 | Unique Medical Co Ltd | Catheter for extradural anesthesia, and electrostimulator using the catheter for extradural anesthesia |
US7465298B2 (en) | 2002-06-28 | 2008-12-16 | Mercator Medsystems, Inc. | Methods and systems for delivering liquid substances to tissues surrounding body lumens |
US6893414B2 (en) | 2002-08-12 | 2005-05-17 | Breg, Inc. | Integrated infusion and aspiration system and method |
US6991617B2 (en) | 2002-08-21 | 2006-01-31 | Hektner Thomas R | Vascular treatment method and device |
US7063679B2 (en) | 2002-09-20 | 2006-06-20 | Flowmedica, Inc. | Intra-aortic renal delivery catheter |
EP1585572A4 (en) | 2002-09-20 | 2010-02-24 | Flowmedica Inc | Method and apparatus for intra aortic substance delivery to a branch vessel |
US20040146546A1 (en) | 2002-09-26 | 2004-07-29 | Angiotech Pharmaceuticals, Inc. | Perivascular wraps |
US7282213B2 (en) | 2002-09-30 | 2007-10-16 | Medtronic, Inc. | Method for applying a drug coating to a medical device |
AU2003279842A1 (en) | 2002-10-04 | 2004-05-04 | Microchips, Inc. | Medical device for controlled drug delivery and cardiac monitoring and/or stimulation |
US7599730B2 (en) | 2002-11-19 | 2009-10-06 | Medtronic Navigation, Inc. | Navigation system for cardiac therapies |
US20040106952A1 (en) | 2002-12-03 | 2004-06-03 | Lafontaine Daniel M. | Treating arrhythmias by altering properties of tissue |
JP2006517827A (en) | 2003-01-29 | 2006-08-03 | イー−ピル・ファーマ・リミテッド | Delivery of active drugs in the gastrointestinal tract |
US6923808B2 (en) | 2003-02-24 | 2005-08-02 | Boston Scientific Scimed, Inc. | Probes having helical and loop shaped inflatable therapeutic elements |
WO2004078066A2 (en) | 2003-03-03 | 2004-09-16 | Sinus Rhythm Technologies, Inc. | Primary examiner |
US20040213770A1 (en) | 2003-04-22 | 2004-10-28 | Endobionics, Inc. | Methods and systems for treating ischemic cardiac and other tissues |
US7221979B2 (en) | 2003-04-30 | 2007-05-22 | Medtronic, Inc. | Methods and apparatus for the regulation of hormone release |
JP4212949B2 (en) | 2003-05-06 | 2009-01-21 | 朝日インテック株式会社 | Chemical injection device |
JP2004337400A (en) | 2003-05-16 | 2004-12-02 | Terumo Corp | Medication kit |
JP4616252B2 (en) | 2003-06-04 | 2011-01-19 | シネコー・エルエルシー | Intravascular electrophysiology system and method |
US7149574B2 (en) | 2003-06-09 | 2006-12-12 | Palo Alto Investors | Treatment of conditions through electrical modulation of the autonomic nervous system |
DE202004021942U1 (en) | 2003-09-12 | 2013-05-13 | Vessix Vascular, Inc. | Selectable eccentric remodeling and / or ablation of atherosclerotic material |
US7435248B2 (en) | 2003-09-26 | 2008-10-14 | Boston Scientific Scimed, Inc. | Medical probes for creating and diagnosing circumferential lesions within or around the ostium of a vessel |
US7416549B2 (en) | 2003-10-10 | 2008-08-26 | Boston Scientific Scimed, Inc. | Multi-zone bipolar ablation probe assembly |
AU2004289362A1 (en) | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Intravascular devices and fibrosis-inducing agents |
WO2005046746A2 (en) | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
US7273469B1 (en) | 2003-12-31 | 2007-09-25 | Advanced Cardiovascular Systems, Inc. | Modified needle catheter for directional orientation delivery |
US20050182479A1 (en) | 2004-02-13 | 2005-08-18 | Craig Bonsignore | Connector members for stents |
US20050228286A1 (en) | 2004-04-07 | 2005-10-13 | Messerly Jeffrey D | Medical system having a rotatable ultrasound source and a piercing tip |
US20060018949A1 (en) | 2004-04-07 | 2006-01-26 | Bausch & Lomb Incorporated | Injectable biodegradable drug delivery system |
US8412348B2 (en) | 2004-05-06 | 2013-04-02 | Boston Scientific Neuromodulation Corporation | Intravascular self-anchoring integrated tubular electrode body |
US20050267556A1 (en) | 2004-05-28 | 2005-12-01 | Allan Shuros | Drug eluting implants to prevent cardiac apoptosis |
US7640046B2 (en) | 2004-06-18 | 2009-12-29 | Cardiac Pacemakers, Inc. | Methods and apparatuses for localizing myocardial infarction during catheterization |
US7197354B2 (en) | 2004-06-21 | 2007-03-27 | Mediguide Ltd. | System for determining the position and orientation of a catheter |
CA2575458C (en) | 2004-07-28 | 2015-06-02 | Ardian, Inc. | Methods and devices for renal nerve blocking |
EP1796568A1 (en) | 2004-09-09 | 2007-06-20 | Vnus Medical Technologies, Inc. | Methods and apparatus for treatment of hollow anatomical structures |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US7524318B2 (en) | 2004-10-28 | 2009-04-28 | Boston Scientific Scimed, Inc. | Ablation probe with flared electrodes |
WO2006055845A1 (en) | 2004-11-15 | 2006-05-26 | Cytyc Corporation | System for drug delivery |
WO2006054299A2 (en) | 2004-11-18 | 2006-05-26 | Transpharma Medical Ltd. | Combined micro-channel generation and iontophoresis for transdermal delivery of pharmaceutical agents |
EP2327429B1 (en) | 2005-03-23 | 2014-09-17 | Abbott Laboratories | Delivery of highly lipophilic agents via medical devices |
WO2006127096A2 (en) | 2005-05-20 | 2006-11-30 | Omeros Corporation | Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures |
WO2007002304A2 (en) | 2005-06-22 | 2007-01-04 | Vnus Medical Technologies, Inc. | Methods and apparatus for introducing tumescent fluid to body tissue |
US7390894B2 (en) | 2005-07-07 | 2008-06-24 | Mayo Foundation For Medical Education And Research | Glutathione S-transferase sequence variants |
AU2006268238A1 (en) | 2005-07-11 | 2007-01-18 | Medtronic Ablation Frontiers Llc | Low power tissue ablation system |
CN101305052B (en) | 2005-09-09 | 2012-10-10 | 渥太华健康研究所 | Interpenetrating networks, and related methods and compositions |
US8140170B2 (en) | 2005-09-12 | 2012-03-20 | The Cleveland Clinic Foundation | Method and apparatus for renal neuromodulation |
US20070299043A1 (en) | 2005-10-03 | 2007-12-27 | Hunter William L | Anti-scarring drug combinations and use thereof |
US20070208134A1 (en) | 2005-10-03 | 2007-09-06 | Hunter William L | Anti-scarring drug combinations and use thereof |
US8257338B2 (en) | 2006-10-27 | 2012-09-04 | Artenga, Inc. | Medical microbubble generation |
EP1782852A1 (en) | 2005-11-04 | 2007-05-09 | F.Hoffmann-La Roche Ag | Device for automatic delivery of a liquid medicament into the body of a patient |
US20080045890A1 (en) | 2005-12-16 | 2008-02-21 | Mercator Medsystems, Inc. | Methods and systems for ablating tissue |
EP2529761B1 (en) | 2006-01-31 | 2017-06-14 | Nanocopoeia, Inc. | Nanoparticle coating of surfaces |
US8585753B2 (en) | 2006-03-04 | 2013-11-19 | John James Scanlon | Fibrillated biodegradable prosthesis |
US20070219576A1 (en) | 2006-03-16 | 2007-09-20 | Medtronic Vascular, Inc. | Reversibly and Radially Expandable Electroactive Polymer Element for Temporary Occlusion of a Vessel |
US20080004596A1 (en) | 2006-05-25 | 2008-01-03 | Palo Alto Institute | Delivery of agents by microneedle catheter |
US20080039746A1 (en) | 2006-05-25 | 2008-02-14 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US20090221955A1 (en) | 2006-08-08 | 2009-09-03 | Bacoustics, Llc | Ablative ultrasonic-cryogenic methods |
US20080039727A1 (en) | 2006-08-08 | 2008-02-14 | Eilaz Babaev | Ablative Cardiac Catheter System |
AU2007296573B2 (en) | 2006-09-11 | 2013-01-17 | Enbio Limited | Method of doping surfaces |
US7691080B2 (en) | 2006-09-21 | 2010-04-06 | Mercator Medsystems, Inc. | Dual modulus balloon for interventional procedures |
US8641660B2 (en) | 2006-10-04 | 2014-02-04 | P Tech, Llc | Methods and devices for controlling biologic microenvironments |
AU2007310988B2 (en) | 2006-10-18 | 2013-08-15 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US8388680B2 (en) | 2006-10-18 | 2013-03-05 | Guided Delivery Systems, Inc. | Methods and devices for catheter advancement and delivery of substances therethrough |
US8226648B2 (en) | 2007-12-31 | 2012-07-24 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Pressure-sensitive flexible polymer bipolar electrode |
US20080208162A1 (en) | 2007-02-26 | 2008-08-28 | Joshi Ashok V | Device and Method For Thermophoretic Fluid Delivery |
JP2010523595A (en) | 2007-04-04 | 2010-07-15 | マサチューセッツ インスティテュート オブ テクノロジー | Poly (amino acid) targeting part |
US9259233B2 (en) | 2007-04-06 | 2016-02-16 | Hologic, Inc. | Method and device for distending a gynecological cavity |
US8263104B2 (en) | 2007-06-08 | 2012-09-11 | Northwestern University | Polymer nanofilm coatings |
US8630704B2 (en) | 2007-06-25 | 2014-01-14 | Cardiac Pacemakers, Inc. | Neural stimulation with respiratory rhythm management |
US8613721B2 (en) | 2007-11-14 | 2013-12-24 | Medrad, Inc. | Delivery and administration of compositions using interventional catheters |
US20090287120A1 (en) | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US20100069837A1 (en) | 2008-09-16 | 2010-03-18 | Boston Scientific Scimed, Inc. | Balloon Assembly and Method for Therapeutic Agent Delivery |
WO2010042653A1 (en) | 2008-10-07 | 2010-04-15 | Mc10, Inc. | Catheter balloon having stretchable integrated circuitry and sensor array |
US20100249702A1 (en) | 2009-03-24 | 2010-09-30 | Abbott Cardiovascular Systems Inc. | Porous catheter balloon and method of making same |
NZ619320A (en) | 2009-04-22 | 2015-08-28 | Mercator Medsystems Inc | Use of guanethidine for treating hypertension by local vascular delivery |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
US20110137155A1 (en) | 2009-12-09 | 2011-06-09 | Boston Scientific Scimed, Inc. | Delivery device for localized delivery of a therapeutic agent |
WO2011094367A1 (en) | 2010-01-26 | 2011-08-04 | Evans Michael A | Methods, devices, and agents for denervation |
WO2013169741A1 (en) | 2012-05-08 | 2013-11-14 | Stein Emily A | Agents and devices for affecting nerve function |
CN102917748B (en) | 2010-03-24 | 2015-04-01 | 施菲姆德控股有限责任公司 | Intravascular tissue disruption |
EP2560703A2 (en) | 2010-04-20 | 2013-02-27 | MiniPumps, LLC | Electrolytically driven drug pump devices |
JP5877162B2 (en) | 2010-12-21 | 2016-03-02 | テルモ株式会社 | Balloon catheter and energization system |
BR112013021126A2 (en) | 2011-02-18 | 2019-09-24 | Medivation Technologies Inc | method for reducing blood pressure, method for increasing renal blood flow or decreasing sodium reabsorption, method for treating a disease, kit, compound and pharmaceutical composition |
CA2832311A1 (en) | 2011-04-08 | 2012-11-29 | Covidien Lp | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
US9237925B2 (en) | 2011-04-22 | 2016-01-19 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US8663190B2 (en) | 2011-04-22 | 2014-03-04 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
CN103648521A (en) | 2011-04-28 | 2014-03-19 | 阿布拉科斯生物科学有限公司 | Intravascular delivery of nanoparticle compositions and uses thereof |
US20130053792A1 (en) | 2011-08-24 | 2013-02-28 | Ablative Solutions, Inc. | Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation |
US20130274673A1 (en) | 2011-08-24 | 2013-10-17 | Ablative Solutions, Inc. | Intravascular ablation catheter with enhanced fluoroscopic visibility |
US9056185B2 (en) | 2011-08-24 | 2015-06-16 | Ablative Solutions, Inc. | Expandable catheter system for fluid injection into and deep to the wall of a blood vessel |
US9278196B2 (en) | 2011-08-24 | 2016-03-08 | Ablative Solutions, Inc. | Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation |
US20130274674A1 (en) | 2011-08-24 | 2013-10-17 | Ablative Solutions, Inc. | Intravascular ablation catheter with precision depth of penetration calibration |
EP2768568B1 (en) | 2011-10-18 | 2020-05-06 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
AU2012325801B2 (en) | 2011-10-19 | 2016-05-12 | Mercator Medsystems, Inc. | Localized modulation of tissues and cells to enhance therapeutic effects including renal denervation |
JP2014532654A (en) | 2011-10-26 | 2014-12-08 | シュタイン, エミリー, エイ.STEIN, Emily, A. | Agents, methods, and devices that affect neural function |
CN107468330B (en) | 2012-01-26 | 2021-06-22 | 奥托诺米克斯医药有限公司 | Controlled sympathectomy and micro-ablation systems and methods |
US8562573B1 (en) | 2012-06-05 | 2013-10-22 | Fischell Innovations, Llc | Guiding catheter for accessing the renal arteries |
US20150151077A1 (en) | 2012-06-13 | 2015-06-04 | Douglas C. Harrington | Devices And Methods For Renal Denervation |
US20150315188A1 (en) | 2012-08-22 | 2015-11-05 | Medivation Technologies, Inc. | Compounds and methods for treatment of hypertension |
US9526827B2 (en) | 2012-10-29 | 2016-12-27 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US8740849B1 (en) | 2012-10-29 | 2014-06-03 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US9301795B2 (en) | 2012-10-29 | 2016-04-05 | Ablative Solutions, Inc. | Transvascular catheter for extravascular delivery |
WO2014070820A2 (en) | 2012-11-02 | 2014-05-08 | Lixiao Wang | Chemical ablation formulations and methods of treatments for various diseases |
CA2889674C (en) | 2012-11-05 | 2023-02-28 | Autonomix Medical, Inc. | Systems, methods, and devices for monitoring and treatment of tissues within and/or through a lumen wall |
WO2014078301A1 (en) | 2012-11-13 | 2014-05-22 | Silk Road Medical, Inc. | Devices and methods for endoluminal delivery of either fluid or energy for denervation |
US20140271717A1 (en) | 2013-03-14 | 2014-09-18 | Kyphon Sarl | Devices containing a chemical denervation agent and methods for treating chronic back pain using chemical denervation |
US9108030B2 (en) | 2013-03-14 | 2015-08-18 | Covidien Lp | Fluid delivery catheter with pressure-actuating needle deployment and retraction |
AU2014268737A1 (en) | 2013-05-20 | 2015-12-03 | Mayo Foundation For Medical Education And Research | Devices and methods for ablation of tissue |
-
1997
- 1997-04-11 US US08/837,294 patent/US6302875B1/en not_active Expired - Lifetime
-
1998
- 1998-04-10 AU AU73581/98A patent/AU749373B2/en not_active Ceased
- 1998-04-10 AT AT98920833T patent/ATE370699T1/en not_active IP Right Cessation
- 1998-04-10 ES ES98920833T patent/ES2293679T3/en not_active Expired - Lifetime
- 1998-04-10 WO PCT/US1998/007134 patent/WO1998046119A1/en active IP Right Grant
- 1998-04-10 DE DE69838287T patent/DE69838287T2/en not_active Expired - Lifetime
- 1998-04-10 EP EP98920833A patent/EP0964636B1/en not_active Expired - Lifetime
- 1998-04-10 EP EP07005781A patent/EP1820436B1/en not_active Expired - Lifetime
- 1998-04-10 CA CA002285001A patent/CA2285001A1/en not_active Abandoned
- 1998-04-10 IL IL13219798A patent/IL132197A0/en unknown
- 1998-04-10 DE DE69842030T patent/DE69842030D1/en not_active Expired - Lifetime
- 1998-04-10 JP JP54405998A patent/JP4019112B2/en not_active Expired - Lifetime
- 1998-04-10 AT AT07005781T patent/ATE489888T1/en not_active IP Right Cessation
-
2001
- 2001-07-24 US US09/912,122 patent/US7648517B2/en not_active Expired - Fee Related
-
2009
- 2009-12-10 US US12/634,850 patent/US8753366B2/en not_active Expired - Fee Related
-
2014
- 2014-03-06 US US14/199,901 patent/US9713483B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE370699T1 (en) | 2007-09-15 |
US8753366B2 (en) | 2014-06-17 |
US9713483B2 (en) | 2017-07-25 |
DE69838287D1 (en) | 2007-10-04 |
AU7358198A (en) | 1998-11-11 |
ES2293679T3 (en) | 2008-03-16 |
US20100094259A1 (en) | 2010-04-15 |
WO1998046119A1 (en) | 1998-10-22 |
JP2002514111A (en) | 2002-05-14 |
JP4019112B2 (en) | 2007-12-12 |
EP1820436A3 (en) | 2007-11-14 |
AU749373B2 (en) | 2002-06-27 |
US7648517B2 (en) | 2010-01-19 |
US20010047165A1 (en) | 2001-11-29 |
EP1820436B1 (en) | 2010-12-01 |
US6302875B1 (en) | 2001-10-16 |
US20140236207A1 (en) | 2014-08-21 |
IL132197A0 (en) | 2001-03-19 |
ATE489888T1 (en) | 2010-12-15 |
EP0964636A4 (en) | 2004-07-21 |
DE69838287T2 (en) | 2008-07-03 |
EP0964636B1 (en) | 2007-08-22 |
EP1820436A2 (en) | 2007-08-22 |
EP0964636A1 (en) | 1999-12-22 |
DE69842030D1 (en) | 2011-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2285001A1 (en) | Catheters and related devices for forming passageways between blood vessels or other anatomical structures | |
JP4448614B2 (en) | Tissue penetrating catheter system with built-in image transducer | |
US7637870B2 (en) | Tissue penetrating catheters having integral imaging transducers and their methods of use | |
US5389096A (en) | System and method for percutaneous myocardial revascularization | |
US5906579A (en) | Through-wall catheter steering and positioning | |
US6508824B1 (en) | Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels | |
US6726677B1 (en) | Stabilized tissue penetrating catheters | |
US7641634B2 (en) | Contact and penetration depth sensor for a needle assembly | |
US5885272A (en) | System and method for percutaneous myocardial revascularization | |
WO2008063935A2 (en) | Devices for creating passages and sensing for blood vessels | |
JP2021516131A (en) | Catheter and recanalization catheter system | |
MXPA99009274A (en) | Catheters and related devices for forming passageways between blood vessels or other anatomical structures | |
MXPA00009497A (en) | Tissue penetrating cathethers having integral imaging transducers and their methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |